<PAGE>
================================================================================
U.S. SECURITIES EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 10-KSB
(Mark One)
[X] ANNUAL REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended December 31,1999
[ ] TRANSITION REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ________________to ________________
Commission file number: 0-24640
COMMUNITY MEDICAL TRANSPORT, INC.
---------------------------------
(Exact name of small business issuer in its charter)
Delaware 13-3507464
-------- ----------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
4 Gannett Drive, White Plains, New York 10604
-------------------------------------------------
(Address of principal executive offices) (Zip Code)
Issuer's telephone number (914) 697-9233
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.001 par value
-----------------------------
(Title of Class)
Redeemable Warrants expiring on September 29, 1999
--------------------------------------------------
(Title of Class)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12
months (or for such shorter period that the issuer was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. Yes__X__ No._____
Check if there is no disclosure of delinquent filers in response to
Item 405 of Regulation S-B contained herein, and no disclosure will be
contained, to the best of issuer's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-KSB or any
amendment to this Form 10-KSB. [ ]
Issuer's revenues for the year ended December 31, 1999 are $[ ]
The aggregate market value of the voting and non-voting common stock
held by nonaffiliates of the issuer is $[ ] (as of March 30, 2000).
The number of shares outstanding of the issuer's common stock is
[ ] (as of March 30, 2000).
DOCUMENTS INCORPORATED BY REFERENCE
================================================================================
<PAGE>
PART I
Item 1. Description of Business
Introduction
Community Medical Transport, Inc. (the "Company"), through its
subsidiaries, provides medical transportation and other specialized
transportation services in the New York-New Jersey metropolitan area. These
services include specialized transportation for the handicapped, disabled,
mentally retarded, elderly and chronically ill to and from day treatment
centers, day care programs, hospitals, nursing homes, dialysis centers, and
other health care facilities. This service is provided in ambulettes -
specialized vans that contain ramps and other equipment designed to secure and
safely transport wheelchair bound passengers. These services also include
emergency and non-emergency ambulance transportation services, including limited
"911" emergency service, for patients who require basic medical care or
supervision during transport to and from hospitals, nursing homes and other
health care facilities.
During the 1990's as overall demand for ambulance and ambulette
services is increasing, contracting parties and regulatory authorities are
imposing more stringent requirements in terms of quality of care and cost of
service. Ambulance and ambulette service providers are facing increasing demand
to deploy vehicles and provide more highly trained personnel cost effectively
and otherwise operate more cost-efficiently. These requirements and their
associated costs produces consolidation opportunities. The Company formed to
participate in the consolidation process but recent losses in part resulting
from new regulatory and reimbursement policies, and other adverse trends forced
the Company to abandon its efforts to make acquisitions.
The principal executive offices of the Company are located at 4 Gannett
Drive, White Plains, New York 10604 and its telephone number is (914) 697-9233.
Unless the context otherwise requires, references to the "Company"
contained in this Annual Report include the subsidiaries of the Company.
Share information herein retroactively reflects a one for six reverse
stock split of the Company's common stock effected in November 1998.
Recent Developments
In February 1999 the Company entered into a new financing arrangement
with Finova Capital Corporation. The Company obtained a term loan of $3,950,000,
a revolving credit line of $4,000,000 and availability of $1,000,000 for future
equipment acquisitions. The prior loan was satisfied with the proceeds of the
Finova loan.
Ambulette Services
The Company provides specialized transportation for the handicapped,
disabled, mentally retarded, elderly and chronically ill to and from day
treatment centers, day care programs, hospitals, nursing homes, dialysis
centers, and other health care facilities in the New York-New Jersey
metropolitan area. This service is provided in ambulettes, which are specialized
vans that contain ramps and other equipment designed to secure and safely
transport wheelchair bound passengers as well as ambulatory passengers. The
Company provides two principal types of ambulette services to its customers:
"pre-scheduled" and "scheduled daily in advance."
<PAGE>
The "pre-scheduled" services, which accounted for over 29% of the
Company's revenues during 1997 and approximately 26% of the Company's revenues
during 1998, are provided to customers both with and without contracts. Under
this service, the customer or provider typically retains the Company to provide
regularly scheduled transportation services for patients who attend the
provider's facilities on a daily or other regularly scheduled basis.
Transportation is generally between the patient's residence and the customer's
health care facility and is provided five days a week except for long term care
and other specialized situations in which service is provided seven days a week.
Users of such services include; health care facilities such as dialysis centers,
adult day centers that service the elderly, day treatment programs that service
individuals with mental retardation and, in certain cases, other developmental
disabilities and comprehensive health care facilities, which serve as a
long-term "day care" alternative to nursing homes.
The "scheduled daily in advance" services are provided to nursing homes
and other health care facilities on an "as-needed basis" pursuant to direct
calls from the customer. Transportation for this service is generally between
residences or nursing homes and hospitals or other health care facilities and is
generally requested by the customer not more than one day in advance.
The Company has entered into an agreement with Union County, New Jersey
in connection with para-transit services (including medical and non-medical
transportation) provided by the county. Drivers required by the county are
provided by the Company pursuant to this agreement. Commencing January 1, 1998,
these services were expanded pursuant to a separate agreement to include
dispatching of the vehicles.
The Company has been notified that its contract with Union County has
not been renewed. The Company has been notified that its low bid on the renewal
of the contract has been challenged by the Bronx County. The Company is
currently subject to a legal proceeding involving the bid.
Ambulance Services
The Company, through its subsidiaries, provides general ambulance
services to patients requiring various levels of medical supervision during
transfer to and from residences and health care facilities. The Company's
ambulance business commenced in February 1994 and was significantly augmented as
a result of acquisitions and marketing efforts.
Ambulance operations generated approximately 49% and 45% of the
Company's total revenues during the years ended December 31, 1997 and 1998,
respectively. Presently, the Company's ambulance services are provided in New
York City, particularly Manhattan and the Bronx, as well as the Hudson Valley
and Westchester area of the New York-New Jersey Metropolitan area. The Company
initiated limited ambulance services in northern New Jersey in 1996 and
significantly expanded such services in 1997. While limited to basic life
support ("BLS") services under New Jersey regulation, the Company expanded the
northern New Jersey operations to a 24 hour, 7 days per week basis in early
1998.
The Company is licensed to provide ambulance services in New York City,
Westchester, Rockland, Orange, Putnam, Dutchess, Ulster, Greene, northern New
Jersey and other counties in southeastern New York State. The Company's
ambulances provide both BLS services and advanced life support services ("ALS").
BLS service is utilized by patients requiring a basic level of medical care
during transport. BLS services may include basic airway management, hemorrhage
control and stabilization of fractures. ALS service requires advanced life
support systems such as cardiac monitoring, defibrillators, oxygen delivery and
advanced clinical care.
<PAGE>
The Company currently provides only limited "911" emergency services
because such services are provided by municipal authorities in the geographic
areas in which the Company operates. The Company provides exclusive 911 services
to two townships in Rockland County and on a non-exclusive basis in Ulster
County.
Ambulance units are staffed by two EMTs and are equipped with medical
supplies, oxygen delivery systems, and equipment necessary to administer first
aid and other medical treatment. ALS ambulance units, staffed by crews of
specially certified EMTs (paramedics), are equipped with advanced life support
equipment, such as cardiac monitors, defibrillators, specialty pharmaceuticals
and medical supplies. The Company's ambulance services are typically provided
pursuant to arrangements with health care facilities and are either scheduled in
advance or provided on an as-needed basis.
Marketing and Sales
The general managers of each of the Company's sites are responsible for
each site's marketing efforts. The Company's marketing department was removed as
part of the Company's cost-cutting efforts.
The Company markets its ambulette services principally to day treatment
centers and day care programs which provide programs for the handicapped,
disabled and elderly, as well as other health care facilities that require a
stable and reliable source of medical transportation for its patients. The
Company provides its ambulance services to several major hospitals and nursing
homes in New York City, Rockland, Ulster and Westchester counties. As part of
its marketing strategy, the Company has developed more than two dozen managed
care provider contracts and is seeking to enter into arrangements to become a
single source transportation provider for medical institutions.
Personnel Training and Quality Assurance
As of December 31, 1998, the Company employed 130 EMTs and 62
paramedics. In general, EMTs furnish basic and emergency treatment while
transporting patients in ambulances. EMTs must be state certified to perform
basic and emergency care services. Certification as an EMT in the geographic
area in which the Company provides services requires completion of a training
program designed by the state. Paramedics providing ALS are required to complete
advanced training courses and obtain New York state and regional certifications
for more advanced emergency care services. The Company carefully screens all job
applicants and is committed to providing consistently high quality transport and
other services. All of the Company's ambulette drivers are subject to state
regulation. They must have a commercial driver's license with a designation to
transport passengers. Additionally, the Company verifies the driving record of
each new driver.
Billing and Collection
The Company derives a substantial majority of its revenue from
reimbursement by third-party payors, particularly Medicaid and Medicare,
typically invoicing and collecting payments directly from the third party payor.
During the fiscal years ended December 31, 1997 and 1998, the Company derived
approximately 44% and 39%, respectively, of its net revenues from Medicaid and
Medicare; 9% and 11%, respectively, of its net revenues pursuant to contracts
with Beth Abraham Hospital (the Company's only fixed-cost provider); and 47% and
50%, respectively, of its net revenues from private insurers and other
non-governmental sources.
The Company has only two contracts with municipalities or health care
facilities which require the Company to provide services without regard to a
patient's insurance coverage or ability to pay. Such requirements are generally
imposed on ambulance services which provide "911" or other emergency services on
an exclusive basis. The Company provides 911 services to two towns in Rockland
County. Overall, the Company believes that on an ongoing basis, uncompensated
trips will not be significant. See "Description of Business - Recent
Developments."
<PAGE>
The Company has developed an expertise in processing claims to
third-party payors. The Company uses specialized software systems to
specifically tailor and electronically submit most claims to Medicaid, Medicare
and certain other third-party payors. The Company believes that its expertise in
processing third-party claims reduces the collection time on its receivables and
results in fewer rejected claims based on incomplete or inaccurate information.
See "Description of Business--Recent Developments" and "Management's Discussion
and Analysis of Financial Condition and Results of Operations" for information
with respect to this write down.
Principal Customers
During 1998 the majority of the Company's services are provided
pursuant to written agreements. Most of these agreements are for a one year
renewable term and designate the Company as a preferred provider. The Company
provides ambulette services to a significant customer, Beth Abraham Hospital
(and affiliates) located in Bronx County, New York, pursuant to written
contracts since 1988. Under these contracts, the Company provides ambulette
services on an exclusive basis for the hospital's comprehensive care management
center, an innovative alternative to nursing home care for many people who are
elderly and have physical disabilities. These agreements, as amended, will
expire on December 31, 1999. During the years ended December 31, 1997 and 1998,
the Company derived approximately 9% and 12%, respectively, of its revenues from
services provided on behalf of Beth Abraham Hospital and its affiliates
including amounts reimbursed by third parties. Dean Sloane, President of the
Company, serves as honorary director of Beth Abraham Hospital, without
compensation.
The Company provided para-transit transportation services to the County
of Union, New Jersey pursuant to written contracts, which have been extended
through December 31, 1999. During the years ended December 31, 1998 and 1999,
the Company derived approximately 9% and 11.4%, respectively, of its revenues
from services provided to the County of Union, New Jersey. The Company's
revenues from this source increased for the fiscal year ending 1998 since the
Company provided additional services to the County of Union, New Jersey. The
Company no longer derives revenues from the County of Union because of the
circumstances described in Ambulette Services.
The Company provides transportation services to several day treatment
centers. In some cases, the majority of the people transported live in group
homes, which are operated by either voluntary or state agencies. The Company
negotiates separate arrangements with the group homes and day treatment centers
for the transportation needs of their clients.
Competition
The ambulance and ambulette service industry is highly competitive.
Principal participants include government entities, large regional ambulance
service providers, hospitals and numerous local providers. The Company competes
with several large firms in its New York City market, including American Medical
Response (a subsidiary of Laidlaw), Transcare and Metropolitan Ambulance as well
as Mobile Life Support in the Hudson Valley region. The Company also encounters
competition, particularly with respect to ambulette services, from small
commercial providers operating in the New York - New Jersey metropolitan area.
The Company believes that health care facilities in the geographic area serviced
by the Company consider quality of care, reliability and reputation to be the
most important factors in utilizing a medical transportation provider, although
other factors such as financial stability, personnel policies and practices and
cost are also considered. In addition to present competition, other companies
that do not currently operate ambulance or ambulette services may enter the
ambulance or ambulette service business. There can be no assurance that health
care facilities that presently contract for ambulance or ambulette services will
not choose to provide ambulance or ambulette services directly in the future.
Due to difficulties in obtaining a license, persons or entities seeking
to enter the ambulance industries have typically been required to acquire an
existing entity already in possession of an ambulance license. Consequently, the
Company believes that competition has been occurring in the environment of a
substantially fixed number of ambulance licenses.
<PAGE>
The Company believes that it may encounter significant competition for
acquisitions of other medical transportation service providers, particularly as
the industry consolidates. There are many companies with greater capital and
other resources than the Company which are actively seeking to acquire ambulance
service providers. Prospective acquirers of ambulance and ambulette service
providers compete primarily on the basis of price, form of consideration,
operating synergy opportunities and management. Competition for acquisition
candidates is intensifying within the ambulance service industry as the industry
consolidates. Such competition may result in the inflation of purchase prices to
levels which exceed the Company's financial capability or otherwise inhibit its
acquisition program.
Government Regulation
The ambulance and ambulette service industry is subject to governmental
regulation at the federal, state and local levels. At the federal level, the
Company is subject to regulations under the Occupational Safety and Health Act
designed to protect employees of the Company. The federal government also
recommends standards for ambulance design and construction, medical training
curriculum, and designation of appropriate trauma facilities, which standards
may be modified by state agencies.
Various aspects of the Company's operations are subject to and
regulated by New York State law. State requirements govern the licensing or
certification of ambulance service providers, training and certification of
medical personnel, the scope of services that may be provided by medical
personnel, staffing requirements, medical control, medical procedures,
communication systems, license and qualification of drivers and vehicles and
equipment.
In addition, the operation of the Company's ambulette services are
subject to regulation by various state and local agencies. These regulations
encompass the licensing and qualification of drivers, vehicles, and equipment.
Applicable federal, state and local laws and regulations are subject to
change. The Company currently believes that it is substantially in compliance
with regulatory requirements applicable to its ambulance and ambulette service
business. These regulatory requirements, however, may require the Company in the
future to increase its capital and operating expenditures in order to maintain
current operations or initiate new operations.
Reimbursement
The Company must comply with various requirements in connection with
its participation in the Medicaid and Medicare programs. Medicaid is a combined
federal-state program for medical assistance to impoverished individuals who are
aged, blind, disabled or members of families with dependent children. The
various authorities of Medicare/Medicaid, including the New York State
Department of Social Services have the authority to set levels of reimbursement
within federal guidelines. The Company receives from its customers that are
covered by Medicaid, only the reimbursement permitted by Medicaid and is not
permitted to collect from the patient any difference between its customary
charge to such customers and the amount reimbursed. Any difference between the
Company's customary charge to its customers that are covered by Medicaid and
amounts reimbursed by Medicaid are not material to the Company's operating
results because the Company's customary charges to such customers generally do
not exceed amounts reimbursable by Medicaid.
Medicare is a federal health insurance program for the elderly and for
chronically disabled individuals, which pays for ambulance services when
medically necessary. Medicare uses a charge-based reimbursement system for
ambulance services and reimburses 80% of charges determined to be reasonable by
Medicare, subject to the limits fixed for the particular geographic area. The
patient, Medicaid or secondary insurer is responsible for paying the remaining
20%, and Medicare requires the Company to expend reasonable efforts to collect
the balance. Medicare does not reimburse the Company for amounts the Company can
not collect from the patient. In determining reasonable charges, Medicare
considers and applies the lowest of various charge factors including the actual
charge, the customary charge, the prevailing charge in the same locality, the
amount of reimbursement for comparable services or the inflation-indexed charge
limit.
<PAGE>
The Company, like other Medicaid and Medicare providers, is subject to
governmental audits of its Medicaid and Medicare reimbursement claims. To date
the Company has not experienced significant adjustments as a result of any such
audit. As a provider of services under the Medicaid and Medicare programs, the
Company is also subject to the Medicaid and Medicare fraud and abuse laws. The
laws prohibit any bribe, kickback or rebate in return for the referral of
Medicaid or Medicare patients. Violations of these prohibitions may result in
civil and criminal penalties and exclusion from participation in the Medicaid
and Medicare programs.
Pursuant to the federal/state statutory schemes for the regulation and
administration of the Medicaid program, each state has a Medicaid Fraud Control
Unit. The Company believes that it has complied with all appropriate
regulations.
Government funding for health care programs is subject to statutory and
regulatory changes, administrative rulings, interpretations of policy,
determinations by intermediaries and governmental funding restrictions, all of
which could materially increase or decrease program reimbursements for ambulance
services. In recent years, Congress has consistently attempted to curb federal
spending on such programs. Amounts under reimbursement programs are subject to
administrative interpretation and enforcement policies. Currently, several
agencies have taken restrictive positions concerning Medicaid reimbursement. It
is likely that future funding levels for Medicare and Medicaid programs will be
reduced from present levels. The current Congress and various states are
considering proposals to reduce expenditures under various reimbursement
programs. Government agencies in the areas in which the Company operates have
proposed extensive budgetary reductions and rule changes for these programs.
The Company can not predict the overall effect on it as a result of any budget
or policy cuts, but such actions could adversely affect the Company.
Moreover, the Company anticipates that Congress and state and local
legislatures will continue to review and assess alternative health care delivery
systems and cost-control measures, and public debate of these issues will likely
continue in the future. The Company cannot predict the effect any measures, if
adopted in the future, will have on the Company's business.
Insurance
The Company carries a broad range of general liability, comprehensive
property damage, worker's compensation, professional liability, automobile and
other insurance coverage that management considers adequate for the protection
of its assets and operations, although there can be no assurance that the
coverage limits of such policies will be adequate. A successful claim against
the Company in excess of its insurance coverage could have a material adverse
effect on the Company and its financial condition. Claims against the Company,
regardless of their merit or outcome, may also have an adverse effect on the
Company's reputation and business. The Company is also subject to accident
claims as a result of the normal operation of its fleet of vehicles.
Equipment As of December 31, 1999, the Company's fleet included 110
ambulettes and 39 ambulances. Except for 31 leased vehicles, the Company owns
all of its vehicles.
<PAGE>
Employees
As of December 31, 1999, the Company had a total of 383 employees of
which approximately 297 were full-time and 86 were part-time employees. Of
these, 383 employees were involved in medical transport services and [54]
management, administrative and clerical personnel. Prior to the acquisition of
A-1 Ambulance Service, Inc. ("A-1"), the Company was not a party to any
collective bargaining agreements. The drivers, EMTs and paramedics of A-1 were
subject to a collective bargaining agreement until 1997 when they voted to
decertify the union. During 1997, ambulance drivers located in Yonkers, New York
and ambulette drivers located in Yonkers, New York and Union, New Jersey voted
to be unionized. As of December 31, 1999, the Company had negotiated and signed
agreements with the unions for the ambulette drivers located in Yonkers, New
York and Union, New Jersey and was in the final phase of negotiating a formal
agreement with the union for the ambulance drivers located in Yonkers, New York.
The Company considers its relations with employees to be good.
Item 2. Description of Property
The Company leases approximately 7,600 square feet in a facility
located in White Plains, New York, utilized for the Company's executive offices
and administrative purposes (accounts receivable collection, dispatch and
related functions). The base rental expense for the facility is currently
$159,600 per year, increasing $1,896 per year each second year commencing in
2000. The lease for the facility expires in March 2005.
The Company leases a facility located in Yonkers, New York, for
dispatch and vehicle basing, garaging and maintenance. The base rental expense
for the facility is currently $120,000 per year, increasing approximately $3,600
per year each year commencing in 1998. The lease for the facility expires in
March 2002.
The Company leases a 3,500 square foot facility in located in Kingston,
New York which acts as physical plant and is partially the site for a hospital
The Company leases a small office in Union, New Jersey for the
administration, including dispatch, of its Union County para-transit contract.
In conjunction with the Elite Acquisition, the subsidiary of the
Company entered into a lease for garage and operating facilities in Orange, New
Jersey. This facility consists of garage, dispatch and office facilities. At
December 31, 1998, these facilities consist of the following: the facility in
Orange is 16,000 square feet for office space and a garage at an annual rental
of $57,000 pursuant to a lease that expires in March 1999.
<PAGE>
Item 3. Legal Proceedings
In April 1997, a former employee of a subsidiary of the Company
commenced an action against the Company and the subsidiary entitled Allen Bemus
v. Community Medical Transport, Inc. and Empire Ambulance and Ambulette, Inc.,
in the Superior Court of Connecticut (the "Bemus Action"). The Bemus Action
alleges breach of an employment agreement and a covenant not to compete, a
breach of the covenant of good faith and fair dealing in connection with the
aforesaid agreements, defamation, lost wages and negligent infliction of
emotional distress. The Bemus Action seeks damages of approximately $250,000,
plus punitive damages. The Company believes that it has valid and meritorious
defenses to the Bemus Action, as well as offsets against the claims asserted in
the complaint, and has prepared an appropriate answer. The trial, without a jury
has been completed but a decision has not been rendered.
A second action was filed against the Company and the subsidiary by two
former officers and shareholders of A-1 Ambulance Service ("A-1 Ambulance"). In
June 1996, the Company had acquired from A-1 Ambulance certain assets pursuant
to an asset purchase agreement dated December 29, 1995. That action, entitled
A-1 Ambulance Service, Inc., David J. Warburg and Helen H. Hendrie v. Community
Medical Transport, Inc. and Empire Ambulance and Ambulette, Inc. (the "Warburg
Action"), was filed on June 25, 1997 in the Supreme Court of the State of New
York, County of Westchester and was served upon the Company on July 10, 1997.
The Warburg Action alleges breach of the employment agreements entered into
between the Company and the former shareholders of A-1 Ambulance and seeks
damages, in the aggregate, of approximately $325,000. On September 8, 1997, the
Company served a motion to stay the action and to compel arbitration since the
written agreements upon which the claims in the Warburg Action are based provide
that disputes under those agreements are subject to arbitration. On October 22,
1997, the Company's motion was granted and the Company was awarded statutory
motion costs. As of this date, the plaintiffs in the Warburg Action have not
commenced arbitration. In the event that plaintiffs do commence an arbitration,
the Company believes that it has valid and meritorious defenses to the Warburg
Action, as well as offsets against the claims asserted in the complaint, and it
will continue to vigorously oppose that action.
In February 1998, the Company filed an action against a provider of day
treatment and/or day rehabilitation services for which the Company previously
had provided ambulette and transportation services pursuant to a transportation
agreement. That action, entitled Community Medical Transport, Inc. v.
Professional Service Centers For The Handicapped, Inc. (the "CMTI Action"), was
filed on February 4, 1998 in Supreme Court of the State of New York, County of
Westchester. The CMTI Action alleges breach of contract by Professional Service
Centers For The Handicapped, Inc. ("PSCH") as a result of its failure and
refusal to pay the Company an outstanding balance of $187,422 for the Company's
services and quantum meruit based upon the reasonable value of those services.
PSCH served an answer which contains one counterclaim for unspecified damages
based upon the PSCH's claim that the Company breached the transportation
agreement. The answer which was served was defective. PSCH's counsel was
promptly notified of the deficiency and requested it to serve a properly signed
pleading. The Company intends to vigorously prosecute this action and oppose the
counterclaim.
In an action entitled Medical Transportation Corp. v. Community Medical
Transport, Inc., and Community Ambulette Service, Inc., Medical Transportation
Corp. ("Med-Trans") alleges that during the 12 month period commencing December
1, 1996 and ending November 30, 1997, the Company willfully, voluntarily and
deliberately terminated relationships with numerous customers and unilaterally
ceased to provide services to said customers. Med-Trans is the holder of
promissory note from the Company, the principal of which is subject to
adjustment based on total annual revenues from an ambulette business acquired
from Med-Trans. Med-Trans is seeking a payment in the amount of $228,000. The
Company filed an answer to the complaint, together with affirmative defenses,
stating, among other things, that at no time did the Company voluntarily decide
not to service a customer. This action is in the pre-trial stage.
<PAGE>
An action entitled Kenneth P. Silverman, Esq., Trustee of the Estate of
BR Ambulance Service, Inc. d/b/a American Ambulance and Oxygen Service, Inc. v.
Community Medical Transport, Inc., et al., was filed in the Bankruptcy Court for
the Eastern District of New York. By complaint dated February 12, 1998, the
Chapter 7 Trustee of BR Ambulance Service, Inc. ("BR") has sued the Company
alleging that the Company was the recipient of fraudulent conveyances from BR
arising out of an asset purchase agreement between the Company and BR, dated
March 12, 1995, wherein the Company allegedly agreed to purchase the assets of
BR for a base purchase price of $2,000,000 plus additional consideration to be
calculated pursuant to a specified formula. The complaint further alleges that
subsequently BR transferred various assets to the Company but the Company did
not pay the specified consideration and accordingly owes the Trustee of BR not
less than $2,000,000. This action is in the pre-trial stage.
The Company commenced an action, Community Medical Transport, Inc., et
ano. v. Harvey H. McGeorge Co., Inc. et al. Ambulance and Ambulette, Inc.
("Century") filed in Supreme Court State of New York, County of Westchester
against Harvey H. McGeorge Co., Inc. Richards/Decker Operating Co., Inc.,
Hudvalco, Inc. doing business as Hudson Valley Ambulance, Alan McGeorge, Tor
Avenue Realty, Inc. (all of the foregoing together referred to herein as the
"McGeorge Defendants") and Richard A. Eisner & Company, LLP. The Company alleges
damages of 5.4 million dollars resulting from fraud, negligent and intentional
breech of warranty, breach of contract, material omission, negligent
misrepresentation, fraud in the inducement and violation of the implied covenant
of good faith and fair dealing on the part of the McGeorge Defendants in the
course of disclosures made regarding a business acquired from the McGeorge
Defendants and negligence and breach of contract on the part of defendant
Richard A. Eisner and Company, LLP, in the course of accounting services
rendered relating to the acquisition of the business from the McGeorge
Defendants. The Company intends to vigorously prosecute this action.
In an action entitled Oxford Health Plans (NY), Inc. v. Community
Medical Transport, Inc., filed in the Supreme Court, New York County, the
plaintiff claims $140,000 in health insurance premiums. The company vigorously
disputes the material allegations of the complaint and intends to interpose a
counterclaim for outstanding claims for transportation services authorized by
Oxford.
In an action filed in the Supreme Court, Bronx County, the plaintiff, a
former employee of defendant is suing for commissions and severance pay pursuant
to an employment contract. The plaintiff also demands statutory damages pursuant
to the New York Labor Law. The Company vigorously disputes the material
allegations of the complaint.
John Bondra v. Community Medical Transport, Inc. et al. is an action
brought by John Bondra, a former employee of Community Medical Transport, Inc.,
seeking damages under the theories of breach of contract, failure to provide a
contract of employment, quantum, meruit, unjust enrichment and Labor Law Section
198 (1-a). Presently, there is a motion pending seeking to dismiss the summons
and complaint as it pertains to the individually named defendants, Dean Sloane,
James Dickinson and Nicholas Puglisi.
Community Ambulette Service, Inc. v. Allcity Ins. Co., is an action
pending in Supreme Court, New York County against Community's insurance carrier
for its motor vehicles. The basis of the action is that the defendant carrier
improperly assessed premiums and Community is seeking to recoup approximately
$47,351.00. This action has progressed through the pleadings state, and inasmuch
as Allcity has failed to voluntarily respond to discovery demands, we are now
filing a Request for Judicial Intervention, so as to hold a Preliminary
Conference and thereby compel the completion of discovery.
Torchy White v. First Help Ambulance and Ambulette Service, Inc. and
Community Medical Transport, Inc. is an action pending in Supreme Court, Bronx
county, arising out of an employment agreement entered into between the
plaintiff and First Help and guaranteed by Community.
The plaintiff claims a breach of her employment agreement that she was
not discharged for cause as required by the contract, that the defendants failed
to comply with the terms and conditions of her employment contract. The action
is in the pre-trial stage. Plaintiff has moved for summary judgement, seeking
damages in the sum of $125,000.00. She also seeks an accounting in order to
determine and assess if she is which was deemed entitled to any commissions
pursuant to the terms of the employment agreement.
<PAGE>
The Company believes that they have not breached this agreement. The
Company has agreed to provide Ms. White with an accounting, as it is their good
faith belief that she is not on any commission herein.
Edward Weiss v. Community Medical Transport, Inc. is an action arising
out of an asset purchase agreement between BR Ambulance Service, Inc., of which
Edward Weiss was a principal and Community, which was never consummated. The
plaintiff claims that he entered into an employment agreement entitling him to
an annual salary of $100,000.00 plus commission and other benefits. The
defendants have denied liability. The action is in the pre-trial stage.
Anthony J. Monteiro v. Community Medical Transport, Inc. is an action
to recover property damages caused to leased premises by the defendant tenant in
the sum of $22,580.10. The case is currently on the trial calendar and a jury
demand has been filed.
<PAGE>
Fox Ridge Transportation, Inc. and John Gillen v. Community Medical
Transport, Inc. is an action brought against Community Medical Transport, Inc.
with regard to a Purchase Agreement. There is a Trial Readiness Conference
presently scheduled for May 2, 2000.
Oxford Health Plans (NY) Inc. v. Community Medical Transport, Inc. is
an action which seeks premiums for medical coverage of employees of Community
Medical Transport, Inc. which are no longer employees. Community Medical
Transport, Inc. has made a motion to dismiss the plaintiff=s complaint, which is
presently returnable before Justice Solomon on April 17, 2000.
Cellular One of Upstate New York, Inc. v. Century Ambulance and
Ambulette, Inc. d/b/a Community Medical Transport is an action brought in
Supreme Court, Westchester County seeking payment for telephone services
provided by the plaintiff to the defendants. There is a motion outstanding for
summary judgement against the defendants.
Financial Solutions Group, Ltd. v. Community Medical Transport, Inc. is
an action the plaintiff alleges a breach of contract for medical transportation
and is demanding judgement against the defendant in an amount of at least
$50,000.00 together with interest from January 15, 1999.
From time to time the Company is a party to litigation arising in the
ordinary course of business. There can be no assurance that the Company's
insurance coverage will be adequate to cover all liabilities occurring out of
such claims. In the opinion of management and except as described above, the
Company is not engaged in any legal proceedings expected to have a material
adverse effect on the financial condition or results of operations of the
Company.
Item 4. Submission of Matters to a Vote of Security Holders
No matters.
PART II
Item 5. Market for Common Equity and Related Stockholder Matters
The Company's common stock and redeemable warrants are currently traded
on The Nasdaq Small Cap Market under the symbols "CMTI" and "CMTIW",
respectively.
Prior to August 1997, the Company's common stock and redeemable
warrants were listed on the Nasdaq National Market. Although the Company did not
agree with the decision to terminate the listing of the Company's securities
from The Nasdaz National
Set forth below are the high and low bids for the Company's common
stock and redeemable warrants on The Nasdaq Small Cap Market during the last two
years. Such quotations reflect interdealer prices without retail mark-up,
mark-down or commissions, and may not reflect actual transactions. The Company's
redeemable warrants expired in September 1999.
Common Stock
--------------------------
High Low
-------- -------
1998
- ----
First Quarter [$7-1/2 $4-7/8
Second Quarter 7-1/8 4-1/2
Third Quarter 6-3/8 3-3/4
Fourth Quarter 4-1/8 2-5/8
1999
- ----
First Quarter $3-7/8 $2.00
Second Quarter 3 1-7/8
Third Quarter 2-7/8 1-1/8
Fourth Quarter 1-26/32 1-2/32
<PAGE>
As of December 31, 1999, there were approximately 66 recordholders of
the Company's common stock, although the Company believes that there are more
than 500 beneficial owners of its common stock.
The Company plans to retain any future earnings for use in its business
and, accordingly, the Company does not anticipate paying dividends in the
foreseeable future to its common stockholders. Payment of dividends is within
the discretion of the Company's Board of Directors and will depend, among other
factors, upon the Company's earnings, financial condition and capital
requirements.
<PAGE>
Item. 6. Management's Discussion and Analysis of Financial Condition and Results
of Operations
Introduction
For all periods presented, the following financial information includes
the accounts of all operating subsidiaries of the Company.
The Company's total revenue, which is comprised primarily of ambulette
and ambulance service fees charged to Medicare, Medicaid, other third party
payers such as private insurance carriers and health maintenance organizations,
and directly to patients, is presented net of contractual adjustments. The
reimbursement from Medicare and Medicaid has been reduced as a percentage of
revenues from 39% in 1998 to 35% in 1999, while the reimbursement from private
insurers and other non governmental agencies has increased from 50% in 1998 to
55% in 1999.
Forward Looking Statements
The following statements and certain other statements in this annual
report on Form 10-KSB are based on current expectations. Such statements are
forward looking statements that involve a number of risks and uncertainties.
Factors that could cause actual results to differ materially include, but are
not limited to the following (i) general economic conditions, (ii) competitive
market influences (iii) third party reimbursement rate changes (iv) availability
of insurance at reasonable cost (v) customer relations and (vi) increased
competition.
Results of Operations
Year Ended December 31, 1999 as Compared with Year Ended December 31,
1998
Revenues decreased by $2,405,000, or 13.2%, to $15,840,000 in 1999 from
$18,245,000 in 1998. The decrease is due substantially to the Company losing
certain business to the competition.
Operating expenses decreased by $1,544,000, or 11.5%, to $11,894,000 in
1999 from $13,438,000 in 1998. Total operating expenses as a percentage of
revenue for 1999 is 75.1% as compared to 73.6% in 1998. The increase of 1.5% as
a percentage of revenue was primarily due to an increase in depreciation
combined with certain fixed costs remaining constant as revenue decreased. As a
result of the foregoing, gross profit decreased minimally as a percentage of
revenues from 26.3% to 25% while gross profit decreased by $861,000 or 17.9%, to
$3,946,000 in 1999 from $4,807,000 in 1998.
<PAGE>
Selling, general and administrative expenses decreased by $298,000, or
5.2%, to $5,459,000 in 1999 from $5,757,000 in 1998. The decrease was a direct
result of reductions primarily in administrative operating costs, marketing
salaries and benefits, administrative salaries and benefits, and amortization of
intangibles. This was partially offset by an increase in bad debt expense.
Selling, general and administrative expenses as a percentage of revenues
increased by 3% to 34.5% for the year ended December 31, 1999, from 31.5% for
the year ended December 31, 1998, primarily as a result of the fixed costs
remaining constant as revenue decreased.
Loss from operations increased by $563,000, or 59.2%, to a
loss of $1,513,000 in 1999 from a loss of $950,000. This decrease was a result
of the factors described above, primarily the reduced revenues and the increase
increases in operating expenses and the provision for bad debts.
Interest expense increased to $709,000 in 1999 as compared to $663,000
in 1998. The $46,000 increase or 6.9% is due to an increase in the interest rate
charged to the Company in 1999.
Interest income decreased by $47,000, or 90.3%, to $5000 in 1999 from
$52,000 in 1998. The reduction in interest income is primarily due to
expenditures, which reduced available cash.
The Company's income taxes amounted to a benefit of $432,000 for the
year ended December 31, 1999 compared with a tax benefit of $516,000 for the
year ended December 31, 1998. The tax benefits resulted from the Company
sustaining taxable losses for both 1998 and 1999. The 1998 and 1999 tax benefit
results from the recognition of a deferred tax asset as management believes
there is a strong likelihood that such amounts will be realized based upon their
assessment of expected future sales of certain assets. Certain current taxes
were payable irrespective of the losses the Company incurred.
The Company's net loss amounted to $1,787,000 or $1.76 per share, for
the year ended December 31, 1999, as compared to net loss of $1,045,000, or
$1.05 per share, for the year ended December 31, 1998.
Liquidity and Capital Resources
Cash used by operating activities was $722,000 in 1999 compared with
cash provided by operating activities of $926,000 in 1998. The increase in cash
used by operating activities in 1999, was largely the result of a increase
losses, an increase in accounts receivables written off and cash used in prepaid
items as compared to 1998, offset partially by a increases in accounts payable
and accrued expenses.
Cash provided by investing activities in 1999 was $538,000 as compared
to cash used in 1998 of $46,000. The increase in cash provided in investing
activities was largely the result of decreases in the short-term cash
investments held by the Company.
<PAGE>
Cash provided by financing activities for the year ended December 31,
1999 was $11,000 as compared to Cash used in financing activities of $1,713,000
for the same period in 1998. In 1998 the company made additional principal
payments for its senior debt with no additional borrowings. In 1999 the
Company's principal payments were offset by additional loans.
In December 1996, the Company entered into a $10,000,000 credit
facility to replace its previously existing $3,200,000 credit facility for
working capital and capital expenditures. A portion of the $10,000,000 credit
facility consists of a $6,500,000 revolving credit arrangement, which may only
be drawn down if the Company has sufficient qualified accounts receivable. The
balance of the credit facility is available under term notes. The Company, at
times was unable to draw down desired amounts because of slow payment by
reimbursement agents resulting in delays in collection. In addition, the Company
was required from time to time to repay a portion of this facility under the
provisions of the credit agreement. At December 31, 1997, there was $6,260,000
outstanding under this facility consisting of $4,000,000 under the revolving
credit arrangement and $2,260,000 under the term notes.
At December 31, 1997, the Company was not in compliance with several
financial covenants of its existing loan agreement. The lenders have provided a
waiver in connection with an amendment to the loan agreement, which was
completed on April 14, 1998. As a result of such amendment, the lenders amended
certain financial covenants at future measurement dates to accommodate the
Company's current financial status. The lenders also extended the maturity date
of the revolving credit arrangement to January 18, 1999 and in conjunction with
such revisions, reduced the amount under the revolving credit arrangement from
$6,500,000 to $3,500,000. In February 1999 the Company entered into a new
financing arrangement with Finova Capital Corporation. The Company obtained a
term loan of $3,950,000, a revolving credit line of $4,000,000 and availability
of $1,000,000 for future equipment acquisitions. Under the revolver, the Company
has approximately a $2.5 million available line of credit may use subject to the
availability of eligible accounts receivable. The prior loan was satisfied with
the proceeds of the Finova loan.
Since July of 1999 the Company has been in default on the Finova Loan.
The default relates to certain financial covenants. The company remains current
on its debt service payments.
At December 31, 1999, the Company had working capital deficit of
$3,948,000 as compared to working capital of $1,877,000 at December 31, 1998.
This is large due to the Debt previously classify as long-term now due to the
default being classified as current.
The company is exploring various options to fund future operations,
including the sale of assets and raising capital from other sources, including
the sale of part or all of the Company. The company expects that one or a
combination of these options will enable the company to continue in existence.
<PAGE>
Inflation
The Company believes that the relatively moderate rates of inflation in
recent years have not had a significant impact on its net revenues or its
profitability.
Year 2000 Compliance
The Company had upgraded any possible problem areas and has experienced
no year 2000 issues.
Item 7. Financial Statements
Reference is made to pages F-1 through F-21 comprising a portion of
this annual Report on Form 10-KSB.
Item 8. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosure
Reports on Form 8-K
The Company filed a Current Report on Forms 8-K and 8-K/A-1, dated May
18, 1998, relating to items 4 and 7 Form 8-K. Such Current Report includes the
termination of Richard A. Eisner & Company, LLP ("Eisner") as the Company's
independent auditors, and Eisner's response agreeing to the disclosures in such
filing.
The Company filed a Current Report on Form 8-K, dated June 29, 1998,
relating to items 4 and 7 of Form 8-K. Such Current Report includes the
appointment of Edward Isaacs and Company, LLP ("Isaacs") as the Company's
independent auditors to succeed Eisner.
PART III
Item 9. Directors, Executive Officers, Promoters and Control Persons;
Compliance with Section 16(a) of the Exchange Act
<PAGE>
The directors and executive officers of the Company are as follows:
<TABLE>
<CAPTION>
Name Age Position
- ---- --- --------
<S> <C> <C>
Dean L. Sloane 54 President, Chairman of the Board, Chief
Executive Officer and Director
Craig V. Sloane 49 Vice President-Operations, Secretary
and Director
Nicholas Puglisi 38 Chief Financial Officer and Treasurer
Bernard M. Kruger, M.D. 57 Director
Lucius J. Riccio, Ph.D. 52 Director
</TABLE>
Dean L. Sloane has served as Chairman of the Board, President, Chief
Executive Officer and a Director of the Company since December 1988. Mr. Sloane
has been a member of the Young Presidents Organization since 1985. Mr. Sloane is
a Certified Public Accountant but does not practice.
Craig V. Sloane has served as Vice President-Operations and a Director
of the Company since December 1990. From 1985 through October 1990, he was a
futures analyst at Smith Barney Harris & Upham.
Nicholas Puglisi has recently joined the Company in June as Chief
Financial Officer. Mr. Puglisi, a Certified Public Accountant, was a managing
partner for the accounting firm engaged by CMTI since 1989. Mr. Puglisi was
engaged over the ten year period in various capacities on a regular basis. Work
performed included due diligence of ambulance and ambulette businesses,
auditing, tax planning and preparation and other consulting functions related to
the business of the Company.
Bernard M. Kruger, M.D. has been in the private practice of internal
medicine and medical oncology since 1979, and is affiliated with Lenox Hill
Hospital, Beth Israel Hospital, Mount Sinai Hospital and the Orthopedic
Institute.
Lucius J. Riccio, Ph.D. has served as a management consultant on
transportation issues since January 1994. From February 1990 to December 1993 he
served as Commissioner of the New York City Department of Transportation. From
1986 to 1990 he served as Deputy Commissioner, Highway Operations, of the New
York City Department of Transportation.
Dean L. Sloane and Craig V. Sloane are brothers.
Section 16(a) of the Securities Exchange Act of 1934 requires that
officers, directors and 10% or greater stockholders of the Company file reports
of their ownership with the Securities and Exchange Commission. No officer,
director or 10% or greater stockholder of the Company was late with his filings.
Item 10. Executive Compensation
The following table sets forth information concerning compensation paid
or accrued by the Company or its subsidiaries for services rendered during the
fiscal years ended December 31, 1997, 1998 and 1999 to the Company's Chief
Executive Officer and to each executive officer whose compensation exceeded
$100,000 during its fiscal year ended December 31, 1999:
<PAGE>
Summary Compensation Table
<TABLE>
<CAPTION>
Long Term
Annual Compensation Compensation Awards
--------------------------------------------------------- ----------------------
Name and Other Annual Securities Underlying
Principal Position Year Salary Bonus Compensation (1) Options
------------------ ---- ------ ----- ---------------- -------
<S> <C> <C> <C> <C> <C>
Dean Sloane 1999 $215,000 0 $28,000 0
President and Chief 1998 $236,000 $22,000 $26,000 0
Executive Officer 1997 $225,000 0 $34,000 0
Craig Sloane 1999 $ 88,100 0 $12,000 1,667
Vice-President - 1998 $ 97,000 $15,000 $12,000 1,667
Operations 1997 $ 94,000 $15,000 $12,000 1,667
</TABLE>
(1) Consists primarily of automobile lease payments.
The following table sets forth information as to options exercised by each of
the named executives during the fiscal year ended December 31, 1999 and the
value of in-the-money options held by such executives at December 31, 1999.
Option Exercises in Last Fiscal Year and Fiscal Year End Option Values
There were no options exercised by each of the named executives during
the fiscal year ended December 31, 1999.
Employment Agreements
In September 1994, the Company entered into an employment agreement
with Dean L. Sloane, President and Chief Executive Officer of the Company. The
agreement has a three-year term which renews for an additional year on each
anniversary of the agreement, and provides for an annual base compensation of
$225,000, with annual increases based on a published cost of living index. In
addition, Mr. Sloane is entitled to such bonuses as may be awarded by the Board
in its discretion. The agreement calls for payment of benefits, including life
insurance and automobile expenses, similar to that received prior to execution
of the agreement. In the event the Company terminates Mr. Sloane's employment
without cause or Mr. Sloane terminates the agreement for "good reason" (as
defined in the agreement), the Company has agreed to pay to Mr. Sloane as
severance, an amount equal to Mr. Sloane's monthly salary multiplied by the
greater of (i) the number of months remaining between the date of termination
and the then expiration date of the agreement, and (ii) twelve. The agreement
also contains a non-competition provision covering the term of the agreement
plus one year following termination.
In September 1994, the Company also entered into an employment
agreement with Craig V. Sloane, Vice President-Operations of the Company. The
agreement has a three-year term which renews for an additional year on each
anniversary of the agreement, and provides for an annual base compensation of
$85,000 subject to increase at least 5% per year. The agreement calls for
payment of automobile expenses. The agreement also contains a non-competition
provision covering the term of the agreement plus one year following
termination.
The Company also entered into an employment agreement with Nicholas
Puglisi, Vice President and Chief Financial Officer of the Company on June 1,
1999. The agreement has a three-year term which renews for an additional year on
each anniversary of the agreement, and provides for an annual base compensation
of $135,000 subject to increases reflecting increases with in the consumer price
index. The agreement calls for benefits including health insurance and
automobile expenses. The agreement also contains a non-competition provision
covering the term of the agreement plus one year following termination.
<PAGE>
Employee Stock Option Plan
The Company has adopted a 1992 Employee Stock Option Plan (the
"Employee Plan") for officers, employees, and consultants of the Company and any
of its subsidiaries. In 1996 the Company's stockholders approved increasing the
number of shares subject to the Employee Plan from 43,917 shares of the
Company's Common Stock to 125,000 shares (shares are restated to reflect the one
for six reverse stock split). As of February 28, 1999, options to purchase
25,250 shares of Common Stock were outstanding and options to purchase 93,083
shares of Common Stock were available for grant.
The Employee Plan is administered by a Stock Option Committee (the
"Committee"), consisting of two disinterested members of the Board of Directors.
In general, the Committee will select the persons to whom options will be
granted and will determine, subject to the terms of the Employee Plan, the
number, the exercise period and other provisions of such options. The options
granted under the Employee Plan will be exercisable in such installments as may
be provided in the grant.
Options granted to employees may be either incentive stock options
under the Internal Revenue Code ("ISOs") or non-ISOs. The Committee may
determine the exercise price provided that, in the case of ISOs, such price may
not be less than 100% (110% in the case of ISOs granted to holders of 10% of the
voting power of the Company's stock) of the fair market value (as defined in the
Employee Plan) of the Company's Common Stock at the date of grant. The aggregate
fair market value (determined at time of option grant) of stock with respect to
which ISOs become exercisable for the first time in any year cannot exceed
$100,000.
The options are evidenced by a written agreement containing the above
terms and such other terms and conditions consistent with the Employee Plan as
the Committee may impose. Each option, unless sooner terminated, shall expire no
later than 10 years (five years in the case of ISOs granted to holders of 10% of
the voting power of the Company's stock) from the date of the grant, as the
Committee may determine. The Committee has the right to amend, suspend or
terminate the Employee Plan at any time, provided, however, that unless ratified
by the Company's stockholders within 12 months thereafter, no amendment or
change in the Employee Plan will be effective: (a) increasing the total number
of shares which may be issued under the Employee Plan; (b) reducing below fair
market value on the date of grant the price per share at which any option which
is an ISO may be granted; (c) extending the term of the Employee Plan or the
period during which any option which is an ISO may be granted or exercised; (d)
altering in any way the class of persons eligible to participate in the Employee
Plan; (e) materially increasing the benefits accruing to participants under the
Employee Plan; or (f) with respect to options which are ISOs, amending the
Employee Plan in any respect which would cause such options to no longer qualify
for incentive stock option treatment pursuant to the Internal Revenue Code of
1986.
Compensation of Directors
Directors who are not employed by the Company will be paid a fee of
$1,000 for each board of directors meeting attended and $500 for each committee
meeting attended. All directors are reimbursed for expenses incurred on behalf
of the Company.
The Company has adopted a 1994 Directors' Stock Option Plan (the
"Directors' Plan") for non-employee directors of the Company and any of its
subsidiaries. The Directors' Plan authorizes the granting of stock options to
purchase an aggregate of 8 ,333 shares of the Company's Common Stock. Options
granted under the Directors' Plan do not qualify as incentive stock options
within the meaning of Section 422 of the Internal Revenue Code. The Directors'
Plan, as amended in 1996, provides for the automatic grant to each of the
Company's non-employee directors of options to purchase 833 shares of Common
Stock on the first day of the Company's fiscal year. The options will have an
exercise price of 100% of the fair market value of the Common Stock on the date
of grant, have a ten year term and become exercisable in two equal annual
installments commencing on the date of the grant. The options may be exercised
by payment in cash of the full option exercise price. At the discretion of the
Board, the exercise price may be paid by tendering of shares of Common Stock
having a fair market value equal to the option exercise price or by tendering
cash in an amount equal to the aggregate par value of the shares being
purchased, together with an interest bearing note for the remainder of the
purchase price in form, and having terms satisfactory to the Board, in its sole
discretion.
<PAGE>
Item 11. Security Ownership of Certain Beneficial Owners and Management
The following table sets forth certain information regarding beneficial
ownership of the Common Stock as of February 28, 1999 by (i) each stockholder
known by the Company to be the beneficial owner of more than 5% of the
outstanding Common Stock, (ii) each director of the Company, and (iii) all
directors and executive officers as a group. Except as otherwise indicated, the
Company believes that the beneficial owners of the Common Stock listed below,
based on information furnished by such owners, have sole investment and voting
power with respect to such shares, subject to community property laws where
applicable.
<TABLE>
<CAPTION>
Name and address of Beneficial Number of Shares
Owner Beneficially Owned Percentage of Class
- -------------------------------- -------------------- --------------------
Amount and Nature of
Beneficial Ownership Percent of Class
Name of Beneficial Owner of Voting Securities of Voting Securities
- ------------------------ -------------------- --------------------
<S> <C> <C>
Dean L. Sloane 231,766(1) 22.8%
45 Morris Street
Yonkers, NY 10705
Craig V. Sloane 15,833(2) 1.6%
45 Morris Street
Yonkers, NY 10705
Bernard M. Kruger 19,983(3) 1.9%
170 East 78th Street
New York, NY 10021
Lucius J. Riccio 1,583(3) *
315 East 69th Street
New York, NY 10021
Ronald V. Davis 62,778(4) 6.3%
c/o Davis Capital LLC
2015 West Main Street
Stamford, Connecticut, 06902
Andrew M. Lessak 55,747(5) 5.6%
c/o Joseph Charles & Assoc.
2500 North Military Trail
Boca Raton, Florida 33431
Nicholas Puglisi 50,000(6) 4.9%
55 Lambert Ridge
Cross River, New York 10158
Herbard Limited 120,227(7) 11.8%
Road Town, Tortola
British Virgin Islands
Michael A. Duchesneau, M.D. 68,000(8) 6.7%
4015 Bayshore Blvd. #16E
Tampa, FL 33611
All directors and executive 319,165 31.4%
officers as a
group (6 persons)
</TABLE>
<PAGE>
- ------------
* Less than 1%
(1) Does not include 16,667 shares owned by Mary K. Sloane, Dean L. Sloane's
wife. Dean L. Sloane disclaims beneficial ownership of such shares.
(2) Includes 15,833 shares of the Company's Common Stock subject to presently
exercisable options.
(3) Includes 1,583 shares of the Company's Common Stock subject to presently
exercisable options.
(4) As reported in a Schedule 13D, dated July 3, 1997.
(5) As reported in a Schedule 13G, dated September 23, 1998.
(6) Includes 8,333 shares of the Company's Common Stock subject to presently
exercisable options.
(7) As reported in a Schedule 13D/A, dated November 30, 1998.
(8) As reported in a Schedule 13D, dated January 11, 2000.
Item 12. Certain Relationships and Related Transactions
In connection with the Company's loan from Finova Capital Dean Sloane
has executed a limited guaranty. The Company has agreed to reimburse Mr. Sloane
for any amounts paid under the guarantee and to collateralize the obligation to
Mr. Sloane by granting him a security interest in the same assets that Finova
has a security interest.
Item 13. Exhibits and Reports on Form 8-K
(a) Exhibits
<TABLE>
<CAPTION>
<S> <C>
3.01 Restated Certificate of Incorporation of the Company (1)
(a) Amendment of Certificate of Incorporation of the Company
(b) Amendment of Certificate of Incorporation of the Company
3.02 Certificate of Amendment to the Company's certificate of incorporation
Amended and Restated By-Laws of the Company (1)
4.01 Specimen Certificate representing the Common Stock, par value $.001 per share (1)
10.01* 1992 Employee Stock Option Plan (1)
10.02* 1994 Directors' Stock Option Plan (1)
10.03* Employment Agreement entered into between the Company and Dean L. Sloane (1)
10.04* Employment Agreement entered into between the Registrant and Craig V. Sloane (1)
10.05* Employment Agreement entered into between the Company and Joseph A. Connell, Sr. (5)
10.06 Lease dated January 1, 1997 by and between the Company and 2301 Jerome Avenue Realty Corp. and the Addendum
thereto. (5)
10.07 Lease dated September 1997 by and between the Company and Principal Mutual Life Insurance Company. (5)
10.08 Indemnification Agreement entered into between the Company and each of its directors (1)
10.09+ Agreement dated as of January 1994 between the Company and Beth Abraham Hospital (1)
10.10+ Agreement dated as of January 1, 1994 between the Company and Beth Abraham Hospital (1)
10.11 Amendment to the Agreements between the Company and Beth Abraham Hospital (5)
10.12 Warrant, issued to the Equity Group, to purchase 30,000 shares of Common Stock commencing November 1,
1994 (2)
10.13 Warrant, issued to the Equity Group, to purchase 30,000 shares of Common Stock commencing November 1,
1995 (2)
10.14 Asset Purchase Agreement dated September 25,1995 between the Company and Medical Transportation
Corporation (3)
10.16 A loan and security agreement between Finova Capital Corporation and registrant and its subsidiaries
dated February 2, 1999
21.01 Subsidiaries of the Company
23.01 Consent of Edward Isaac & Company, Inc.
27.01 Financial Data Schedule
</TABLE>
<PAGE>
- ------------
+ Confidential treatment was granted for the deleted portion of this document.
* Management contract or compensatory plan or arrangement.
(1) Such Exhibits were filed with the Company's Registration Statement (File No.
33-80338) declared effective September 30, 1994 and are incorporated herein
by reference.
(2) Such Exhibits were filed with the Company's Annual Report on Form 10-KSB for
the fiscal year ended December 31, 1994 and are incorporated herein by
reference.
(3) Such Exhibit was filed with the Company's Current Report on Form 8-K, dated
November 1, 1995, and is incorporated herein by reference.
(4) Such Exhibit was filed with the Company's Annual Report on Form 10-KSB for
the fiscal year ended December 31, 1996 and is incorporated herein by
reference.
(5) Such Exhibit was filed with the Company's Annual Report on Form 10-KSB for
the fiscal year ended December 31, 1997 and is incorporated herein by
reference.
(b) Reports on Form 8-K
None
<PAGE>
COMMUNITY MEDICAL TRANSPORT, INC. AND SUBSIDIARIES
Contents
<TABLE>
<CAPTION>
Page
-----
<S> <C>
Consolidated Financial Statements
Independent auditors' report F-2
Balance sheet as of December 31, 1999 F -3
Statements of operations for the years ended December 31, 1999 and 1998 F -4
Statements of changes in stockholders' equity for the years ended
December 31, 1999 and 1998 F -5
Statements of cash flows for the years ended December 31, 1999 and 1998 F -6
Notes to financial statements F -7 to F -20
</TABLE>
F-1
<PAGE>
INDEPENDENT AUDITORS' REPORT
Board of Directors and Stockholders
Community Medical Transport, Inc.
We have audited the accompanying consolidated balance sheet of Community Medical
Transport, Inc. and subsidiaries (the "Company") as of December 31, 1999 and the
related consolidated statements of operations, changes in stockholders' equity
and cash flows for each of the years in the two-year period ended December 31,
1999. These consolidated financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Community Medical
Transport, Inc. and subsidiaries at December 31, 1999, and the consolidated
results of their operations, and their consolidated cash flows for each of the
years in the two-year period ended December 31, 1999, in conformity with
generally accepted accounting principles.
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in note K to the
financial statements, the Company has sustained recurring losses of $1,787,000
and $1,045,000 in 1999 and 1998, respectively, and is in default on certain
covenants of its loan agreement and is in arrears on accounts payable with
certain vendors and creditors. These conditions raise substantial doubt about
its ability to continue as a going concern. Management's plans regarding those
matters also are described in note K. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
April 12, 2000
New York, New York
F-2
<PAGE>
COMMUNITY MEDICAL TRANSPORT, INC. AND SUBSIDIARIES
Consolidated Balance Sheet
December 31, 1999
<TABLE>
<S> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 152,000
Accounts receivable - trade, less allowance for doubtful accounts of $1,650,000 3,183,000
Prepaid insurance 285,000
Other current assets 213,000
Deferred tax assets 472,000
------------
Total current assets 4,305,000
Property, equipment and leasehold improvements - net 2,657,000
License - net 650,000
Customer lists - net 1,044,000
Other assets 624,000
Goodwill - net 2,435,000
Deferred tax assets 684,000
------------
$ 12,399,000
LIABILITIES
Current liabilities:
Cash overdraft $ 233,000
Current portion of long-term debt 5,988,000
Accounts payable 1,224,000
Accrued expenses 808,000
------------
Total current liabilities 8,253,000
Long-term debt - net of current portion 234,000
------------
8,487,000
Commitments and contingencies
STOCKHOLDERS' EQUITY
Preferred stock, 4% cumulative, $.001 par value, 1,000,000 shares authorized
Common stock, $.001 par value, 5,000,000 shares authorized, 999,775 shares
issued and outstanding 1,000
Capital in excess of par value 14,084,000
Accumulated deficit (10,173,000)
------------
Total stockholders' equity 3,912,000
------------
$ 12,399,000
============
</TABLE>
See notes to consolidated financial statements F-3
<PAGE>
Consolidated Statements of Operations
<TABLE>
<CAPTION>
Year Ended
December 31
1999 1998
------------ -----------
<S> <C> <C>
Net revenue $ 15,840,000 $ 18,245,000
Expenses:
Salaries and benefits 8,782,000 10,030,000
Fleet maintenance 1,102,000 1,193,000
Insurance 590,000 638,000
Rent 313,000 483,000
Depreciation and amortization 1,107,000 1,094,000
------------ ------------
Total operating expenses 11,894,000 13,438,000
------------ ------------
Gross profit 3,946,000 4,807,000
Selling, general and administrative expenses 5,459,000 5,757,000
------------ ------------
Loss from operations (1,513,000) (950,000)
Interest income 5,000 52,000
Interest expense (709,000) (663,000)
Other expense - net (2,000) 0
Loss before income tax benefit (2,219,000) (1,561,000)
------------ ------------
Income tax expense (benefit):
Current 208,000 0
Deferred (640,000) (516,000)
------------ ------------
(432,000) (516,000)
Net loss $ (1,787,000) $ (1,045,000)
============ ============
Net loss available to common shareholders - basic $ (1,787,000) $ (1,045,000)
============ ============
Net loss available to common shareholders including assumed
conversion - diluted $ (1,787,000) $ (1,045,000)
============ ============
Net loss per share - basic and diluted $ (1.79) $ (1.05)
============ ============
- Diluted $ (1.79) $ (1.05)
------------ ------------
Weighted average number of common shares outstanding - basic 999,775 998,199
------------ ------------
Weighted average number of common shares outstanding -diluted 999,775 998,199
============ ============
</TABLE>
See notes to consolidated financial statements F-4
<PAGE>
Consolidated Statements of Changes in Stockholders' Equity
<TABLE>
<CAPTION>
4% Cumulative
Dividend
Convertible
Preferred Stock
----------------------------------------- Common Stock
Series A Series B Series BB --------------------
Shares Shares Shares Shares Amount
-------- -------- --------- ------ ------
<S> <C> <C> <C> <C> <C>
Balance - December 31,1997 0.0 0.0 778.4 5,761,007 $ 6,000
Net loss
Conversion of series BB preferred stock (778.4) 222,392
Other changes 10,253
Adjustment of shares due to
Due to 1 for 6 reverse stock split (4,994,710) (5,000)
Additional costs in connection with stock
Issuance
------------ ------------ -------- ------------ ------------
Balance - December 31, 1998 0.0 0.0 0.0 998,942 $ 1,000
============ ============ ======== ============ ============
Net loss
Warrents exercised 833
------------ ------------ -------- ------------ ------------
Balance - December 31, 1999 0.0 0.0 0.0 999,775 $ 1,000
============ ============ ======== ============ ============
</TABLE>
<TABLE>
<CAPTION>
Retained
Capital in Earnings
Excess of (Accumulated
Par Value Deficit) Total
------------ ----------- -----
<S> <C> <C> <C>
Balance - December 31,1997 $ 14,043,000 (7,341,000) 6,708,000
Net loss (1,045,000) (1,045,000)
Conversion of series BB preferred stock
Other changes 6,000 6,000
Adjustment of shares due to
Due to 1 for 6 reverse stock split 5,000
Additional costs in connection with stock
Issuance
------------ ------------ ------------
Balance - December 31, 1998 $ 14,054,000 $ (8,386,000) $ 5,669,000
============ ============ ============
Net loss (1,787,000) (1,787,000)
Warrents exercised 30,000 30,000
------------ ------------ ------------
Balance - December 31, 1999 $ 14,084,000 $(10,173,000) $ 3,912,000
============ ============ ============
</TABLE>
See notes to consolidated financial statements F-5
<PAGE>
Consolidated Statements of Cash Flows
<TABLE>
<CAPTION>
Year Ended
December 31,
-------------------------------
1999 1998
----------- -----------
<S> <C> <C>
Cash flows from operating activities:
Net loss $(1,787,000) $(1,045,000)
Adjustments to reconcile net loss to cash provided by (used in) operating
activities:
Depreciation and amortization expense 1,594,000 1,623,000
Common shares issued for employee benefit obligation 0 6,000
Restructuring and other costs
Provision for uncollectible accounts receivable (300,000) 516,000
Deferred income taxes (640,000) (516,000)
Changes in:
Accounts receivable 704,000 725,000
Prepaid insurance and other current assets (200,000) 51,000
Other assets 205,000 151,000
Cash overdraft 233,000 0
Accounts payable and accrued expenses (497,000) (978,000)
Prepaid income taxes 199,000 393,000
----------- -----------
Net cash provided by operating activities (489,000) 926,000
----------- -----------
Cash flows from investing activities:
Acquisition of equipment - net of disposals (286,000)
(358,000)
Decrease in short-term investments 824,000 312,000
----------- -----------
Net cash used in investing activities 538,000 (46,000)
----------- -----------
Cash flows from financing activities:
Proceeds of bank borrowings 5,895,000 55,000
Principal repayments on debt (5,439,000) (1,517,000)
Warrents exercised
30,000 0
Principal payments on capital lease obligations (475,000) (251,000)
----------- -----------
Net cash (used in ) provided by financing activities 11,000 (1,713,000)
----------- -----------
Net increase (decrease) in cash 60,000 (833,000)
Cash - beginning of year 92,000 925,000
----------- -----------
Cash - end of year $ 152,000 $ 92,000
=========== ===========
Supplementary disclosures of cash flow information: Cash paid during the year
for:
Interest $ 672,000 $ 637,000
=========== ===========
Taxes $ 7,000 $ 149,000
=========== ===========
Supplementary disclosures of noncash investing and financing activities:
Equipment acquired under capital leases $ 160,000 $ 55,000
=========== ===========
</TABLE>
See notes to consolidated financial statements F-6
<PAGE>
COMMUNITY MEDICAL TRANSPORT, INC. AND SUBSIDIARIES
Notes to Financial Statements
December 31, 1999 and 1998
NOTE A - ORGANIZATION AND BASIS OF PRESENTATION
The accompanying financial statements include the accounts of Community Medical
Transport, Inc. (the "Company") and its five wholly owned subsidiaries,
Community Ambulette Service, Inc. ("Ambulette"), First Help Ambulance and
Ambulette Inc. ("First Help"), Empire Ambulance and Ambulette Inc. ("Empire"),
Century Ambulance and Ambulette, Inc. ("Century") and Elite Ambulance and
Medical Coach, Inc. ("Elite") (collectively the "Companies"). All intercompany
balances and transactions have been eliminated in consolidation.
The Companies operated in one business segment. It provides specialized
transportation for the handicapped and disabled, mentally retarded, elderly and
chronically ill to and from day treatment centers, day care programs, hospitals,
nursing homes and other health care facilities in the New York metropolitan
area. This service is provided in ambulettes, which are specialized vans that
contain wheelchair lifts or ramps. The Companies also provide emergency and
nonemergency ambulance transportation of patients who require basic medical care
or supervision during transport to and from hospitals, nursing homes and other
health care facilities.
NOTE B - SIGNIFICANT ACCOUNTING POLICIES
Significant accounting policies in the preparation of the financial statements
are as follows:
[1] Revenue recognition:
Revenue is recognized on the date of transportation. Revenue is reported
at the realizable amount from patients, third-party payors and others
under contractual arrangements.
[2] Property, equipment and leasehold improvements:
Property, equipment and leasehold improvements are stated at cost less
accumulated depreciation and amortization. The Company computes
depreciation and amortization using the straight-line method over the
estimated useful lives of the assets as follows:
Ambulette and ambulance fleet 5 - 7 years
Machinery, equipment and office furniture 3 - 10 years
Leasehold improvements Shorter of lease term or
estimated life of asset
[3] Intangible assets:
Intangible assets consist of goodwill, licenses, customer lists and
covenants not to compete. The goodwill is being amortized on a
straight-line basis over twenty five years. The licenses are being
amortized on a straight-line basis over forty years. The customer lists
are being amortized using the straight-line method over the period of
expected benefit, which is from five to ten years. The covenants not to
compete are being amortized using the straight-line method over the period
of the covenants which is three years. Intangible assets are evaluated
periodically, and adjusted if necessary, if events and circumstances
indicate that the carrying amount is impaired. (Note K)
F-7
<PAGE>
NOTE B - SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
[4] Income taxes:
The Company's income tax accounting method has automatically changed from
the cash method of accounting to the accrual method in compliance with
Internal Revenue Code ("IRC") Section 448. In accordance with IRC Section
448, the Company has elected to recognize the impact of such change over a
four-year period commencing January 1, 1996 ending December 31, 1999.
The Company accounts for income taxes utilizing the asset and liability
approach requiring the recognition of deferred tax assets and liabilities
for the expected future tax consequences of temporary differences between
the basis of assets and liabilities for financial reporting purposes and
tax purposes.
[5] Net loss per share:
The Company has adopted Statement of Financial Accounting Standards No.
128 ("SFAS #128"), "Earnings Per Share", which requires the reporting of
earnings (loss) per basic share and earnings (loss) per diluted share.
Earnings (loss) per basic share is calculated by dividing net income
(loss) available to common shareholders by the weighted average
outstanding shares during the period. Earnings per diluted share is
calculated by dividing net income available to common shareholders with
preferred dividends added back (if converted method) by the basic shares
and all dilutive potential common shares, including options and
convertible preferred stock due to the net losses in 1999 and 1998 there
was no dilutive effect of opitions. Net income per share has been
retroactively adjusted for the 1 for 6 reverse stock split in 1998. The
authorized number of common shares was reduced from 20 million to 5
million.
In 1999 and 1998, net loss available to common shareholders was equal to
the net loss, as there were no cumulative preferred stock dividends.
[6] Estimates:
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenue and expenses
during the reported period. Actual results could differ from those
estimates.
F-8
<PAGE>
NOTE B - SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
[7] Fair value of financial instruments:
The carrying value of the Company's cash, and accounts payable approximate
fair value due to their short-term nature. The fair value of short-term
debt approximates the carrying amount as the current rates on similar
instruments are similar to the effective rates.
[8] Stock-based compensation:
The Company has adopted Statement of Financial Accounting Standards No.
123, "Accounting for Stock-Based Compensation" ("SFAS No. 123"). The
provisions of SFAS No. 123 allow companies to either expense the estimated
fair value of employee stock options or to continue to follow the
intrinsic value method set forth in Accounting Principles Board Opinion
25, "Accounting for Stock Issued to Employees" ("APB 25") but disclose the
pro forma effects on net income (loss) had the fair value of the opinions
been expensed. The Company has elected to continue to apply APB 25 in
accounting for its employee stock option incentive plans.
NOTE C - PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS
Property, equipment and leasehold improvements consist of the following:
Ambulette and ambulance fleet $5,486,000
Machinery, equipment and office furniture 1,633,000
Leasehold improvements 269,000
------------
7,388,000
Less accumulated depreciation and amortization (4,731,000)
-----------
$2,657,000
The net book value of property and equipment under capital lease amounted to
approximately $500,000 at December 31, 1999. Depreciation expense includes
depreciation on property and equipment held under capital leases.
F-9
<PAGE>
NOTE D - LEASES
The Company is obligated under long-term noncancelable operating and capital
leases for premises and equipment expiring in various years through the year
2005.
Future minimum lease payments are as follows:
Operating Capital
Leases Leases
2000 $ 638,000 $118,000
2001 384,000 81,000
2002 227,000 70,000
2003 168,000 7,000
2004 165,000 0
Thereafter 165,000 0
-------- ---------
Total minimum lease payments $ 1,747,000 276,000
=========
Amount representing interest (49,000)
---------
Present value of minimum lease payments $227,000
=========
Rent expense for the years ended December 31, 1999 and December 31, 1998 was
approximately $ 462,000 and $ 593,000, respectively.
NOTE E - LONG-TERM DEBT
Long-term debt at December 31, 1999 consists of the following:
Financing Company Debt
<TABLE>
<S> <C>
$4,000,000 revolving credit line, collateralized by substantially all of the
Company's assets, bearing interest at prime plus 1% (9.5% at December 31,1999),
due February 2004. At December 31, 1999 the Company was not in compliance with
certain of the financial covenants and the loan has been classified as a current
liability $1,493,000 (1)
Term note payable, in the original amount of $3,950,000 collateralized by
substantially all of the Company's assets, payable in monthly installments of
$65,800 plus interest at prime plus 1 1/4 % (9.75% at December 31,1999) through
February 2004. At December 31,1999 the Company was not in compliance with
certain of the financial covenants and the loan has been classified as a current liability 3,292,000 (1)
</TABLE>
F-10
<PAGE>
NOTE E - LONG - TERM DEBT ( CONTINUED)
<TABLE>
<S> <C> <C>
$1,000,000 equipment acquisition line of credit, collateralized by substantially
all of the company's assets, bearing interest at prime plus 1% (9.5% at December
31, 1999 ), due February 2004. At December 31,1999 the Company was not in
compliance with certain of the financial covenants and
the loan has been classified as a current liability 445,000(1) $ 5,230,000
Notes payable
Note payable to Jenco Ambulette Service Inc., (net of imputed
interest at 9%) payable in quarterly principal payments of $16,667
due June 15, 1999 $ 159,000 (2)
Note payable to A-1 Ambulance Service Inc., bearing interest at
8.25%, payable in quarterly principal payments of $18,125
due June 12, 1998 109,000 (2)
Note payable for acquired businesses with an effective interest rate of 8.25%
payable in quarterly principal payments of $22,500 due June 12, 1998 135,000 (2)
Note payable to Elite Ambulance and Medical Coach Inc., bearing
interest at 7%, due on December 15, 2001 150,000
Note payable to Medical Transportation Corporation, (net of imputed
interest at 9%) due October 31, 1998 212,000 (2) $ 765,000
Capital lease obligations
For various equipment, collateralized by the underlying equipment, bearing
interest at 10.8% - 17.4% payable in monthly
installments of $6,836 due at various times through November 16, 2002 227,000
-------
6,222,000
Less current maturities (5,988,000)
-----------
$ 234,000
===========
</TABLE>
Future principal payments of long-term debt are as follows:
2000 $ 5,988,000
2001 121,000
2002 107,000
2003 6,000
------------
$ 6,222,000
============
F-11
<PAGE>
NOTE E - LONG TERM DEBT (CONTINUED)
(1) The revolving credit facility agreement, term loan and capital equipment
line of credit imposes certain restrictions on borrowings, capital
expenditures and the payment of dividends and requires the Company to meet
certain net worth and other financial ratios. The obligations are secured
by substantially all of the Company's assets. One of the major shareholders
has provided a limited guarantee of the obligations. At December 31, 1999,
the Company was not in compliance with certain of the financial covenants
and therefore the loan has been classified as a current liability.
(2) Payments of approximately $610,000 under these notes are in arrears because
of certain disputes with the noteholders. Management believes that
resolution of such disputes will not result in any material obligation in
excess of the amounts recorded in the Company's balance sheet.
NOTE F - INCOME TAXES
The differences between the tax benefit and the amount that would be computed by
applying the statutory federal income tax rate to income (loss) before taxes is
attributable to the following:
Year Ended
December 31,
1999 1998
Income tax benefit at 34% $(754,000) $(531,000)
Nondeductible items 11,000 77,000
State and local taxes, net of federal effect (104,000) (144,000)
Write off of prepaid income taxes 208,000 0
Increase (Decrease) in valuation reserve 207,000 70,000
Other 0 12,000
--------- ---------
$(432,000) $(516,000)
========= =========
F-12
<PAGE>
COMMUNITY MEDICAL TRANSPORT, INC. AND SUBSIDIARIES
Notes to Financial Statements
December 31, 1999 and 1998
NOTE F - INCOME TAXES (continued)
The tax effect of temporary differences which give rise to the net deferred tax
assets and deferred tax liabilities are as follows:
<TABLE>
<CAPTION>
Total Current Long-term
<S> <C> <C> <C>
Deferred tax liabilities:
Depreciation on property, equipment and leasehold
improvements $ 252,000 $ 0 $ 252,000
---------- ---------- ----------
Deferred tax assets:
Allowance for doubtful accounts 726,000 726,000 0
Net operating loss carry forwards 1,439,000 0 1,439,000
---------- ---------- ----------
2,165,000 726,000 1,439,000
Valuation allowance 757,000 254,000 _503,000
---------- ---------- ----------
1,408,000 472,000 _936,000
---------- ---------- ----------
Net deferred tax asset $1,156,000 $ 472,000 $ 684,000
========== ========== ==========
</TABLE>
As of December 31, 1999, the Company has approximately $3,269,000 of net
operating loss carryforwards available expiring in 2019.
The valuation allowance is based upon the expected sales of Empire Ambulance and
Ambulette Inc. and the First Help Ambulance and Ambulette Inc. licenses for
approximately $1,500,000 in excess of their tax basis and management's estimate
of the current fair market of Century Ambulance and Ambulette Inc. assets in
excess of the tax basis.
The Company has established a valuation allowance of $757,000 to reduce the
deferred tax asset to the amount management believes is realizable.
The companies 1996 and 1997 corporate income taxes are currently under audit by
the Internal Revenue Service. The Company believes that there will be no
material variance revealed during this audit examination.
NOTE G - STOCKHOLDERS' EQUITY
[1] Public offering:
In October 1994, the Company completed a public offering of 1,136,200
units at $4 per unit, each unit consisting of one share of common stock
and one redeemable ("Warrant") pursuant to a registration statement which
was declared effective by the Securities and Exchange Commission on
October 1, 1994, resulting in net proceeds of $3,343,000.
In connection therewith, the Company issued to the underwriters a warrant
("Underwriters Warrant") to purchase 100,000 units at $5.80 per unit
through September 30, 1999, which have expired. Such units are identical
to those sold in the public offering.
F-13
<PAGE>
NOTE G - STOCKHOLDERS' EQUITY (CONTINUED)
The Warrants are exercisable into one share of common stock, at a price of
$6.00 per share, for a period of five years commencing with the effective
date of the public offering. The Warrants are redeemable at a price of
$.10 per Warrant, if the closing bid quotation of the Company's common
stock is in excess of $8.00 per share for twenty consecutive trading days.
The common stock shares discussed above have not been adjusted for the one
for six reverse stock split in 1998.
[1] Public offering:
In November 1994, the Company issued warrants to purchase 60,000 shares of
common stock at $5.00 per share to its public relations firm, which
expired on October 31, 1999.
The common stock and warrants discussed above do not reflect the six to
one reverse stock split.
[2] Security offerings:
On May 31, 1996, the Company completed a private placement of 277,348
shares of common stock at a price of $6.40 per share, for net proceeds of
approximately $1,337,000. The placement agent of such offering received a
commission, a nonaccountable expense allowance, warrants to purchase up to
138,674 shares of common stock at $10.00 per share and unit purchase
options to purchase up to 27,734 units at $7.68 per unit. Each unit
consists of one share of common stock and one-half of a warrant, each full
warrant entitling the holder to purchase one share of common stock at
$10.00 per share.
On July 31, 1996 and August 7, 1996, the Company completed an equity
financing from foreign investors, for 3,437.5 shares of Series A
convertible preferred stock (the "Series A") with a liquidation value of
$3,437,000 and 5,000 shares of Series B convertible preferred stock (the
"Series B") with a liquidation value of $5,000,000, respectively, for net
proceeds of approximately $5,918,000. The preferred stockholders of each
series are entitled to a 4% cumulative dividend on the stated liquidation
value, and each share is convertible based on their liquidation by value
into shares of common stock at the lower of the market value for the five
trading days prior to conversion or $7.00 per share, and will
automatically convert on July 31, 1998. All fees and commissions
associated with such offerings are recorded against paid in capital. As of
December 31, 1996 all of the Series A have been converted into common
stock and 2,577 shares of Series B were converted into common stock. The
liquidation value of the remaining Series B was $2,423,000. In connection
with such foreign financing, warrants to purchase up to 135,000 shares of
common stock at $5.00 per share have been issued to a designee of a
consultant which expire on September 30, 2001.
During the first quarter of 1997, 467.5 shares of preferred stock were
converted into 145,286 common shares with 1955.5 Series B shares remaining
to be converted. Subsequent to this conversion, the Board of Directors
authorized the adoption of 7,500 shares of the Company authorized
preferred stock to be designated as series BB preferred stock (Series BB).
Series BB has the same rights and preferences as Series B except as
follows: eleven percent of each outstanding share shall be convertible
into common stock at any time after April 1, with an additional eleven
percent of each outstanding share to be convertible on the first day of
each of the next seven months, and the final twelve percent to be
convertible at any time after December 1. All outstanding shares will
automatically convert on July 31, 1998. The conversion was based upon the
liquidation value of the preferred stock and was exchangeable at $3.50 per
share.
The remaining 1955.5 shares of Series B preferred stock were exchanged for
1955.5 shares of Series BB preferred stock and 150,000 common stock
purchase warrants. These warrants are exercisable at an initial exercise
price of $4.00 per share, provided, however, that the purchase price may
be adjusted under certain circumstances. The expiration date of the common
stock purchase warrant is November 18, 2000. As of December 31, 1177.1
shares of Series BB had been converted into common stock. The liquidation
value of the remaining 778.4 Series BB was
F-14
<PAGE>
NOTE G - Stockholders' Equity (continued)
778,400, excluding $75,000 of cumulative dividends. In 1998 all of the
remaining Series BB were converted into 222,392 common shares. The common
stock shares discussed above have not been adjusted for the 1 for 6
reverse stock split.
[3] Stock option plans:
The Company applies Accounting Principles Board Opinion No. 25 in
accounting for its employee stock option and accordingly, recognizes
compensation expense for the difference between the fair value of the
underlying common stock and the exercise price of the option at the date
of the grant. The effect of applying Statement of Financial Accounting
Standards No. 123 ("SFAS # 123") on 1999 and 1998 and pro forma net income
(loss) as stated below is not necessarily representative of the effects on
reported net income for future years due to, among other things: (1) the
vesting period of the stock options and the (2) fair value of additional
stock options in future years. Had compensation cost for the Company's
stock option plans been determined based upon the fair value at the grant
date for awards under the plans consistent with the methodology prescribed
under SFAS No. 123, the Company's net loss in 1999 and 1998 and would have
been approximately $(1,825,000) and $(1,057,000) or $(1.83) per share and
$(1.06) per share, respectively. The weighed average fair value of the
options granted during 1999 and 1998 and are estimated as $1.13 and $ 2.43
per share, respectively, on the date of grant using the Black Scholes
option pricing model with the following assumptions: dividend yield 0%,
volatility of 183%, risk free interest rate of 6.0% for 1999 and dividend
yield 0%, volatility of 45% and risk free rate of 5.5% for 1998 and
expected life of 10 years.
The 1992 Employees Stock Option Plan, as amended (the "Plan") provides for
the granting of options to purchase up to 750,000 shares (125,000 shares
adjusted for the one for six reverse tock split in 1998) of the Company's
common stock. The Plan is administered by a Stock Option Committee (the
"Committee"), consisting of two members of the Board of Directors, which
has the authority to determine when options are granted, the term, the
exercise price and the exercise period.
Options granted to employees may be either incentive stock options
("ISOs") under the Internal Revenue Code or non-ISOs. The Committee may
determine the exercise price provided that in the case of ISOs, such price
may not be less than 100% (110% in the case of ISOs granted to holders of
10% of the voting power of the Company's stock) of the fair market value
of the Company's common stock at the date of grant. The aggregate fair
market value (determined at time of option grant) of stock with respect to
which ISOs become exercisable for the first time in any year cannot exceed
$100,000. Each option, unless sooner terminated, shall expire no later
than 10 years (five years in the case of ISOs granted to holders of 10% of
the voting power of the Company's stock) from the date of the grant.
Additional information with respect to options issued to employees under
the Plan is summarized below: The information set forth below has been
retroactively adjusted for the one for six reverse stock split in 1998.
<TABLE>
<CAPTION>
Year Ended December 31
---------------------------------------------------------
1999 1998
---------------------------------------------------------
Weighted Weighted
Average Average
Exercise Exercise
Shares Prices Shares Price
<S> <C> <C> <C> <C>
Outstanding at beginning of year 25,250 $ 7.21 38,000 $14.98
Options granted 60,000 1.13 4,416 3.75
Options exercised 0 0 0 0
Options canceled (2,500) 3.75 (17,166) 3.52
------- ---- -------- --------
Outstanding at end of year 82,750 $ 2.91 25,250 $ 7.21
====== ====== ======== =======
Options exercisable at year-end 82,750 $ 2.91 23,042 $ 7.54
====== ====== ======== =======
</TABLE>
F-15
<PAGE>
NOTE G - STOCKHOLDERS' EQUITY (CONTINUED)
[3] Stock option plans: (continued)
The following table summarizes information about stock options to employees
at December 31, 1999:
<TABLE>
<CAPTION>
Options Outstanding Options Exercisable
Weighted
Average
Remaining Weighted Weighted
Contractual Average Average
Range of Number Life Exercise Number Exercise
Exercise Price Outstanding (in Years) Price Exercisable Price
-------------- ----------- ---------- ----- ----------- -----
<S> <C> <C> <C> <C> <C>
$ 3.75 1,916 8.6 $ 3.75 1,916 $ 3.75
5.34 16,667 4.7 5.34 16,667 5.34
18.50 4,167 7.5 18.38 4,167 18.38
1.13 60,000 9.6 1.13 60,000 1.13
------ ---- ------ ----
82,750 $ 2.91 82.750 $ 2.91
====== ====== ====== ======
</TABLE>
The directors' stock option plan (the "Directors' Plan"), as amended, authorizes
the granting of stock options to purchase an aggregate of not more than 50,000
shares (8,333 shares adjusted for the one for six reverse tock split in 1998) of
the Company's common stock. Each director of the Company who is not an employee
of the Company shall be eligible for options under this plan. Options to
purchase 5,000 shares of stock shall automatically be granted under the
Directors' Plan each year. Each option granted is exercisable as to 50% of the
number of shares of stock covered thereby on the date of grant and as to the
balance on the first anniversary of the grant. The exercise price of each option
granted shall be the fair market value of the stock on the date the option is
granted. Options granted prior to November 11, 1996 were exercisable as to 50%
of the number of shares covered thereby on the first anniversary of such grant
and as to the balance on the second anniversary.
Additional information with respect to options issued to outside directors
under the Directors' Plan activity is summarized as follows:
<TABLE>
<CAPTION>
Year Ended December 31,
1999 1998
------------------------ ----------------------------
Weighted Weighted
Average Average
Exercise Exercise
Shares Price Shares Price
<S> <C> <C> <C> <C>
Outstanding at beginning of year 4,000 $ 3.75 4,000 $ 18.18
Options granted 833 3.37 4,000 3.75
Options canceled 0 0 (4,000) 18.18
----- ------ ------- ------
Options at end of year 4,833 $ 3.68 4,000 $ 3.75
===== ====== ======= ======
Options exercisable at year-end 4,833 $ 3.68 2,000 $ 3.75
===== ====== ======= ======
</TABLE>
F-16
<PAGE>
NOTE G - STOCKHOLDERS' EQUITY (CONTINUED)
[3] Stock option plans: (continued)
The following table summarizes information about stock options to
directors outstanding at December 31, 1999:
<TABLE>
<CAPTION>
Options Outstanding Options Exercisable
Weighted
Average
Remaining Weighted Weighted
Contractual Average Average
Range of Number Life Exercise Number Exercise
Exercise Price Outstanding In Years Price Exercisable Price
<S> <C> <C> <C> <C> <C>
$ 3.75 4,000 7.6 $ 3.75 4,000 $ 3.75
3.37 833 8.6 3.37 833 3.37
-------- ---------
4,833 4,833
======== =========
</TABLE>
[4] Warrants:
The Company has issued warrants to purchase its common stock principally
in connection with equity financing. Additional information with respect
to warrants is summarized below.
<TABLE>
<CAPTION>
Year Ended December 31, .
1999 1998
Weighted Weighted-
Average Average
Exercise Exercise
Shares Price Shares Price
<S> <C> <C> <C> <C>
Outstanding at the beginning of year 291,899 $ 36.49 291,899 $ 36.49
Warrants expired 281,976 38.15 0 0
-------- ------- ------------- -----------
Warrants outstanding at end of year 72,923 $ 38.40 291,899 $ 36.49
====== ======= ========= ========
Warrants exercisable at year-end 291,899 $ 38.40 291,899 $ 36.49
======= ======= ========= ========
</TABLE>
F-17
<PAGE>
NOTE G - STOCKHOLDERS' EQUITY (CONTINUED)
[4] Warrants:
The following table summarizes information related to warrants outstanding
at December 31, 1999:
<TABLE>
<CAPTION>
Warrants Outstanding Warrants Exercisable
Weighted
Average
Remaining Weighted Weighted
Contractual Average Average
Range of Number Life Exercise Number Exercise
Exercise Price Outstanding In Years Price Exercisable Price
<S> <C> <C> <C> <C> <C> <C>
$24.00 25,000 2 $24.00 25,000 $24.00
$30.00 22,500 2 $30.00 32,500 $30.00
$34.80-$36.00 0 - $35.88 204,354 $35.88
$46.08-$60.00 25,423 1 $57.84 30,045 $57.84
--------- ----------
72,923 291,899
======== ==========
</TABLE>
[5] Shares reserved or available for future issuance:
Shares of common stock reserved for future issuance are:
Options granted under the plan 82,750
Options available for grant under the Plan 42,250
Options granted under the Director Plan 4,833
Options available for grant under the Director's Plan 3,500
Warrants issued in connection with private equity financing 72,923
Issuable in connection with Fox Ridge acquisition 10,833
-------
217,089
NOTE H - CONCENTRATION OF RISK
Revenues from principal sources are as follows:
Year Ended
December 31,
1999 1998
----- ----
Principal Customer 10 % 11%
Medicaid and Medicare 33 39
Private insurance and other 57 50
100 % 100%
F-18
<PAGE>
NOTE H - CONCENTRATION OF RISK (CONTINUED)
[1] Reliance on principal customers:
The Company provides services to a principal customer, a hospital and its
affiliates, pursuant to two written contracts, which expired on December
31, 1999, of which one of the contracts was renewed through December 31,
2001, and the other contract did not renew. These contracts give the
Company the exclusive right to provide medical transportation services for
the patients of this customer. The contracts may be terminated by the
hospital if the Company fails to perform its obligations thereunder. These
contracts can also be renegotiated by the hospital if there is a decrease
in services.
[2] Dependence on governmental reimbursement:
The Company derives the majority of its revenue from reimbursement by
third party payers, particularly Medicaid and Medicare, typically
invoicing and collecting payments directly from the third party payer.
Reimbursement can be influenced by the financial instability of private
third party payers and the budget pressures and cost shifting by
governmental payers. A reduction in coverage or reimbursement rates by
third party payers could have a material adverse effect on the Company's
results of operations.
The Company is subject to audits of its Medicaid and Medicare
reimbursement claims by third-party fiscal intermediaries and governmental
agencies. In the opinion of management adjustments would not be material
to the financial position or results of operations of the Company. As a
provider of services under the Medicaid and Medicare programs, the Company
is also subject to the Medicaid and Medicare fraud and abuse laws.
At December 31, 1999, 32% of accounts receivable was due from Medicaid and
Medicare, 28% from the hospital facilities, which includes its principal
customer and its affiliates and 40% from private insurers and other
nongovernmental sources.
NOTE I - EMPLOYEE BENEFITS
[1] 401(k) Retirement Savings Plan:
In November 1996, the Board of Directors authorized the adoption of a
401(k) Retirement Savings Plan (the "401(k) Plan") with an effective date
of adoption of January 1, 1997. The 401(k) Plan covers all employees who
meet the 401(k) Plan's eligibility requirements. Eligible employees may
elect to defer up to 15% of their yearly compensation, as defined.
Employer contributions are discretionary. A favorable determination letter
has been received from the Internal Revenue Service, and participation in
the Plan began April 1, 1997. The Company elected to make a contribution
to the Plan of 10,253 shares of the Company's common stock. Such shares
were funded in March 1998.
NOTE J - CONTINGENCIES
On February 12,1998, the Chapter 7 Trustee of BR Ambulance Service, Inc. ("BR")
filed a complaint ("Complaint") against the Company alleging that the Company
was the recipient of fraudulent conveyances from BR arising out of an asset
purchase agreement between the Company and BR dated March 12, 1995 wherein the
Company allegedly agreed to purchase the assets of BR for a base price of $2.0
million plus additional consideration to be calculated pursuant to a formula.
The Complaint further alleges that BR subsequently transferred various assets to
the Company but the Company did not pay the specified consideration and
accordingly, owes BR not less than $2.0 million. The Company vigorously disputes
the material allegations of the Complaint.
F-19
<PAGE>
NOTE J - CONTINGENCIES (CONTINUED)
An action was filed by Medical Transportation Corp. ("Med-Trans") alleging that
during the twelve-month period commencing December 1, 1996 and ending November
30, 1997 the Company deliberately terminated relationships with numerous
customers and unilaterally ceased to provide services to such customers.
Med-Trans is the holder of a promissory note (Note E) which is subject to
adjustment based on total annual revenues from an ambulette business acquired
from Med-Trans. Med-Trans is seeking payment in the amount of $228,000. The
Company filed an answer to the complaint on March 30, 1998, together with
affirmative defenses, stating, among other things, that at no time did the
Company voluntarily decide not to service a customer. The Company intends to
vigorously oppose this action.
An action was brought by the former chief operating officer of a subsidiary,
arising out of the termination of his employment. The matter was tried by an
Attorney Trial Referee "(ATF)", and on October 12,1999 the ATF recommended
against the Company awarding the plaintiff $276,000 plus interest. Motion to
correct the recommendation was denied by the ATF. The superior court will decide
whether to accept the recommendation. The Company was required to post a bond in
the amount of $330,000 to ensure satisfaction of the award.
In connection with a 1997 acquisition, in 1999 the seller brought an action
against the Company, seeking among other things approximately $655,000 plus
interest representing the guaranteed amount of 21,828 common shares. (adjusted
for the 1 to 6 reverse split). The Company intends to defend the action
vigorously and believes it has strong defenses and counterclaims.
Various other actions have been filed against the Company principally relating
to alleged breach of employment agreements in connection with certain
acquisitions. The claimants in the actions seek an aggregate of $589,000, plus
punitive damages. The actions are at various stages and the Company believes it
has valid and meritorious defenses.
The ultimate outcome of the above-mentioned Complaint and actions cannot
presently be determined. Accordingly, no provision for any liability that may
result, if any, has been made in the financial statements.
NOTE K - GOING CONCERN
Theses financial statements are presented on the basis that the Company is a
going concern. Going concern contemplated the realization of assets and the
satisfaction of liabilities in the normal course of business over a reasonable
length of time. The Company has sustained recurring operating losses of
$1,787,000 and $1,045,000 in 1999 and 1998, respectively, and is in default on
certain covenants of its loan agreement and is in arrears on account payable
with certain vendors and creditors. In addition the company has a working
capital deficiency of $3,264,000 at December 31, 1999. These conditions raise
substantial doubt about its ability to continue as a going concern.
The company is exploring various options to fund future operations, including
the sale of assets and raising capital from other sources, including the sale of
part or all of the Company.
NOTE L - RECENT ACCOUNTING PRONOUNCEMENTS
In 1999, the Financial Accounting Standards Board issued Statements of
Accounting Standards, No. 133, Accounting for Derivative Instruments and Hedging
Activities. The Company believes that this pronouncement did not have a material
impact on the consolidated financial statements.
F-20
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City of White
Plains, State of New York, on the 15th day of April, 2000.
COMMUNITY MEDICAL TRANSPORT, INC.
By: /s/ Dean L. Sloane
-------------------------------------
Dean L. Sloane,
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signatures Capacity Date
- -------------------------- --------------------------------------------------- ------------------
<S> <C> <C>
/s/ Dean L. Sloane Director, President and Chief Executive April 15, 2000
- ------------------ Officer (Principal Executive Officer, Principal
Dean L. Sloane Financial and Accounting Officer)
/s/ Craig V. Sloane Director April 15, 2000
- -------------------
Craig V. Sloane
/s/ Bernard M. Kruger Director April 15, 2000
- ---------------------
Bernard M. Kruger
/s/ Lucius J. Riccio Director April 15, 2000
- --------------------
Lucius J. Riccio
</TABLE>
<PAGE>
EXHIBIT 3.2
CERTIFICATE OF AMENDMENT
OF
CERTIFICATE OF INCORPORATION
OF
COMMUNITY MEDICAL TRANSPORT, INC.
- --------------------------------------------------------------------------------
Pursuant to Section 242 of the General
Corporation Law of the State of Delaware
- --------------------------------------------------------------------------------
COMMUNITY MEDICAL TRANSPORT, INC., a Delaware corporation (the "Corporation"),
does hereby certify as follows:
FIRST: that this Amendment shall provide for a reverse stock split (the
"Reverse Stock Split") of the Corporation's common stock, par value $.001, per
share (the "Old Common Stock"), whereby each 6 shares of Old Common Stock shall
be combined into one validly issued share of new common stock (the "New Common
Stock"), the par value of which shall remain unchanged. Fractional shares will
be rounded up to the nearest whole number.
SECOND: that this Amendment was duly adopted in accordance with the
provisions of Section 242 of the General Corporation Law of the State of
Delaware.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of
Amendment of Certificate of Incorporation on the 2nd day of December, 1998, and
affirms that the statements contained herein are true under the penalty of
perjury.
COMMUNITY MEDICAL TRANSPORT, INC.
By: /s/ Dean L. Sloane
------------------------------
Name: Dean L. Sloane
Title: Chief Executive Officer
ATTEST:
By: /s/ Craig V. Sloane
-------------------------
Name: Craig V. Sloane
Title: Secretary
<PAGE>
CERTIFICATE OF AMENDMENT
OF
CERTIFICATE OF INCORPORATION
OF
COMMUNITY MEDICAL TRANSPORT, INC.
- --------------------------------------------------------------------------------
Pursuant to Section 242 of the General
Corporation Law of the State of Delaware
- --------------------------------------------------------------------------------
COMMUNITY MEDICAL TRANSPORT, INC., a Delaware corporation (the "Corporation"),
does hereby certify as follows:
FIRST: that this Amendment shall provide for a change in the total
number of shares of capital stock which the Corporation shall have the authority
to issue.
SECOND: that the paragraphs labeled 4 and 4.A in the Company's
Certificate of Incorporation, as amended, is hereby amended so that they shall
read as follows:
4. The total number of shares of stock which the Corporation shall have
authority to issue is 6,000,000, which shall consist of (i) 5,000,000 shares,
par value $.001 per share, designated as Common Stock (the "Common Stock") and
(ii) 1,000,000 shares, par value $.001 per share, designated as Preferred Stock
(the "Preferred Stock").
A. Common Stock. Subject to the provisions of any series of Preferred
Stock which may at the time be outstanding, the holders of shares
of Common Stock shall be entitled to receive, when and as declared
by the Board of Directors out of any funds legally available for
the purpose, such dividends as may be declared from time to time by
the Board of Directors. In the event of the liquidation of the
Corporation, or upon distribution of its assets, after the payment
in full or the setting apart for payment of such preferential
amounts, if any, as the holders of shares of Preferred Stock at the
time outstanding shall be entitled, the remaining assets of the
Corporation available for payment and distribution to holders of
shares of Common Stock shall, subject to any participating or
similar rights of shares of Preferred Stock at the time
outstanding, be distributed ratably among the holders of shares of
Common Stock at the time outstanding. All shares of Common Stock
shall have no preference, conversion, exchange, preemptive or
redemption rights. The entire voting power shall be vested in the
shares of Common Stock. All shares of Common Stock shall have
equal, non-cumulative voting rights.
THIRD: that this Amendment was duly adopted in accordance with the
provisions of Section 242 of the General Corporation Law of the State of
Delaware.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of
Amendment of Certificate of Incorporation on the 2nd day of December, 1998, and
affirms that the statements contained herein are true under the penalty of
perjury.
COMMUNITY MEDICAL TRANSPORT, INC.
By: /s/ Dean L. Sloane
------------------------------
Name: Dean L. Sloane
Title: Chief Executive Officer
ATTEST:
By: /s/ Craig V. Sloane
-------------------------
Name: Craig V. Sloane
Title: Secretary
<PAGE>
EXHIBIT-10.16
FINOVA CAPITAL CORPORATION
LOAN AND SECURITY AGREEMENT
Community Medical Transport, Inc. and Subsidiaries
(each a Borrower and collectively, the "Borrowers" or "Borrower")
4 Gannett Drive
White Plains, New York, 10604
Address
13-3507464
Borrower Fed ID Tax No.
$8,950,000
Credit Limit
February 2, 1999
Date
<PAGE>
================================================================================
HEALTHCARE FINANCE
================================================================================
TABLE OF CONTENTS
to
LOAN AND SECURITY AGREEMENT
1. DEFINITIONS ........................................................ 1
1.1 Defined Terms .............................................. 1
1.2 Other Terms ................................................ 7
2 LOANS, INTEREST RATE AND OTHER CHARGES.............................. 7
2.1 Total Facility ............................................. 7
2.2 Loans ...................................................... 7
2.3 Overlines; Overadvances .................................... 7
2.4 Intentionally Omitted ...................................... 7
2.5 Loan Account ............................................... 7
2.6 Interest; Fees ............................................. 8
2.7 Default Interest Rate ...................................... 8
2.8 Examination Fees ........................................... 8
2.9 Excess Interest ............................................ 8
2.10 Principal Payments; Proceeds of Collateral ................. 9
2.11 Application of Collateral .................................. 10
2.12 Application of Payments .................................... 11
2.13 Notification of Closing .................................... 11
3. SECURITY ........................................................... 11
3.1 Security Interest in the Collateral ........................ 11
3.2 Perfection and Protection of Security Interest ............. 11
3.3 Preservation of Collateral ................................. 12
3.4 Insurance .................................................. 12
3.5 Collateral Reporting; Inventory ............................ 12
3.6 Eligibility; Reserves; Advance Rates; Disputes ............. 12
3.7 Equipment .................................................. 13
3.8 Rental Documents Collateral ................................ 13
3.9 Other Liens; No Disposition of Collateral .................. 13
3.10 Collateral Security ........................................ 13
4. CONDITIONS OF CLOSING............................................... 14
4.1 Initial Advance ............................................ 14
4.2 Subsequent Advances ........................................ 16
5. GENERAL REPRESENTATIONS AND WARRANTIES.............................. 16
5.1 Due Organization ........................................... 16
5.2 Other Names ................................................ 16
5.3 Due Authorization .......................................... 16
5.4 Binding Obligation ......................................... 17
5.5 Intangible Property ........................................ 17
5.6 Capital .................................................... 17
5.7 Material Litigation ........................................ 17
5.8 Title; Security Interests of FINOVA ........................ 17
5.9 Restrictive Agreements; Labor Contracts .................... 17
5.10 Laws ....................................................... 17
5.11 Consents ................................................... 17
<PAGE>
5.12 Defaults ................................................... 17
5.13 Financial Condition ........................................ 17
5.14 ERISA ...................................................... 17
5.15 Taxes ...................................................... 18
5.16 Locations; Federal Tax ID No ............................... 18
5.17 Business Relationships ..................................... 18
5.18 Millennium Compliance ...................................... 18
5.19 Healthcare Representations and Warranties .................. 18
6. COVENANTS............................................................ 22
6.1 Affirmative Covenants ....................................... 22
6.2 Negative Covenants .......................................... 24
7. DEFAULT AND REMEDIES ................................................ 25
7.1 Events of Default ........................................... 25
7.2 Remedies .................................................... 26
7.3 Standards for Determining Commercial Reasonableness ......... 26
8. EXPENSES AND INDEMNITIES ............................................ 27
8.1 Expenses .................................................... 27
8.2 Environmental Matters ....................................... 27
9. MISCELLANEOUS ....................................................... 27
9.1 Examination of Records; Financial Reporting ................. 27
9.2 Term; Termination ........................................... 28
9.3 Recourse to Security; Certain Waivers ....................... 28
9.4 No Waiver by FINOVA ......................................... 28
9.5 Binding on Successor and Assigns ............................ 28
9.6 Severability ................................................ 28
9.7 Amendments; Assignments ..................................... 28
9.8 Integration ................................................. 29
9.9 Survival .................................................... 29
9.10 Evidence of Obligations ..................................... 29
9.11 Loan Requests ............................................... 29
9.12 Notices ..................................................... 29
9.13 Brokerage Fees .............................................. 29
9.14 Disclosure .................................................. 29
9.15 Publicity ................................................... 29
9.16 Captions .................................................... 29
9.17 Injunctive Relief ........................................... 29
9.18 Counterparts; Facsimile Execution ........................... 29
9.19 Construction ................................................ 29
9.20 Time of Essence ............................................. 29
9.21 Limitation of Actions ....................................... 30
9.22 Liability ................................................... 30
9.23 Notice of Breach by FINOVA .................................. 30
9.24 Application of Insurance Proceeds ........................... 30
9.25 Power of Attorney ........................................... 30
9.26 Governing Law; Waivers ...................................... 30
9.27 MUTUAL WAIVER OF RIGHT TO JURY TRIAL ........................ 31
9.28 Lien Termination ............................................ 31
9.29 Intentionally Omitted ....................................... 31
9.30 Releases; Indemnities ....................................... 31
<PAGE>
LOAN AND SECURITY AGREEMENT
This LOAN AND SECURITY AGREEMENT (collectively with the schedule to Loan
Agreement (the "Schedule") attached hereto, the "Agreement") dated the date set
forth on the cover page, is entered into by and between Community Medical
Transport, Inc.; Community Ambulette Service, Inc; First Help Ambulance and
Ambulette, Inc.; Empire Ambulance and Ambulette, Inc.; Century Ambulance and
Ambulette, Inc.; Richards/Decker Operating Company, Inc.; Elite Ambulance and
Medical Coach, Inc.; Hudson Valley Medtex, Inc.; Clove Professional Services,
Inc.; Consolidated Collections, Inc.; and Richards/Decker Payroll Company, Inc.
(each a "Borrower" and collectively, the "Borrowers" or "Borrower"), whose
address is set forth on the cover page and FINOVA Capital Corporation
("FINOVA"), having an office at 311 South Wacker Drive, Suite 4400, Chicago,
Illinois 60606.
1. DEFINITIONS.
1.1 Defined Terms. As used in this Agreement, the following terms have
the definitions set forth below:
"ADA" has the meaning set forth in Section 4.1(z) hereof.
"Additional Sums" has the meaning set forth in Section 2.9(a) hereof.
"Affiliate" means any Person controlling, controlled by or under common
control with Borrower. For purposes of this definition, "control" means the
possession, directly or indirectly, of the power to direct or cause direction of
the management and policies of any Person, whether through ownership of common
or preferred stock or other equity interests, by contract or otherwise. Without
limiting the generality of the foregoing, each of the following shall be an
Affiliate: any officer, director, employee or other agent of Borrower, any
shareholder, member or subsidiary of Borrower, and any other Person with whom or
which Borrower has common shareholders, officers or directors.
"Agreement" has the meaning set forth in the preamble.
"Applicable Usury Law" has the meaning set forth in Section 2.9(b)
hereof.
"Blocked Account" has the meaning set forth in Section 2.10(c) hereof.
"Business Day" means any day on which commercial banks in both Chicago,
Illinois and Phoenix, Arizona are open for business.
"Capital Expenditures" means all expenditures made and liabilities
incurred for the acquisition of any fixed asset or improvement, replacement,
substitution or addition thereto which has a useful life of more than one year
and including, without limitation, those arising in connection with Capital
Leases.
"Capital Lease" means any lease of property by Borrower that, in
accordance with GAAP, should be capitalized for financial reporting purposes and
reflected as a liability on the balance sheet of Borrower.
"Change of Control" means (i) a "person" or "group" (within the meaning
of Sections 13(D) and 14(D)(II) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act") becomes the ultimate "Beneficial Owner" (as defined
in Rule 13D-3 under the Exchange Act) of more than 30% of the total voting power
of the voting stock of the Borrower on a fully diluted basis or (ii) a majority
of the Board of Directors of the Borrower then in office shall not consist of
individuals who on the closing date constitute the Board of Directors of the
Borrower or new Directors whose election or whose nomination for election any
stockholders, was approved by at least two thirds of the members of the Board of
Directors then in office who were either members of the Board of Directors on
the closing date or whose election or nomination was previously so approved.
"Closing Date" means the date of the initial advance made by FINOVA
pursuant to this Agreement.
"Closing Fee" has the meaning set forth in the Schedule.
"Code" means the Uniform Commercial Code as adopted and in effect in the
State of Arizona from time to time.
"Collateral" has the meaning set forth in Section 3.1 hereof.
"Compliance Certificate" has the meaning set forth in Section 9.1(b)
hereof.
"Cost Report Settlements" means, collectively, all amounts owing to
Borrower from the applicable Governmental Authority in connection with Medicare
and Medicaid cost reports, for any period of determination.
<PAGE>
"Current Assets" at any date means the amount at which the current
assets of Borrower would be shown on a balance sheet of Borrower as at such
date, prepared in accordance with GAAP, provided that amounts due from
Affiliates and investments in Affiliates shall be excluded therefrom.
"Current Liabilities" at any date means the amount at which the current
liabilities of Borrower would be shown on a balance sheet of Borrower as at such
date, prepared in accordance with generally accepted accounting principles.
"Deposit Accounts" has the meaning set forth in Section 9-105 of the
Code.
"Depository Account Agreement" has the meaning set forth in Section 2.10
hereof.
"Document Checklist" means that certain Document Checklist listing the
Loan Documents and other documents, instruments and certificates to be delivered
to FINOVA on the Closing Date.
"Dominion Account" has the meaning set forth in Section 2.10(c) hereof.
"Earnings Before Interest, Taxes, Depreciation and Amortization" for any
fiscal period of Borrower means the net income of Borrower for such fiscal
period, plus interest expense, depreciation and amortization, and provision for
income taxes for such fiscal period, and minus non-recurring miscellaneous
income and expenses, all calculated in accordance with GAAP.
"Eligible Receivables" means Receivables arising in the ordinary course
of Borrower's business from the sale of goods or rendition of services, which
FINOVA, in its Permitted Discretion, shall deem eligible based on such
considerations as FINOVA may from time to time deem appropriate. Without
limiting the foregoing, a Receivable shall NOT be deemed to be an Eligible
Receivable if (i) the account debtor or Payor of the claim has failed to pay the
Receivable within a period of one hundred fifty (150) days after the date of
providing the service or goods creating such Receivable, to the extent of any
amount remaining unpaid after such period; (ii) ninety percent (90%) or more of
the outstanding Receivables owed to Borrower by the account debtor or Payor have
been outstanding one hundred fifty (150) days or more after the date the service
or goods were provided; (iii) the Payor is an Affiliate of Borrower; (iv) the
Receivable does not arise out of the delivery by Borrower of medical, surgical,
diagnostic or other professional or institutional medical goods or services, and
as to which a portion if payable by a third-party Payor or intermediary
acceptable to FINOVA including any amounts due Borrower under any cost
settlement reports from any source or the goods relating thereto are subject to
terms pursuant to which payment by the account debtor or Payor may be
conditional; (v) the account debtor or Payor is not located in the United
States; (vi) the account debtor or Payor is the United States or any department,
agency or instrumentality thereof or any State, city or municipality of the
United States and Borrower has not issued remittance directions to such account
debtor or Payor acceptable to FINOVA; (vii) Borrower is or may become liable to
the account debtor or Payor for goods sold or services rendered by the account
debtor or Payor to Borrower; (viii) the account debtor's or Payor's total
obligations to Borrower (except for any Governmental Authority) exceed twenty
percent (20%) of all Eligible Receivables, to the extent of such excess; (ix)
the account debtor or Payor disputes liability or makes any claim with respect
thereto (up to the amount of such liability or claim), or is subject to any
insolvency or bankruptcy proceeding, or becomes insolvent, fails or goes out of
a material portion of its business; (x) the amount thereof consists of late
charges or finance charges to the extent of the amount of such late charges or
finance charges; (xi) the amount thereof consists of a credit balance more than
ninety (90) days past due; or (xii) the face amount of any single claim thereof
exceeds $140,000 unless accompanied by evidence of claim relating thereto
satisfactory to FINOVA in its Permitted Discretion; (xiii) the account debtor is
a Payor not approved by FINOVA or is an individual or private party not in the
business of paying medical claims, (xiv) if the accounts are workers
compensation claims in excess of $5,000 in the aggregate, (xv) the
representations and warranties with respect to such Receivable set forth in
Section 5.19 of this Agreement have been breached or are no longer true and
correct or (xvi) the Receivable is a Governmental Receivable and Borrower is not
duly certified by the applicable Governmental Authority of its Medicare and
Medicaid provider status.
2
<PAGE>
"Equipment Acquisition Line" has the meaning set forth in Schedules.
"Equipment" means all of Borrower's present and hereafter acquired
equipment, durable and non-durable medical equipment, machinery, furniture,
furnishings, fixtures, trade fixtures, motor vehicles, tools, parts, goods and
other tangible personal property (other than Inventory) of every kind and
description used in Borrower's operations or owned by Borrower and any interest
in any of the foregoing, and all attachments, accessories, accessions,
replacements, substitutions, additions or improvements to any of the foregoing,
wherever located.
"ERISA" means the Employee Retirement Income Security Act of 1974, as
amended, and the regulations thereunder.
"ERISA Affiliate" means each trade or business (whether or not
incorporated and whether or not foreign) which is or may hereafter become a
member of a group of which Borrower is a member and which is treated as a single
employer under ERISA Section 4001(b)(1), or IRC Section 414.
"Event of Default" means any of the events set forth in Section 7.1 of
this Agreement.
"Examination Fee" has the meaning set forth in the Schedule.
"Excess Availability" means, as of the date of determination thereof,
the amount by which the average daily total principal balance of the Receivable
Loan which Borrower would be permitted based on the formulas and reserves set
forth in the Schedule hereof and in the Schedule, exceeds the principal amount
of the Receivable Loan then actually outstanding such excess then being reduced
by an amount necessary to provide for the payment of all accounts payable of
Borrower which are more than thirty (30) days past due date and all book
overdrafts.
"Excess Cash Flow" means Operating Cash Flow/Permitted less each of (i)
Total Contractual Debt Service; (ii) Management Fees actually paid, to the
extent permitted hereunder; and (iii) Preferred Stock Dividends actually paid,
to the extent permitted hereunder.
"Expected Net Receivable" means with respect to each Receivable the
amount reasonably expected by FINOVA, in consultation with Borrower, to be
collected on such Receivable within a defined time period based on the amount
billed to the Payor by Borrower multiplied by the applicable Cash-To-Charge
Ratio. The applicable Cash-To-Charge Ratio for each Receivable class recognized
by FINOVA will be subject to change based on actual collection experience and
other relevant factors determined by FINOVA in its sole discretion in order to
assure that over time the Expected Net Receivables of all Receivables is not
less than the amount actually collected with respect to such Receivables within
a defined time period. The Cash-To-Charge Ratio for a Payor class shall reflect
credit losses with respect to such Payor class.
"Facility Fee" has the meaning set forth in the Schedule.
"FINOVA Affiliate" has the meaning set forth in Section 9.22 hereof.
"GAAP" means generally accepted accounting principles in the United
States of America as in effect from time to time as set forth in the opinions
and pronouncements of the Accounting Principles Board and the American Institute
of Certified Public Accountants and the statements and pronouncements of the
Financial Accounting Standards Boards which are applicable to the circumstances
as of the date of determination consistently applied, except that, for the
financial covenants set forth in this Agreement, GAAP shall be determined on the
basis of such principles in effect on the date hereof and consistent with those
used in the preparation of the audited financial statements delivered to FINOVA
prior to the date hereof.
"General Intangibles" means all general intangibles of Borrower, whether
now owned or hereafter created or acquired by Borrower, including, without
limitation, all choses in action, causes of action, corporate or other business
records, Deposit Accounts, inventions, designs, drawings, blueprints,
Trademarks, Copyrights, Licenses and Patents, names, trade secrets, goodwill,
copyrights, registrations, licenses, franchises, customer lists, security and
other deposits, rights in all litigation presently or hereafter pending for any
cause or claim (whether in contract, tort or otherwise), and all judgments now
or hereafter arising therefrom, all claims of Borrower against FINOVA, rights to
purchase or sell real or personal property, rights as a licensor or licensee of
any kind, royalties, telephone numbers, proprietary information, purchase
orders, and all insurance policies and claims (including without limitation
credit, liability, property and other insurance) tax refunds and claims,
computer programs, discs, tapes and tape files, claims under guaranties,
security interests or other security held by or granted to Borrower to secure
payment of any of the Receivables by an account debtor, all contractual rights,
all rights under Provider Agreements, all rights to indemnification and all
other intangible property of every kind and nature (other than Receivables).
3
<PAGE>
"Governmental Authority" means any nation or government, governmental
agency or instrumentality, state or other political subdivision thereof and any
entity exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government; including, without limitation, HCFA
and state Medicaid administrative agencies.
"Governmental Receivables" shall mean Receivables where the Payor is the
United States of America, a state, or any agency or instrumentality thereof
which is obligated to make any payments with respect to Medicare, Medicaid, or
other Receivables representing amounts owing under any other program established
by federal or state law which requires that payments for healthcare services be
made to the providers of such services (including CHAMPUS as set forth in Title
10 U.S.C. Section 1071 et. seq., and the program set forth in Title 38 U.S.C.
Section 1713).
"Guarantor(s)" means any Person described on the Schedule as Guarantor.
"HCFA" means the Health Care Financing Administration.
"Indebtedness" means all of Borrower's present and future obligations,
liabilities, debts, claims and indebtedness, contingent, fixed or otherwise,
however evidenced, created, incurred, acquired, owing or arising, whether under
written or oral agreement, operation of law or otherwise, and includes, without
limiting the foregoing (i) the Obligations, (ii) obligations and liabilities of
any Person secured by a lien, claim, encumbrance or security interest upon
property owned by Borrower, even though Borrower has not assumed or become
liable therefor, (iii) obligations and liabilities created or arising under any
lease (including Capital Leases) or conditional sales contract or other title
retention agreement with respect to property used or acquired by Borrower, even
though the rights and remedies of the lessor, seller or lender are limited to
repossession, (iv) all unfunded pension fund obligations and liabilities and (v)
deferred taxes.
"Initial Term" has the meaning set forth on the Schedule.
"Insurer" means any Person which in the ordinary course of its business
or activities agrees to pay for healthcare goods and services received by
individuals, including a commercial insurance company, a non-profit insurance
company (such as a Blue Cross/Blue Shield entity), an employer or union which
self-insures for employee or member health insurance and a health maintenance
organization. "Insurer" includes, without limitation, insurance companies
issuing health, personal injury, worker's compensation or other types of
insurance, corporations, hospitals and third party intermediaries but does not
include any individual guarantors or employee benefit plans.
"Inventory" means all of Borrower's now owned and hereafter acquired
goods, merchandise or other personal property, wherever located, to be furnished
under any contract of service or held for sale or lease, all raw materials, work
in process, finished goods and materials and supplies of any kind, nature or
description which are or might be used or consumed in Borrower's business or
used in connection with the manufacture, packing, shipping, advertising, selling
or finishing of such goods, merchandise or other personal property, and all
documents of title or other documents representing them.
"IRC" means the Internal Revenue Code of 1986, as amended, and the
regulations thereunder.
"Loan Documents" means, collectively, this Agreement, any note or notes
executed by Borrower and payable to FINOVA, and any other present or future
agreement entered into in connection with this Agreement, together with all
alterations, amendments, changes, extensions, modifications, refinancings,
refundings, renewals, replacements, restatements, or supplements, of or to any
of the foregoing.
"Loan Party" means Borrower, any Guarantor, any Person entering into a
Validity and Support Agreement, any Person entering into a Collection Custodial
Agreement, each Subordinating Creditor and each other party (other than FINOVA)
to any Loan Document.
"Loan Reserves" means as of the date of determination, such amounts as
FINOVA may from time to time establish and revise in good faith reducing the
amount of Receivable Loans which would otherwise be available to Borrower under
the lending formula provided in the Schedule: (a) to reflect events, conditions,
contingencies or risks which, as determined by FINOVA in good faith, do or may
affect either (i) the Collateral or any other property which is security for the
Obligations or its value, (ii) the assets, business or prospects of Borrower or
any Guarantor or (iii) the security interests and other rights of FINOVA in the
Collateral (including the enforceability, perfection and priority thereof) or
(b) to reflect FINOVA's good faith belief that any collateral report or
financial information furnished by or on behalf of Borrower or any Guarantor to
FINOVA is or may have been incomplete, inaccurate or misleading in any material
respect or (c) in respect of any state of facts which FINOVA determines in good
faith constitutes an Event of Default or may, with notice or passage of time or
both, constitute an Event of Default.
4
<PAGE>
"Loan Year" means each twelve month period commencing on the Closing
Date.
"Loans" has the meaning set forth in Section 2.2 hereof.
"Lock Box Accounts" has the meaning set forth in Section 2.10 hereof.
"Maximum Interest Rate" has the meaning set forth in Section 2.9(b)
hereof.
"Multiemployer Plan" means a "multiemployer plan" as defined in ERISA
Sections 3(37) or 4001(a)(3) or IRC Section 414(f) which covers employees of
Borrower or any ERISA Affiliate.
"Minimum Interest Charge" has the meaning set forth in the Schedule.
"Net Worth" at any date means the Borrower's net worth as determined in
accordance with GAAP.
"Obligations" means all present and future loans, advances, debts,
liabilities, obligations, covenants, duties and indebtedness at any time owing
by Borrower to FINOVA, whether evidenced by this Agreement, any note or other
instrument or document, whether arising from an extension of credit, opening of
a letter of credit, banker's acceptance, loan, guaranty, indemnification or
otherwise, whether direct or indirect (including, without limitation, those
acquired by assignment and any participation by FINOVA in Borrower's debts owing
to others), absolute or contingent, due or to become due, including, without
limitation, all interest, charges, expenses, fees, attorney's fees, expert
witness fees, Examination Fees, letter of credit fees, collateral monitoring
fees, closing fees, facility fees, Termination Fees, minimum interest charges
and any other sums chargeable to Borrower hereunder or under any other agreement
with FINOVA.
"Offset Reserve" shall have the meaning set forth in Section 3.6 hereof.
"Operating Cash Flow/Actual" means, for any period, Borrower's net
income or loss (excluding the effect of any extraordinary gains or losses),
determined in accordance with GAAP, plus or minus each of the following items,
to the extent deducted from or added to the revenues of Borrower in the
calculation of net income or loss: (i) depreciation; (ii) amortization and other
non-cash charges; (iii) interest expense paid or accrued; (iv) total federal and
state income tax expense determined as the accrued liability of Borrower in
respect of such period, regardless of what portion of such expense has actually
been paid by Borrower during such period; and (v) Management Fees paid, to the
extent permitted hereunder, and after deduction for each of (a) federal and
state income taxes, to the extent actually paid during such period; (b) any
non-cash income; and (c) all actual Capital Expenditures made during such period
and not financed.
"Operating Cash Flow/Permitted" means, for any period, Borrower's net
income or loss (excluding the effect of any extraordinary gains or losses),
determined in accordance with GAAP, plus or minus each of the following items,
to the extent deducted from or added to the revenues of Borrower in the
calculation of net income or loss: (i) depreciation; (ii) amortization and other
non-cash charges; (iii) interest expense paid or accrued; (iv) total federal and
state income tax expense determined as the accrued liability of Borrower in
respect of such period, regardless of what portion of such expense has actually
been paid by Borrower during such period; and (v) Management Fees and other fees
paid to Subordinating Creditors, to the extent permitted hereunder, and after
deduction for each of (a) federal and state income taxes, to the extent actually
paid during such period; (b) any non-cash income; and (c) all permitted Capital
Expenditures (without regard to any waiver given by FINOVA with respect to any
limitation on such Capital Expenditures) actually made during such period and
not financed.
"Overlines" and "Overadvances" has the meaning set forth in Section 2.3.
"Payor" shall mean any Insurer, any Governmental Authority and any other
Person that is responsible for payment for all or any portion of a Receivable.
"PBGC" means the Pension Benefit Guarantee Corporation.
5
<PAGE>
"Permitted Discretion" means, in FINOVA's sole judgment exercised in
good faith based upon its consideration of any factor which FINOVA believes in
good faith: (i) will or could adversely affect the value of any Collateral, the
enforceability or priority of FINOVA's liens thereon or the amount which FINOVA
would be likely to receive (after giving consideration to delays in payment and
costs of enforcement) in the liquidation of such Collateral; (ii) suggests that
any collateral report or financial information delivered to FINOVA by any Person
on behalf of the Borrower is incomplete, inaccurate or misleading in any
material respect; (iii) materially increases the likelihood of a bankruptcy,
reorganization or other insolvency proceeding involving the Borrower, any Loan
Party, or any of its subsidiaries or any of the Collateral, or (iv) creates or
reasonably could be expected to create an Event of Default. In exercising such
judgment, FINOVA may consider such factors already included in or tested by the
definition of Eligible Receivables or Eligible Inventory, as well as any of the
following: (i) the financial and business climate of the Borrower's industry and
general macroeconomic conditions, (ii) changes in collection history and
dilution with respect to the Receivables, (iii) changes in any concentration of
risk with respect to Receivables, and (iv) any other factors that change the
credit risk of lending to the Borrower on the security of the Receivables. The
burden of establishing lack of good faith hereunder shall be on the Borrower.
"Permitted Encumbrance" means, collectively, the following: (i) liens,
security interests or other encumbrances for taxes, assessments and other
governmental charges or levies arising by operation of law in the ordinary
course of business for sums which are not yet due and payable and the
enforcement of which are, at all times, effectively and fully stayed or are
being contested in good faith by appropriate proceedings (with written notice
thereof to FINOVA) diligently conducted, and for which reserves as required
under GAAP shall have been established by Borrower and Loan Reserves have been
established by FINOVA in respect thereof; (ii) liens arising in the ordinary
course of business in respect of claims or demands of landlords, carriers,
warehousemen, mechanics, laborers, materialmen, workers, repairmen and other
similar Persons, whether arising by operation of law, contractually or
otherwise, provided that the amounts respectively secured thereby are not past
due or if past due, the enforcement of any such liens are, at all times, stayed,
and such liens are being contested in good faith by appropriate proceedings
(with written notice thereof to FINOVA) diligently conducted and reserves as
required under GAAP shall have been established by Borrower and Loan Reserves
have been established by FINOVA in respect thereof; and (iii) liens securing
purchase money Indebtedness to any extent permitted by Section 6.2.5 hereof and
described in the Schedule.
"Person" means any individual, sole proprietorship, partnership, joint
venture, trust, unincorporated organization, association, corporation, limited
liability company, government, or any agency or political division thereof, or
any other entity.
"Plan" means any plan described in ERISA Section 3(2) maintained for
employees of Borrower or any ERISA Affiliate, other than a Multiemployer Plan.
"Prepared Financials" means the consolidated and consolidating financial
statements of Borrower as of December 31, 1997 the date of Borrower's most
recent audited financial statements, and as of each subsequent date on which
audited financial statements are delivered to FINOVA from time to time
hereunder, and the related statements of operations, changes in stockholder's
equity and changes in cash flow for the periods ended on such dates.
"Prime Rate" has the meaning set forth in the Schedule.
"Prohibited Transaction" means any transaction described in Section 406
of ERISA which is not exempt by reason of Section 408 of ERISA, and any
transaction described in Section 4975(c) of the IRC which is not exempt by
reason of Section 4975(c)(2) of the IRC.
"Provider Agreements" means all agreements, certifications,
reimbursement contracts, and other contracts and agreements required for or
relating to the operation of Borrower's health care facilities and services,
whether now existing or hereafter issued to Borrower by, and/or entered into by
Borrower with any Insurer, Governmental Authority, Payor or Person.
"Receivable Loans" has the meaning set forth on the Schedule.
"Receivable Loan Limit" has the meaning set forth in the Schedule.
6
<PAGE>
"Receivables" or "Receivable" means all of Borrower's now owned and
hereafter acquired accounts (whether or not earned by performance), proceeds of
any letters of credit naming Borrower as beneficiary, contract rights, chattel
paper, instruments, documents and all other forms of obligations at any time
owing to Borrower, all guaranties and other security therefor, whether secured
or unsecured, and all rights of stoppage in transit and all other rights or
remedies of an unpaid vendor, lienor or secured party. Receivables includes all
accounts and general intangibles, all rights, remedies, guaranties, security
interests and liens, all records (other than medical records, unless patient
consents with respect thereto have been received) and other property evidencing
any and all proceeds which relate to or are associated with such Receivables
subject to the confidentiality rights under applicable law and under rights and
rules of JCAHO.
"Renewal Term" has the meaning set forth on the Schedule.
"Reportable Event" means a reportable event described in Section 4043 of
ERISA or the regulations thereunder, a withdrawal from a Plan described in
Section 4063 of ERISA, or a cessation of operations described in Section 4068(f)
of ERISA.
"Revolving Interest Rate" has the meaning set forth in the Schedule.
"Schedule" has the meaning set forth in the preamble.
"Senior Contractual Debt Service" means, for any period, the sum of
payments made or required to be made by Borrower during such period for (i)
interest and scheduled principal payments due on the Term Loans (excluding
voluntary prepayment and payments made from Borrower's Excess Cash Flow, as
required pursuant to the Schedule), any scheduled payments under Equipment
Acquisition Line (ii) interest only payments due on the Revolving Credit Loans
facility plus the Facility Fee, Minimum Interest Charge and the Unused Line Fee.
"Start Date" has the meaning set forth in the Schedule.
"Stock Pledge Agreement" has the meaning set forth in Section 4.1(bb)
hereof.
"Stock Pledgors" has the meaning set forth in Section 4.1 hereof.
"Subordinated Debt" means liabilities of Borrower the repayment of which
is subordinated, to the payment and performance of the Obligations, pursuant to
a subordination agreement acceptable to FINOVA.
"Subordinating Creditor" means the Persons set forth in the Schedule.
"Subsidiaries" or "Subsidiary" means, with respect to any Person, any
corporation of which an aggregate of more than fifty percent (50%) of the
outstanding capital stock having ordinary voting power to elect a majority of
the Board of Directors of such corporation (irrespective of whether, at the
time, stock of any other class or classes of such corporation shall have or
might have voting power by reason of the happening of any contingency) is at the
time, directly or indirectly, owned, legally or beneficially, by such Person
and/or one or more Subsidiaries of such Person.
"Term Loans" has the meaning set forth in the Schedule.
"Termination Fee" has the meaning set forth in Section 9.2(d) hereof.
"Total Contractual Debt Service" means, for any period, the sum of
payments made (or, as to clause (i) of this sentence, required to be made) by
Borrower during such period for (i) Senior Contractual Debt Service, and (ii)
interest and scheduled principal payments due on any and all other Indebtedness
of Borrower, including without limitation the Subordinated Indebtedness.
"Total Facility" has the meaning set forth on the Schedule.
7
<PAGE>
"Trademarks, Copyrights, Licenses and Patents" means all of Borrower's
right, title and interest in and to, whether now owned or hereafter acquired:
(i) trademarks, trademark registrations, trade names, trade name registrations,
and trademark or trade name applications, including without limitation such as
are listed on the Schedule as the same may be amended from time to time, and (a)
renewals thereof, (b) all income, royalties, damages and payments now and
hereafter due and/or payable with respect thereof, including, without
limitation, damages and payments for past or future infringements thereof, (c)
the right to sue for past, present and future infringements thereof, (d) all
rights corresponding thereto throughout the world, and (e) the goodwill of the
business operated by Borrower connected with and symbolized by any trademarks or
trade names; (ii) copyrights, copyright registrations and copyright
applications, including without limitation such as are listed on the Schedule
attached hereto and made a part hereof, as the same may be amended from time to
time, and (a) renewals thereof, (b) all income, royalties, damages and payments
now and hereafter due and/or payable with respect thereto, including without
limitation, damages and payments for past or future infringements thereof, (c)
the right to sue for past, present and future infringements thereof, and (d) all
rights corresponding thereto throughout the world; (iii) license agreements,
including without limitation such as are listed on the Schedule and the right to
prepare for sale, sell, and advertise for sale any Inventory now or hereafter
owned by Borrower and now or hereafter covered by such licenses; and (iv)
patents and patent applications, registered or pending, including without
limitation such as are listed on the Schedule, attached hereto, together with
all income, royalties, shop rights, damages and payments thereto, the right to
sue for infringements thereof, and all rights thereto throughout the world and
all reissues, divisions, continuations, renewals, extensions and
continuations-in-part thereof, and all goodwill of the business connected with
the use of and symbolized by such patents.
"Unused Line Fee" has the meaning set forth in the Schedule.
1.2 Other Terms. All accounting terms used in this Agreement, unless
otherwise indicated, shall have the meanings given to such terms in accordance
with GAAP. All other terms contained in this Agreement, unless otherwise
indicated, shall have the meanings provided by the Code, to the extent such
terms are defined therein.
2. LOANS, INTEREST RATE AND OTHER CHARGES.
2.1 Total Facility. Upon the terms and conditions set forth herein and
provided that no Event of Default or event which, with the giving of notice or
the passage of time, or both, would constitute an Event of Default, shall have
occurred and be continuing, FINOVA shall, upon Borrower's request, make advances
to Borrower from time to time in an aggregate outstanding principal amount not
to exceed the Total Facility amount (the "Total Facility") set forth on the
Schedule hereto subject to deduction of reserves for accrued interest and such
other Loan Reserves as FINOVA deems proper from time to time, and less amounts
FINOVA may be obligated to pay in the future on behalf of Borrower. The Schedule
is an integral part of this Agreement and all references to "herein", "herewith"
and words of similar import shall for all purposes be deemed to include the
Schedule.
2.2 Loans; Joint and Several Obligations. Advances under the Total
Facility ("Loans" and individually, a "Loan") shall be comprised of the amounts
shown on the Schedule . Each of the following corporations shall be jointly and
severally liable for the Loans and all other Obligations hereunder: (i)
Community Medical Transport, Inc. (ii) Community Ambulette Service, Inc.; (iii)
First Help Ambulance and Ambulette, Inc.; (iv) Empire Ambulance and Ambulette,
Inc.; (v) Century Ambulance and Ambulette, Inc.; (vi) Richards/Decker Operating
Company, Inc.; (vii) Elite Ambulance and Medical Coach, Inc.; (viii) Hudson
Valley Medtex, Inc.; (ix) Clove Professional Services, Inc.; (x) Consolidated
Collections, Inc.; and (xi) Richards/Decker Payroll Company, Inc. References in
this Agreement and any other Loan Document to Borrower shall mean each of the
foregoing corporations, jointly and severally, as Borrowers, individually and
collectively, as the context requires.
2.3 Overlines; Overadvances. If at any time or for any reason the
outstanding amount of advances extended or issued pursuant hereto exceeds any of
the dollar limitations ("Overline") or percentage limitations ("Overadvance")
contained in the Schedule, then Borrower shall, upon FINOVA's demand,
immediately pay to FINOVA, in cash, the full amount of such Overline or
Overadvance which, at FINOVA's option, may be applied to reduce the outstanding
principal balance of the Loans. Without limiting Borrower's obligation to repay
to FINOVA on demand the amount of any Overline or Overadvance, Borrower agrees
to pay FINOVA interest on the outstanding principal amount of any Overline or
Overadvance, on demand, at the rate set forth in on the Schedule and applicable
to the Loan or Loans in respect to which any Overline or Overadvance exists.
8
<PAGE>
2.4 Intentionally Omitted.
2.5 Loan Account. All advances made hereunder shall be added to and
deemed part of the Obligations when made. FINOVA may from time to time charge
all Obligations of Borrower to Borrower's loan account with FINOVA.
2.6 Interest; Fees. Borrower shall pay FINOVA interest on the daily
outstanding balance of the Obligations at the per annum rate set forth on the
Schedule. Borrower shall also pay FINOVA the fees set forth on the Schedule.
2.7 Default Interest Rate. Upon the occurrence and during the
continuation of an Event of Default, Borrower shall pay FINOVA interest on the
daily outstanding balance of the Obligations at a rate per annum which is two
percent (2%) in excess of the rate which would otherwise be applicable thereto
pursuant to the Schedule.
2.8 Examination Fees. Borrower agrees to pay to FINOVA the Examination
Fees in the amount set forth on the Schedule in connection with each audit or
examination of Borrower performed by FINOVA prior to or after the date hereof.
Without limiting the generality of the foregoing, Borrower shall pay to FINOVA
an initial Examination Fee in an amount equal to the amount set forth on the
Schedule. Such initial Examination Fee shall be deemed fully earned at the time
of payment and due and payable upon the closing of this transaction, and shall
be deducted from any good faith deposit paid by Borrower to FINOVA prior to the
date of this Agreement.
2.9 Excess Interest.
A. The contracted for rate of interest of the Loans contemplated hereby,
without limitation, shall consist of the following: (i) the interest rate set
forth on the Schedule, calculated and applied to the principal balance of the
Obligations in accordance with the provisions of this Agreement; (ii) interest
after an Event of Default, calculated and applied to the amount of the
Obligations in accordance with the provisions hereof; and (iii) all Additional
Sums (as herein defined), if any. Borrower agrees to pay an effective contracted
for rate of interest which is the sum of the above- referenced elements. The
Examination Fees, attorneys' fees, expert witness fees, closing fees, Facility
Fees, Termination Fees, Minimum Interest Charges, other charges, goods, things
in action or any other sums or things of value paid or payable by Borrower,
whether pursuant to this Agreement or any other documents or instruments in any
way pertaining to this lending transaction, or otherwise with respect to this
lending transaction, that under any applicable law may be deemed to be interest
with respect to this lending transaction, for the purpose of any applicable law
that may limit the maximum amount of interest to be charged with respect to this
lending transaction (collectively, the "Additional Sums"), shall be payable by
Borrower as, and shall be deemed to be, additional interest and for such
purposes only, the agreed upon and "contracted for rate of interest" of this
lending transaction shall be deemed to be increased by the rate of interest
resulting from the inclusion of the Additional Sums.
<PAGE>
B. It is the intent of the parties to comply with the usury laws of the
State of Arizona (the "Applicable Usury Law"). Accordingly, it is agreed that
notwithstanding any provisions to the contrary in this Agreement, or in any of
the documents securing payment hereof or otherwise relating hereto, in no event
shall this Agreement or such documents require the payment or permit the
collection of interest in excess of the maximum contract rate permitted by the
Applicable Usury Law (the "Maximum Interest Rate"). In the event (a) any such
excess of interest otherwise would be contracted for, charged or received from
Borrower or otherwise in connection with the loan evidenced hereby, or (b) the
maturity of the Obligations is accelerated in whole or in part, or (c) all or
part of the Obligations shall be prepaid, so that under any of such
circumstances the amount of interest contracted for, shared or received in
connection with the loan evidenced hereby, would exceed the Maximum Interest
Rate, then in any such event (1) the provisions of this paragraph shall govern
and control, (2) neither Borrower nor any other Person or entity now or
hereafter liable for the payment of the Obligations shall be obligated to pay
the amount of such interest to the extent that it is in excess of the Maximum
Interest Rate, (3) any such excess which may have been collected shall be either
applied as a credit against the then unpaid principal amount of the Obligations
or refunded to Borrower, at FINOVA's option, and (4) the effective rate of
interest shall be automatically reduced to the Maximum Interest Rate. It is
further agreed, without limiting the generality of the foregoing, that to the
extent permitted by the Applicable Usury Law; (x) all calculations of interest
which are made for the purpose of determining whether such rate would exceed the
Maximum Interest Rate shall be made by amortizing, prorating, allocating and
spreading during the period of the full stated term of the loan evidenced
hereby, all interest at any time contracted for, charged or received from
Borrower or otherwise in connection with such loan; and (y) in the event that
the effective rate of interest on the loan should at any time exceed the Maximum
Interest Rate, such excess interest that would otherwise have been collected had
there been no ceiling imposed by the Applicable Usury Law shall be paid to
FINOVA from time to time, if and when the effective interest rate on the loan
otherwise falls below the Maximum Interest Rate, to the extent that interest
paid to the date of calculation does not exceed the Maximum Interest Rate, until
the entire amount of interest which would otherwise have been collected had
there been no ceiling imposed by the Applicable Usury Law has been paid in full.
Borrower further agrees that should the Maximum Interest Rate be increased at
any time hereafter because of a change in the Applicable Usury Law, then to the
extent not prohibited by the Applicable Usury Law, such increases shall apply to
all indebtedness evidenced hereby regardless of when incurred; but, again to the
extent not prohibited by the Applicable Usury Law, should the Maximum Interest
Rate be decreased because of a change in the Applicable Usury Law, such
decreases shall not apply to the indebtedness evidenced hereby regardless of
when incurred.
9
<PAGE>
2.10 Principal Payments; Proceeds of Collateral.
A. Principal Payments. Except where evidenced by notes or other
instruments issued or made by Borrower to FINOVA specifically containing payment
provisions which are in conflict with this Section 2.10 (in which event the
conflicting provisions of said notes or other instruments shall govern and
control), that portion of the Obligations consisting of principal payable on
account of Loans shall be payable by Borrower to FINOVA immediately upon the
earliest of (i) the receipt by FINOVA or Borrower of any proceeds of any of the
Collateral, to the extent of said proceeds, (ii) the occurrence of an Event of
Default in consequence of which FINOVA elects to accelerate the maturity and
payment of such Loans, or (iii) any termination of this Agreement pursuant to
Section 9.2 hereof; provided, however, that any Overline or Overadvance shall be
payable on demand pursuant to the provisions of Section 2.3 hereof.
B. Collections. Until FINOVA notifies Borrower to the contrary, Borrower
may make collection of all Receivables for FINOVA by directing all account
debtors and other third parties to remit all payments owing to Borrower to the
lockbox established in connection with the Blocked Account. In the event
Borrower shall nevertheless directly receive any payments or other financial
proceeds of any Collateral (other than for Governmental Receivables), Borrower
shall receive all payments as trustee of FINOVA and immediately deliver all
payments to FINOVA in their original form as set forth below, duly endorsed in
blank or cause the same to be deposited into a Blocked Account.
C. Establishment of a Lockbox Account or Dominion Account.
(1) Unless Borrower shall be otherwise directed by FINOVA in
writing, Borrower shall cause all proceeds of Collateral to be deposited into a
lockbox account, or such other "blocked account" as FINOVA may require (each, a
"Blocked Account") pursuant to an arrangement with such bank as may be selected
by Borrower and be acceptable to FINOVA which proceeds, unless otherwise
provided herein, shall be applied in payment of the Obligations in such order as
FINOVA determines in its sole discretion. Borrower shall issue to any such bank
an irrevocable letter of instruction directing said bank to transfer such funds
so deposited to FINOVA, either to any account maintained by FINOVA at said bank
or by wire transfer to appropriate account(s) of FINOVA. Except with respect to
Governmental Receivables, all funds deposited in a Blocked Account shall
immediately become the sole property of FINOVA and Borrower shall obtain the
agreement by such bank to waive any offset rights against the funds so
deposited. FINOVA assumes no responsibility for any Blocked Account arrangement,
including without limitation, any claim of accord and satisfaction or release
with respect to deposits accepted by any bank thereunder. Alternatively, FINOVA
may establish depository accounts in the name of FINOVA (and in the name of
Borrower with respect to Governmental Receivables) at a bank or banks for the
deposit of such funds (each, a "Dominion Account") and Borrower shall deposit
all proceeds of Receivables and all cash proceeds of any sale of any other
Collateral, to the extent permitted herein, or cause same to be deposited, in
kind, in such Dominion Accounts of FINOVA in lieu of depositing same to Blocked
Accounts and all such funds shall be applied by FINOVA to the Obligations in
such order as FINOVA determines in its sole discretion.
(2) Borrower shall notify all Payors, prior to the initial
Receivable Loan advance, using forms of notices approved by FINOVA
(collectively, the "Payor Notices") to remit payment to the appropriate Blocked
Account or Dominion Account at LaSalle National Bank (the "FINOVA Bank") or at a
bank designated by Borrower and approved by FINOVA (the "Borrower Bank"). After
the initial Receivable Loan advance, Borrower shall send subsequent notices to
Payors to remit payment to the appropriate account at the FINOVA Bank or at the
designated Borrower Bank, as FINOVA may from time to time reasonably request.
(3) With respect to payments from Payors in respect of
Receivables, Borrower agrees as follows:
(i) Borrower shall establish two accounts (the "Lockbox
Accounts") with respect to the collection of Receivables: one for Governmental
Receivables (the "Borrower Collection Lockbox Account"), and one for all other
Receivables (the "FINOVA Lockbox Account"), at either the FINOVA Bank or the
Borrower Bank. The Borrower Collection Lockbox Account shall be an account in
the name of Borrower, and shall be the sole and exclusive property of Borrower
subject to an executed Depository Account Agreement among Borrower, FINOVA and
either the FINOVA Bank or the Borrower Bank in a form acceptable to FINOVA (the
"Depository Account Agreement"). The FINOVA Lockbox Account shall be in the name
of FINOVA and shall be the sole and exclusive property of FINOVA. Borrower
agrees that it shall not deposit any funds other than payments on Governmental
Receivables into the Borrower Collection Lockbox Account without the prior
written consent of FINOVA so long as this Agreement is in effect.
10
<PAGE>
(ii) Upon receipt of a copy of each remittance advice and
all such payments on Receivables, Borrower shall, within two (2) Business Days
after receipt thereof, post such funds to the specific Receivable (the
"Application of Payments"). In the event that Borrower directly receives any
payments in respect of Receivables, Borrower shall remit the funds to the
Borrower Collection Lockbox Account and send to FINOVA or its designee clear
copies of all remittance advices accompanying such payments or, if no such
remittance advice accompanies any such payment, notice of the amount so
received. In addition, after the occurrence of an Event of Default, all payments
received by the Borrower Bank from Payors will be deposited in the applicable
Lockbox Account.
(iii) Borrower shall instruct the Borrower Bank, pursuant to
a standing wire transfer instruction, to transfer automatically all amounts
collected in the Borrower Collection Lockbox Account to FINOVA's account
maintained at the FINOVA Bank or such other account as FINOVA shall designate
(the "Collection Account") at the end of each Business Day. The Borrower shall
have no right to or interest in the Collection Account. Borrower shall not, so
long as any Receivable Loan remains outstanding, change or cancel such automatic
transfer order at any time, or, without the prior written consent of FINOVA,
change either the identity of the Lockbox Accounts or the instructions to each
Payor on the related Receivable to make its payments to such account.
(iv) All payments on Receivables received directly by the
Borrower shall be held by Borrower, in trust, for the benefit of FINOVA until
such amounts are deposited into the Borrower Collection Lockbox Account.
(v) Borrower and FINOVA and their respective agents will
cooperative with each other in the identification of sums deposited into the
Lockbox Accounts, which cooperation shall survive the termination of this
Agreement and continue until all Obligations due to FINOVA have been paid in
full and collected by FINOVA.
(vi) If a Payor makes payment of a Receivable to Borrower at
a location other than that provided in the Payor Notice (a "Misdirected
Payment"), Borrower (at its own cost and expense) shall (i) use its best efforts
to promptly take all necessary steps to effect collection of such Misdirected
Payment from any other Person claiming an interest therein or having possession
thereof, (ii) hold such payment in trust for FINOVA, (iii) segregate such
payment and not deposit such payment in Borrower's own account, nor commingle
such payment with Borrower's own funds or other assets, and (iv) deliver such
payment to the Borrower Bank for deposit in the applicable Lockbox Account no
later than the close of Business on the third (3rd) Business Day after receipt.
(vii) If FINOVA shall receive any payment from any Payor of
any Receivable or claim included as a Receivable which cannot be identified to
any particular Receivable within five (5) Business Days after its receipt based
upon the information submitted with such payment by the Payor, such payment
shall be deemed an Unidentified Payment (each, an "Unidentified Payment"). All
Unidentified Payments shall be held by FINOVA until either identified by
Borrower or applied by FINOVA to a Receivable as provided herein. In the absence
of any identification made by Borrower FINOVA may, at FINOVA's option after
consultation with Borrower, apply Unidentified Payments held by FINOVA to any
Obligations then due from Borrower to FINOVA, or FINOVA may hold any such
Unidentified Payment until the payment has been identified by mutual agreement.
D. Governmental Receivables. It is the intent of the parties to comply
with the laws and regulations of the United States under (i) 42 U.S.C.
1395u(b)(6) in connection with Medicare, (ii) 42 U.S.C. 1396a(a)(32) in
connection with Medicaid, and (iii) 32 CFR 199.1 et. seq. in connection with
CHAMPUS, and any other provisions affecting Governmental Receivables.
Accordingly, it is agreed that, notwithstanding any provisions to the contrary
in this Agreement or in any of the Loan Documents, in no event shall this
Agreement or the Loan Documents require any pledge, action or other conduct to
the extent they are violative of the aforementioned laws and regulations.
E. Payments Without Deductions. Borrower shall pay principal, interest,
and all other amounts payable hereunder, or under any other Loan Document,
without any deduction whatsoever, including, but not limited to, any deduction
for any setoff or counterclaim.
F. Collection Days Upon Repayment. In the event Borrower repays the
Obligations in full at any time hereafter, such payment in full shall be
credited (conditioned upon final collection) to Borrower's loan account two (2)
Business Days after FINOVA's receipt thereof.
G. Monthly Accountings. FINOVA shall provide Borrower monthly with an
account of advances, charges, expenses and payments made pursuant to this
Agreement. Such account shall be deemed correct, accurate and binding on
Borrower and an account stated (except for reverses and reapplications of
payments made and corrections of errors discovered by FINOVA), unless Borrower
notifies FINOVA in writing to the contrary within thirty (30) days after each
account is rendered, describing the nature of any alleged errors or admissions.
11
<PAGE>
2.11 Application of Collateral. Except as otherwise provided herein,
FINOVA shall have the continuing and exclusive right to apply or reverse and
re-apply any and all payments to any portion of the Obligations in such order
and manner as FINOVA shall determine in its sole discretion. To the extent that
Borrower makes a payment or FINOVA receives any payment or proceeds of the
Collateral for Borrower's benefit which is subsequently invalidated, declared to
be fraudulent or preferential, set aside or required to be repaid to any Person,
including without limitation, a trustee, debtor in possession, receiver or any
other party under any bankruptcy law, common law or equitable cause or
otherwise, then, to such extent, the Obligations or part thereof intended to be
satisfied shall be revived and continue as if such payment or proceeds had not
been received by FINOVA, and FINOVA may adjust the balance of the Loans as
FINOVA, in its sole discretion, deems appropriate under the circumstances.
2.12 Application of Payments.
A. The amount of all payments or amounts received by FINOVA with respect
to the Receivable Loans shall be applied to the extent applicable under this
Agreement: (i) first, to accrued interest through the date of such payment,
including any Default Interest; (ii) then, to any late fees, overdue risk
assessments, Examination Fees and expenses, collection fees and expenses, and
any other fees and expenses due to FINOVA hereunder; and (iii) last, the
remaining balance, if any, to the unpaid principal balance of the Receivable
Loan; provided, however, while an Event of Default exists under this Agreement,
or under any other Loan Document, each payment hereunder shall be (x) held as
cash collateral to secure Obligations relating to any Letters of Credit or other
contingent obligations arising under the Loan Documents and/or (y) applied to
amounts owed to FINOVA by Borrower as FINOVA in its sole discretion may
determine. In calculating interest and applying payments as set forth above: (a)
interest shall be calculated and collected through the date a payment is
actually applied by FINOVA under the terms of this Agreement; (b) interest on
the outstanding balance shall be charged during any grace period permitted
hereunder; and (c) at the end of each month, all accrued and unpaid interest and
other charges provided for hereunder shall be added to the principal balance of
the Receivable Loan.
B. The amount of all payments or amounts received by FINOVA with respect
to any Term Loan shall be applied to the extent applicable under this Agreement:
(i) first, to any past due payments of interest hereunder and to accrued
interest through the date of such payment, including any Default Interest; (ii)
then, to any interest on delinquent interest, late fees, overdue risk
assessments, Examination Fees and expenses, collection fees and expenses, and
any other fees and expenses due to FINOVA hereunder; and (iii) last, the
remaining balance, if any, to the unpaid principal balance of the Term Loan;
provided, however, while an Event of Default exists under this Agreement, or
under any other Loan Document, each payment hereunder shall be (x) held as cash
collateral to secure Obligations relating to any other contingent obligations
arising under the Loan Documents and/or (y) applied to amounts owed to FINOVA by
Borrower as FINOVA in its sole discretion may determine. In calculating interest
and applying payments as set forth above: (a) interest shall be calculated and
collected through the date a payment is actually applied by FINOVA under the
terms of this Agreement; (b) interest on the outstanding balance shall be
charged during any grace period permitted hereunder; and (c) on each annual
anniversary of the closing date of the Term Loan, all past due interest and
other past due charges provided for hereunder shall be added to the principal
balance of such Term Loan
2.13 Notification of Closing. Borrower shall provide FINOVA with at
least forty-eight (48) hours prior written notice of the Closing Date, to enable
FINOVA to arrange for the availability of funds. In the event the closing does
not take place on the date specified in Borrower's notice to FINOVA, other than
through the fault of FINOVA, Borrower agrees to reimburse FINOVA for FINOVA's
costs to maintain the necessary funds available for the closing, at the Term
Interest Rate with respect to the amount specified in the Schedule, and at the
Revolving Interest Rate with respect to an amount equal to the initial advance
under the Receivable Loan which is to be made on the Closing Date, for the
number of days which elapse between the date specified in Borrower's notice and
the date upon which the closing actually occurs (which number of days shall not
include the date specified in Borrower's notice, but shall include the Closing
Date.
12
<PAGE>
3. SECURITY.
3.1 Security Interest in the Collateral. To secure the payment and
performance of the Obligations when due, Borrower hereby (i) grants to FINOVA a
first priority security interest (subject only to Permitted Encumbrances) in all
of Borrower's now owned or hereafter acquired or arising Receivables, Inventory,
Equipment, life insurance policies and proceeds thereof, Trademarks, Copyrights,
Licenses and Patents, Investment Property (as defined in Section 9-115 of the
Code), Provider Agreements and General Intangibles, including, without
limitation, all of Borrower's Deposit Accounts, money, any and all property now
or at any time hereafter in FINOVA's possession (including claims and credit
balances), and all proceeds (including proceeds of any insurance policies,
proceeds of proceeds and claims against third parties), all products and all
books and records and computer data related to any of the foregoing and (ii)
assigns, transfers and sets over to FINOVA all of its right, title and interest,
powers, privileges and other benefits of all leases, rental agreements and
related documents entered into by Borrower with respect to any Equipment leased
by Borrower, together with all income, proceeds and other benefits thereof (all
of the foregoing, together with all other property in which FINOVA may be
granted a lien or security interest, is referred to herein, collectively, as the
"Collateral").
3.2 Perfection and Protection of Security Interest. Borrower shall, at
its expense, take all actions requested by FINOVA at any time to perfect,
maintain, protect and enforce FINOVA's first priority security interest and
other rights in the Collateral and the priority thereof from time to time,
including, without limitation, (i) executing and filing financing or
continuation statements and amendments thereof and executing and delivering such
documents and titles in connection with motor vehicles as FINOVA shall require,
all in form and substance satisfactory to FINOVA, (ii) maintaining a perpetual
inventory or other accounting system satisfactory to FINOVA and complete and
accurate stock records, (iii) delivering to FINOVA appropriate documents as
required by FINOVA covering any portion of the Collateral located in warehouses
and for which warehouse receipts are issued, (iv) placing notations on
Borrower's books of account to disclose FINOVA's security interest therein and
(v) delivering to FINOVA all letters of credit on which Borrower is named
beneficiary. FINOVA may file, without Borrower's signature, one or more
financing statements disclosing FINOVA's security interest under this Agreement.
Borrower agrees that a carbon, photographic, photostatic or other reproduction
of this Agreement or of a financing statement is sufficient as a financing
statement. If any Collateral is at any time in the possession or control of any
warehouseman, bailee or any of Borrower's agents or processors, Borrower shall
notify such Person of FINOVA's security interest in such Collateral and, upon
FINOVA's request, instruct them to hold all such Collateral for FINOVA's account
subject to FINOVA's instructions. From time to time, Borrower shall, upon
FINOVA's request, execute and deliver confirmatory written instruments pledging
the Collateral to FINOVA, but Borrower's failure to do so shall not affect or
limit FINOVA's security interest or other rights in and to the Collateral. Until
the Obligations have been fully satisfied and any obligation of FINOVA to make
further advances hereunder has terminated, FINOVA's security interest in the
Collateral shall continue in full force and effect.
3.3 Preservation of Collateral. FINOVA may, in its Permitted Discretion,
at any time discharge any lien or encumbrance on the Collateral or bond the
same, pay any insurance, maintain guards, pay any service bureau, obtain any
record or take any other action to preserve the Collateral and charge the cost
thereof to Borrower's loan account as an Obligation.
3.4 Insurance. Borrower will maintain and deliver evidence to FINOVA of
such insurance as is required by FINOVA, written by insurers, in amounts, and
with lender's loss payee, additional insured, and other endorsements,
satisfactory to FINOVA and cause FINOVA to be named as an additional insured on
all liability policies. All premiums with respect to such insurance shall be
paid by Borrower as and when due. Accurate and complete copies of the policies
shall be delivered by Borrower to FINOVA. If Borrower fails to comply with this
Section, FINOVA may (but shall not be required to) procure such insurance and
endorsements at Borrower's expense and charge the cost thereof to Borrower's
loan account as an Obligation. The net proceeds of any property or casualty
insurance and endorsements insuring the Collateral, after deducting all costs
and expenses (including attorneys' fees) of collection, shall be applied at
FINOVA's option, either toward replacing or restoring the Collateral, in a
manner and on terms satisfactory to FINOVA, or toward payment of the
Obligations. Any proceeds applied to the payment of Obligations shall be applied
in such manner as FINOVA may elect in its sole discretion. In no event shall
such application relieve Borrower from payment in full of all installments of
principal and interest which thereafter become due in the order of maturity
thereof.
13
<PAGE>
3.5 Collateral Reporting; Inventory.
A. Invoices. Borrower shall not re-date any invoice or service from the
original date thereof or make any claims for reimbursement or sales on extended
terms beyond those customary in Borrower's industry, or otherwise extend or
modify the term of any Receivable except Borrower shall be permitted to re-date
any invoices which are re-invoiced to insurers after the original invoice was
sent to the primary reasonable party provided that the initial date of service
is not changed. If Borrower becomes aware of any matter adversely affecting any
material Receivable, including information affecting the credit of the account
debtor thereon, Borrower shall promptly notify FINOVA in writing.
B. Instruments. In the event any Receivable is or becomes evidenced by a
promissory note, trade acceptance or any other instrument for the payment of
money, Borrower shall immediately deliver such instrument to FINOVA
appropriately endorsed to FINOVA and, regardless of the form of any presentment,
demand, notice of dishonor, protest and notice of protest with respect thereto,
Borrower shall remain liable thereon until such instrument is paid in full.
3.6 Eligibility; Reserves; Advance Rates; Disputes.
A. Borrower represents and warrants that each Receivable covers and
shall cover a bona fide sale, lease or rental and delivery by it of goods or the
rendition by it of services in the ordinary course of its business, and shall be
for a liquidated amount and FINOVA's security interest shall not be subject to
any offset, deduction, counterclaim, rights of return or cancellation, lien or
other condition other than in the ordinary course of Borrower's business but
solely to the extent arising in connection with regular, periodic reviews of
Borrower's collection history or billing as undertaken from time to time by
Governmental Authorities. If any representation or warranty herein is breached
as to any Receivable or any Receivable ceases to be an Eligible Receivable for
any reason other than payment thereof, then FINOVA may, in addition to its other
rights hereunder, designate any and all Receivables owing by that account debtor
as not Eligible Receivables; provided, that FINOVA shall in any such event
retain its security interest in all Receivables, whether or not Eligible
Receivables, until the Obligations have been fully satisfied and FINOVA's
obligation to provide loans hereunder has terminated.
B. FINOVA at any time shall, in the exercise of its Permitted
Discretion, be entitled to (i) establish and increase or decrease Loan Reserves
against Eligible Receivables, (ii) reduce the advance rates set forth in the
Schedule or restore such advance rates to any level equal to or below the
advance rates set forth in the Schedule, (iii) impose additional restrictions
(or eliminate the same) to the standards of eligibility set forth in the
definition of "Eligible Receivables," or (iv) adjust the calculation or alter
its determination of "Expected Net Receivables" and the "Cash to Charge Ratio."
FINOVA may, but shall not be required to, rely on the schedules and/or reports
delivered to FINOVA in connection herewith in such determinations. Reliance
thereon by FINOVA from time to time shall not be deemed to limit the rights of
FINOVA under this Section 3.6(b). In determining whether to reduce the lending
formula, FINOVA may consider events, conditions, contingencies or risks which
are also considered in determining Eligible Receivables, or in establishing Loan
Reserves. The burden of establishing lack of good faith hereunder shall be on
the Borrower.
C. FINOVA, at any time, in the exercise of its Permitted Discretion,
shall be entitled to establish a reserve against Eligible Receivables, as a
percentage of each advance or otherwise, with respect to offset liability in
connection with Governmental Receivables (the "Offset Reserve"). After net
collections with respect to Governmental Receivables subject to such offset
liability have been collected, the Offset Reserve applicable to such
Governmental Receivables will be credited to Borrower on the next determination
date. Borrower hereby grants to FINOVA the right to make payments from amounts
withheld from advances under the Receivables Loans to any Payor or other Person
in connection with the Offset Reserve.
D. Borrower shall notify FINOVA promptly of all disputes or claims and
settle or adjust such disputes or claims at no expense to FINOVA, but no
discount, credit or allowance in excess of $10,000 shall be granted to any
account debtor or Payor without FINOVA's consent, except for discounts, credits
and allowances made or given in the ordinary course of Borrower's business but
solely to the extent such adjustments in the ordinary course of Borrower's
business arise pursuant to regular, periodic reviews of Borrower's billing or
collection history as undertaken from time to time by Governmental Authorities,
or which are adjustments designed to cause the payments actually received by
Borrower to come into accordance with fee schedules previously established with
Borrower by the applicable Payor and disclosed to FINOVA. FINOVA may, at any
time after the occurrence of an Event of Default, settle or adjust disputes or
claims directly with account debtors for amounts and upon terms which FINOVA
considers advisable in its reasonable credit judgment and, in all cases, FINOVA
shall credit Borrower's loan account with only the net amounts received by
FINOVA in payment of any Receivables.
14
<PAGE>
3.7 Equipment. Borrower shall keep and maintain the Equipment in good
operating condition and repair and make all necessary replacements thereto to
maintain and preserve the value and operating efficiency thereof at all times
consistent with Borrower's past practice, ordinary wear and tear excepted.
Borrower shall not permit any item of Equipment to become a fixture (other than
a trade fixture) to real estate or an accession to other property.
3.8 Rental Documents Collateral. In furtherance of the security interest
and assignment to FINOVA, pursuant to Section 4.1(ii) hereof, of all of
Borrower's right, title and interest in all leases, rental agreements and
related documents entered into by Borrower with respect to any Equipment leased
by Borrower, Borrower shall segregate and maintain, at a clearly identified
location in each of Borrower's facilities, all documents comprising or related
to such leases, rental agreements and related documents (collectively, the
"Rental Documents"). FINOVA shall have the right, at any time, to take
possession of the original Rental Documents. Immediately upon the execution of
this Agreement, and upon entering into any new Rental Documents hereafter,
Borrower shall stamp or type a notice legend on each original lease or rental
agreement, and all other related Rental Documents, identifying the security
interest of FINOVA therein, as follows: "THIS AGREEMENT, ALL RELATED DOCUMENTS
AND ALL INCOME, PROCEEDS, RENTAL PAYMENTS AND OTHER BENEFITS THEREOF HAS BEEN
ASSIGNED TO, AND IS SUBJECT TO A FIRST PRIORITY SECURITY INTEREST IN FAVOR OF,
FINOVA CAPITAL CORPORATION."
3.9 Other Liens; No Disposition of Collateral. Borrower represents,
warrants and covenants that (a) all Collateral is and shall continue to be owned
by it free and clear of all liens, claims and encumbrances whatsoever (except
for FINOVA's security interest, Permitted Encumbrances, and such other liens,
claims and encumbrances as may be permitted by FINOVA in its sole discretion
from time to time in writing), and (b) Borrower shall not, without FINOVA's
prior written approval, sell, encumber or dispose of or permit the sale,
encumbrance or disposal of any Collateral or all or any substantial part of any
of its other assets (or any interest of Borrower therein), except for the
replacement of Equipment deemed by Borrower in good faith to be commercially
obsolete to Borrower's business. In the event FINOVA gives any such prior
written approval with respect to any such sale of Collateral, the same may be
conditioned on the sale price being equal to, or greater than, an amount
acceptable to FINOVA. The proceeds of any such sales of Collateral shall be
remitted to FINOVA pursuant to this Agreement for application to the
Obligations.
3.10 Collateral Security. The Obligations shall constitute one loan
secured by the Collateral. FINOVA may, in its sole discretion, (i) exchange,
enforce, waive or release any of the Collateral, (ii) apply Collateral and
direct the order or manner of sale thereof as it may determine, and (iii)
settle, compromise, collect or otherwise liquidate any Collateral in any manner
without affecting its right to take any other action with respect to any other
Collateral.
4. CONDITIONS OF CLOSING.
4.1 Initial Advance. The obligation of FINOVA to make the initial
advance hereunder is subject to the fulfillment, to the satisfaction of FINOVA
and its counsel, of each of the following conditions on or prior to the date set
forth on the Schedule:
A. Loan Documents. FINOVA shall have each of the following Loan
Documents: (i) this Agreement fully and properly executed by Borrower; (ii)
promissory notes, in such amounts and on such terms and conditions as FINOVA
shall specify, executed by Borrower; (iii) Guaranties or Validity and Support
Agreements executed by each of the individuals described in the Schedule; (iv)
such security agreements, intellectual property assignments, pledge agreements,
mortgages and deeds of trust as FINOVA may require with respect to this
Agreement and any Guaranties, executed by each of the parties thereto and, if
applicable, duly acknowledged for recording or filing in the appropriate
governmental offices; (v) Subordination Agreements in form and substance
acceptable to FINOVA, executed by each of the Subordinating Creditors, together
with copies of all instruments subject thereto showing a legend indicating such
subordination; (vi) such Blocked Account or Dominion Account agreements as it
shall determine; and (vii) such other documents, instruments and agreements in
connection herewith as described in the Document Checklist and as FINOVA shall
require, executed, certified and/or acknowledged by such parties as FINOVA shall
designate;
B. Minimum Excess Availability. Borrower shall have Excess Availability
under the Receivable Loans of not less than the amount specified in the
Schedule, after giving effect to the initial advance hereunder and after giving
effect to any applicable Loan Reserves against borrowing availability under the
Revolving Line of Credit Loans.
C. Terminations by Existing Lender. Borrower's existing lender(s) shall
have executed and delivered UCC termination statements and other documentation
evidencing the termination of its liens and security interests in the assets of
Borrower or a subordination agreement in form and substance satisfactory to
FINOVA in its sole discretion;
15
<PAGE>
D. Charter Documents. FINOVA shall have received copies of the By-laws
and Articles or Certificate of Incorporation, or Operating Agreement and
Certificate of Formation or Partnership Agreement, as applicable, of Borrower as
amended, modified, or supplemented to the Closing Date, certified by the
Secretary or other officer, as applicable;
E. Good Standing. FINOVA shall have received a certificate of corporate
or partnership status with respect to Borrower, dated within ten (10) days of
the Closing Date, by the Secretary of State of the state of organization of
Borrower, which certificate shall indicate that Borrower is in good standing in
such state;
F. Foreign Qualification. FINOVA shall have received certificates of
corporate or partnership status with respect to Borrower, each dated within ten
(10) days of the Closing Date, issued by the Secretary of State of each state in
which such party's failure to be duly qualified or licensed would have a
material adverse effect on its financial condition or assets, indicating that
such party is in good standing;
G. Authorizing Resolutions and Incumbency. FINOVA shall have received a
certificate from the Secretary or General Partner of Borrower attesting to (i)
the adoption of resolutions of Borrower's Board of Directors (and shareholders
if necessary), members or partners, as applicable, authorizing the borrowing of
money from FINOVA and execution and delivery of this Agreement and the other
Loan Documents to which Borrower is a party, and authorizing specific officers
of Borrower to execute same, and (ii) the authenticity of original specimen
signatures of such officers;
H. Insurance. FINOVA shall have received the insurance certificates and
certified copies of policies required by Section 3.4 hereof, in form and
substance satisfactory to FINOVA and its counsel, together with an additional
insured endorsement in favor of FINOVA with respect to all liability policies,
and a lender's loss payable endorsement in favor of FINOVA with respect to all
casualty and business interruption policies, each in form and substance
acceptable to FINOVA and its counsel;
I. Intentionally Omitted.
J. Searches; Certificates of Title. FINOVA shall have received searches
reflecting the filing of its financing statements and fixture filings in such
jurisdictions as it shall determine, and shall have received certificates of
title with respect to the Collateral which shall have been duly executed in a
manner sufficient to perfect all of the security interests granted to FINOVA;
K. Landlord, Bailee and Mortgagee Waivers. FINOVA shall have received
landlord, mortgagee or bailee waivers from the lessors, mortgagees and bailees
of all locations where any Collateral is located;
L. Fees. Borrower shall have paid all fees payable by it on the Closing
Date pursuant to this Agreement;
M. Opinion of Counsel. FINOVA shall have received an opinion of
Borrower's counsel covering such matters as FINOVA shall determine in its sole
discretion;
N. Officer Certificate. FINOVA shall have received a certificate of the
President and the Chief Financial Officer or similar official of Borrower,
attesting to the accuracy of each of the representations and warranties of
Borrower set forth in this Agreement and the fulfillment of all conditions
precedent to the initial advance hereunder;
O. Solvency Certificate. If requested by FINOVA, a signed certificate of
the Borrower's duly elected Chief Financial Officer concerning the solvency and
financial condition of Borrower, on FINOVA's standard form;
P. Blocked Account and/or other Account Agreements. The Blocked Account
and other accounts referred to in Section 2.10(c) hereof shall have been
established to the satisfaction of FINOVA in its sole discretion;
Q. Environmental Assessment. If required by FINOVA, Borrower shall have
caused a Phase I Environmental Assessment to be conducted on the property or
properties owned or occupied by Borrower, all at Borrower's own expense and the
results of such assessment(s) shall have been in form and substance satisfactory
to FINOVA in its sole discretion. Such assessment(s) shall have included, in
FINOVA's discretion, core samplings, and shall have been conducted by an
environmental engineer acceptable to FINOVA;
16
<PAGE>
R. Environmental Certificate. FINOVA shall have received an
Environmental Certificate from Borrower, in form and substance satisfactory to
FINOVA in its discretion, with respect to all locations of Collateral;
S. Search and References. FINOVA shall have received and approved the
results of (i) UCC, tax lien, litigation, judgment, and bankruptcy searches, and
(ii) customer, vendor and credit reference checks, each with respect to
Borrower, members of the management of Borrower and other Loan Parties (as
determined by FINOVA);
T. No Material Adverse Changes. Prior to the Closing Date, there shall
have occurred no material adverse change in the financial condition, operations,
assets or business of Borrower, or in the condition of the Collateral, from that
shown on the most recent financial statements for Borrower, including, without
limitation, the Prepared Financials. At the closing, Borrower shall deliver to
FINOVA an officer's certification confirming that Borrower is unaware of the
existence of any such material adverse change;
U. Projections. Borrower shall submit cash flow projections and pro
forma balance sheet with adjusting entries (i) showing that the proposed
financing will provide sufficient funds for the Borrower's projected working
capital needs, and (ii) showing: (1) that the Borrower will have reasonably
sufficient capital for the conduct of its business following the initial
funding, and (2) that the Borrower will not incur debts beyond its ability to
pay such debts as they mature;
V. Pending Litigation. FINOVA shall have received and found acceptable,
in its sole discretion, information and documents pertaining to all pending
litigation to which Borrower is a party as of the Closing Date.
W. Material Agreements. FINOVA shall have received, reviewed and
approved (i) all material agreements to which Borrower shall be a party, and
(ii) all Provider Agreements and Payor and account debtor contracts and
certifications, including, but not limited to, managed care Payors, commercial
Payors, Medicare, Medicaid and CHAMPUS, to the extent applicable;
X. Healthcare Regulatory Matters. FINOVA shall have reviewed and found
acceptable, in its sole discretion, all healthcare regulatory matters affecting
Borrower and the Receivables, including, without limitation: (i) copies of all
Medicare and Medicaid cost reports for the last three years, and information as
to whether any costs reports of Borrower (under previous ownership or otherwise)
have been audited by the relevant Governmental Authority, (ii) copies of the
most recent Department of Health Survey and Plan of Corrections Reports, and
(iii) evidence of compliance with healthcare related laws and licensure for the
operation of each facility of Borrower including, without limitation,
certificates of need, evidence of licensure, and evidence of JCAHO accreditation
(if applicable).
Y. Closing Date Compliance Certificate. FINOVA shall have received a
Compliance Certificate from the Chief Financial Officer of Borrower showing
Borrower's compliance with each of the financial covenants set forth in Section
6.1.13 of this Agreement, as of the Closing Date.
Z. Opinions. To the extent any Person other than Borrower shall be
parties to the Loan Documents, FINOVA reserves the right to require satisfactory
opinions of counsel for each such Person concerning the proper organization of
such Person and the due authorization, execution, delivery, enforceability,
validity and binding effect of the Loan Documents to which such Person is a
party. Each such opinion of counsel shall confirm, to the satisfaction of
FINOVA, that the opinion is being delivered to FINOVA at the instruction of the
party represented by such counsel, that FINOVA is entitled to rely on such
opinion and that for purposes of such reliance, FINOVA is deemed to be in
privity with the opining counsel;
AA. ADA Compliance. As of the Closing Date, with respect to each
property leased or occupied by Borrower involving a "public accommodation"
within the meaning of the Americans with Disabilities Act of 1990 ("ADA"), each
such property is and shall be in compliance with the provisions of the ADA to
the extent applicable to such property leased or occupied by Borrower;
BB. Subordination and Intercreditor Agreements. FINOVA and each
Subordinating Creditor shall have entered into a Subordination Agreement, in
form and substance satisfactory to FINOVA. Without limiting the generality of
the foregoing, Seller shall enter into one or more Subordination Agreements with
FINOVA, in form and substance satisfactory to FINOVA, providing that Seller's
right to payments in respect of the Seller Subordinated Indebtedness shall be
subordinated in right of payment to the Loan;
17
<PAGE>
CC. Stock Pledge. Community Medical Transport, Inc., as pledgor ("Stock
Pledgor") under separate Stock Pledge Agreements of even date herewith ("Stock
Pledge Agreements") shall have executed and delivered the Stock Pledge
Agreements, pledging in favor of FINOVA all of the issued and outstanding common
capital stock of (i) Community Ambulette Service, Inc.; (ii) First Help
Ambulance and Ambulette, Inc.; (iii) Empire Ambulance and Ambulete, Inc.; (iv)
Century Ambulance and Ambulette, Inc.; (v) Richards/Decker Operating Company,
Inc.; (vi) Elite Ambulance and Medical Coach, Inc.; (vii) Hudson Valley Meddtex,
Inc.; (viii) Clove Professional Services, Inc.; (ix) Consolidated Collections,
Inc.; and (x) Richards/Decker Payroll Company, Inc. FINOVA shall be in
possession on the Closing Date of original stock certificates evidencing the
shares of stock so pledged to FINOVA, and of undated stock Powers and
Assignments Apart from Certificate, executed in blank by Stock Pledgors with
respect to all such shares;
DD. Employment and Non-compete Agreements. FINOVA shall have reviewed
and approved all employment and non-compete agreements to be in effect as of the
Closing Date between Borrower and any employee of Borrower;
EE. Asset Appraisal. Borrower shall have provided to FINOVA, at
Borrower's sole cost and expense, an asset appraisal of all Borrower's fixed
assets upon which FINOVA shall be granted a first priority lien and security
interest, which appraisal must be acceptable to FINOVA in all respects;
FF. Transaction Costs. Borrower shall provide to FINOVA a complete,
itemized summary of all transaction costs paid or incurred by any Person in
connection with the making of the Loan and the consummation of the Acquisition,
which transaction costs shall not exceed the amount set forth in the Schedule,
as well as appropriate documentation evidencing such costs and the payment
thereof. All such information must be acceptable to FINOVA, in FINOVA's sole
discretion, exercised in good faith;
GG. Schedule Conditions. Borrower shall have complied with all
additional conditions precedent as set forth in the Schedule attached hereto;
and
HH. Other Matters. All other documents and legal matters in connection
with the transactions contemplated by this Agreement shall have been delivered,
executed and recorded and shall be in form and substance satisfactory to FINOVA
and its counsel, including without limitation, each of the documents listed on
the Document Checklist.
4.2 Subsequent Advances. The obligation of FINOVA to make any advance
shall be subject to the further conditions precedent that, on and as of the date
of such advance: (a) the representations and warranties of Borrower set forth in
this Agreement shall be accurate, before and after giving effect to such advance
or issuance and to the application of any proceeds thereof; (b) no Event of
Default and no event which, with notice or passage of time or both, would
constitute an Event of Default has occurred and is continuing, or would result
from such advance or issuance or from the application of any proceeds thereof;
(c) no material adverse change has occurred in the Borrower's business,
operations, financial condition, in the condition of the Collateral, or other
assets of Borrower or in the prospect of repayment of the Obligations; and (d)
FINOVA shall have received such other approvals, opinions or documents as FINOVA
shall reasonably request.
5. GENERAL REPRESENTATIONS AND WARRANTIES.
Borrower represents and warrants that:
5.1 Due Organization. It is a corporation, limited liability company or
partnership duly organized, validly existing and in good standing under the laws
of the State set forth on the Schedule, is qualified and authorized to do
business and is in good standing in all states in which such qualification and
good standing are necessary in order for it to conduct its business and own its
property, and has all requisite power and authority to conduct its business as
presently conducted, to own its property and to execute and deliver each of the
Loan Documents to which it is a party and perform all of its Obligations
thereunder, and has not taken any steps to wind-up, dissolve or otherwise
liquidate its assets;
5.2 Other Names. Borrower has not, during the preceding five (5) years,
been known by or used any other corporate or fictitious name except as set forth
on the Schedule, nor has Borrower been the surviving corporation of a merger or
consolidation or acquired all or substantially all of the assets of any Person
during such time;
5.3 Due Authorization. The execution, delivery and performance by
Borrower of the Loan Documents to which it is a party have been authorized by
all necessary corporate, limited liability company or partnership action and do
not and shall not constitute a violation of any applicable law or of Borrower's
Articles or Certificate of Incorporation or By-Laws, Operating Agreement,
Partnership Agreement, or other organizational or governing documents, as
applicable, or any other document, agreement or instrument to which Borrower is
a party or by which Borrower or its assets are bound;
18
<PAGE>
5.4 Binding Obligation. Each of the Loan Documents to which Borrower is
a party is the legal, valid and binding obligation of Borrower enforceable
against Borrower in accordance with its terms;
5.5 Intangible Property. Borrower possesses adequate assets, licenses,
patents, patent applications, copyrights, trademarks, trademark applications and
trade names for the present and planned future conduct of its business without
any known conflict with the rights of others, and each is valid and has been
duly registered or filed with the appropriate governmental authorities; each of
Borrower's patents, patent applications, copyrights, trademarks and trademark
applications which have been registered or filed with any governmental authority
(including the U.S. Patent and Trademark Office and the Library of Congress) are
listed by name, date and filing number on the Schedule or other Loan Documents;
5.6 Capital. Borrower has capital sufficient to conduct its business, is
able to pay its debts as they mature, and owns property having a fair salable
value greater than the amount required to pay all of its debts (including
contingent debts);
5.7 Material Litigation. Borrower has no pending or overtly threatened
litigation, actions or proceedings which would materially and adversely affect
its business, assets, operations, prospects or condition, financial or
otherwise, or the Collateral or any of FINOVA's interests therein;
5.8 Title; Security Interests of FINOVA. Borrower has good, indefeasible
and merchantable title to the Collateral and, upon the execution and delivery of
the Loan Documents, the filing of UCC-1 Financing Statements, delivery of the
certificate(s) evidencing any pledged securities, the filing of any collateral
assignments or security agreements regarding Borrower, Trademarks, Copyrights,
Licenses and/or Patents, if any, with the appropriate governmental offices and
the recording of any mortgages or deeds of trust with respect to real property,
and the recording of motor vehicle liens, in each case in the appropriate
offices, this Agreement and such documents shall create valid and perfected
first priority liens in the Collateral, subject only to Permitted Encumbrances;
5.9 Restrictive Agreements; Labor Contracts. Borrower is not a party or
subject to any contract or subject to any charge, corporate restriction,
judgment, decree or order materially and adversely affecting its business,
assets, operations, prospects or condition, financial or otherwise, or which
restricts its right or ability to incur Indebtedness, and it is not party to any
labor dispute. In addition, no labor contract is scheduled to expire during the
Initial Term of this Agreement, except as disclosed to FINOVA in writing prior
to the date hereof;
5.10 Laws. Neither Borrower nor any Subsidiary of Borrower is in
violation of any applicable statute, regulation, ordinance or any order of any
court, tribunal or governmental agency, in any respect materially and adversely
affecting the Collateral or its business, assets, operations, prospects or
condition, financial or otherwise;
5.11 Consents. Borrower has obtained or caused to be obtained or issued
any required consent of a governmental agency or other Person in connection with
the financing contemplated hereby;
5.12 Defaults. Borrower is not in default with respect to any note,
indenture, loan agreement, mortgage, lease, deed or other material agreement to
which it is a party or by which it or its assets are bound (including, without
limitation, the Subordinated Debt), nor has any event occurred which, with the
giving of notice or the lapse of time, or both, would cause such a default;
5.13 Financial Condition. The Prepared Financials fairly present
Borrower's financial condition and results of operations and those of such other
Persons described therein as of the date thereof in accordance with GAAP; there
are no material omissions from the Prepared Financials or other facts or
circumstances not reflected in the Prepared Financials; and there has been no
material and adverse change in such financial condition or operations since the
date of the initial Prepared Financials delivered to FINOVA hereunder;
5.14 ERISA. None of Borrower, any ERISA Affiliate, or any Plan is or has
been in violation of any of the provisions of ERISA, any of the qualification
requirements of IRC Section 401(a) or any of the published interpretations
thereunder, nor has Borrower or any ERISA Affiliate received any notice to such
effect. No notice of intent to terminate a Plan has been filed under Section
4041 of ERISA, nor has any Plan been terminated under ERISA. The PBGC has not
instituted proceedings to terminate, or appointed a trustee to administer, a
Plan. No lien upon the assets of Borrower has arisen with respect to a Plan. No
prohibited transaction or Reportable Event has occurred with respect to a Plan.
Neither Borrower nor any ERISA Affiliate has incurred any withdrawal liability
with respect to any Multiemployer Plan. Borrower and each ERISA Affiliate have
made all contributions required to be made by them to any Plan or Multiemployer
Plan when due. There is no accumulated funding deficiency in any Plan, whether
or not waived;
19
<PAGE>
5.15 Taxes. Borrower has filed all tax returns and such other reports as
it is required by law to file and has paid or made adequate provision for the
payment on or prior to the date when due of all taxes, assessments and similar
charges that are due and payable;
5.16 Locations; Federal Tax ID No. Borrower's chief executive office and
the offices and locations where it keeps the Collateral (except for Collateral
in transit) are only at the locations set forth on the Schedule, except to the
extent that such locations may have been changed after written notice to FINOVA
in accordance with Section 9.12 hereof; Borrower's federal tax identification
number is as shown on the Schedule;
5.17 Business Relationships. There exists no actual or threatened
termination, cancellation or limitation of, or any modification or change in,
the business relationship between Borrower and any Payor or any group of Payors
whose unpaid claims individually or in the aggregate are material to the
business of Borrower, or with any material supplier, and there exists no present
condition or state of facts or circumstances which would materially and
adversely affect Borrower or prevent Borrower from conducting such business
after the consummation of the transactions contemplated by this Agreement in
substantially the same manner in which it has heretofore been conducted; and
5.18 Millennium Compliance. Borrower has taken all action necessary to
assure that there will be no material adverse change to Borrower's business by
reason of the advent of the year 2000, including, without limitation, that all
computer-based systems, embedded microchips and other processing capabilities
effectively recognize and process dates after April 1, 1999, except for personal
office computers and network stations which will be compliant by October 1,
1999.
5.19 Healthcare Representations and Warranties.
A With respect to each Receivable, as of the date such Receivable
is created and included as an Eligible Receivable by FINOVA:
(1) All documents and agreements relating to the Receivable
requested by FINOVA have been delivered to FINOVA with respect to such
Receivable and such documents are true and correct in all material respects;
Borrower has timely and properly billed the applicable Payor of the Receivable
(except where supporting claim documents must be forwarded to such Payor before
a bill may be submitted in which case Borrower shall promptly complete
documentation and billing of such Payors), and Borrower has delivered or caused
to be delivered to such Payor all Payor requested supporting claim documents
with respect to such Receivable including all documentation required by the
applicable Payor(s) for payment on the Receivable, and the statutory period for
issuing an explanation of benefits ("EOB") in connection with such Receivable
has not expired; and all information set forth in the bill and supporting claim
documents submitted to a Payor with respect to such Receivable is true, complete
and correct in all material respects, and, if additional information is
requested by such Payor in connection therewith, Borrower will promptly provide
the same and, if necessary, will rebill or, if requested by the primary servicer
(if other than Borrower) cooperate with such servicer(s) to rebill such
Governmental Receivable;
(2) Each such Receivable is exclusively owned by Borrower, and
there is no security interest in or lien against such Receivable in favor of any
third party other than FINOVA, nor is there any recording or filing against
Borrower, as debtor, covering or purporting to cover any interest of any kind in
any Receivable, except as has been or will be released or terminated by each
party holding such adverse interest in the Receivable prior to or concurrently
with the initial Loan made by FINOVA to Borrower. Borrower shall defend the
first priority security interest of FINOVA in all Receivables against the claims
of all persons claiming any interest adverse to FINOVA. With respect to any
Governmental Receivable the rights transferred to FINOVA in connection with this
Agreement do not include the right to claim payment in FINOVA's name from the
applicable Payor or the right to direct such Payor to remit payment directly to
FINOVA except as permitted by applicable laws and regulations governing such
Governmental Receivables;
(3) Each such Receivable (A) is payable, in an amount not less
than its Expected Net Receivable, by the Payor identified by Borrower as being
obligated with respect to such Receivable, (B) is based on an actual and bona
fide rendition of services or sale of goods to a patient by Borrower in the
ordinary course of its business, (C) is denominated and payable only in lawful
currency of the United States, and (D) is an "account" within the meaning of the
Uniform Commercial Code of the state in which the services or goods were
provided or sold to the patient by Borrower and in which Borrower has its
principal place of business, or is a right to payment under a policy of
insurance or the proceeds thereof, and is not evidenced by an instrument or
chattel paper unless specifically identified in writing to FINOVA; and there is
no Payor other than the applicable Payor identified by Borrower as the Payor
primarily liable, on any such Receivable;
20
<PAGE>
(4) No such Receivable is (A) subject to any audit, action, suit,
proceeding or dispute (pending or threatened), set-off, counterclaim, defense,
abatement, suspension, deferment, deductible, reduction or termination by the
Payor (except as described in the Schedule), or (B) with respect to each
Receivable for which FINOVA has advanced an amount greater than $10, within
fewer than ninety (90) days prior to, or past, the statutory limit for
collection applicable to the Payor;
(5) Borrower does not have any guaranty of, letter of credit
providing credit support for, or collateral security for, such Receivable, other
than any such guaranty, letter of credit or collateral security as has been
assigned to FINOVA, and any such guaranty, letter of credit or collateral
security is not subject to any lien in favor of any other person;
(6) To the best of Borrower's knowledge and belief the goods or
services provided and creating such Receivable were medically necessary for the
patient, and the patient has received such goods or services;
(7) Where required by applicable law or contract, the fees
charged for the goods or services constituting the basis for such Receivable are
(a) consistent with the usual, customary and reasonable fees charged by other
similar medical service providers in Borrower's community or the community in
which the patient resides, whichever is less, of the same or similar service by
Borrower or (b) pursuant to negotiated fee contracts, or imposed fee schedules,
with or by the applicable Payors;
(8) No action by Borrower or any Loan Party other than the
execution and delivery of this Agreement and the other Loan Documents, the
issuance and delivery of any required Payor Notices (in a form approved by
FINOVA), the filing of UCC financing statements in the State in which the
Borrower's principal place of business and chief executive office is located,
and the delivery to FINOVA of any original instrument or chattel paper is
required to perfect the first priority security interest of FINOVA in such
Receivable, and all such actions have been or will be accomplished no later than
the date of the initial Loan advance by FINOVA;
(9) Each such Receivable complies, in all material respects which
would affect the timely collectibility of such receivable, with all laws and
regulations applicable thereto;
(10) No such Receivable represents services or goods furnished or
provided to or on behalf of any subsidiary, parent, or other entity or any
Person affiliated with Borrower, and there is no Payor, other than as designated
by Borrower, that is primarily liable on such Receivable;
(11) The Payor with respect to each such Receivable is (A) not
currently the subject of any bankruptcy, insolvency or receivership proceeding,
nor is it unable to make payments on its obligations when due, (B) located in
the United States, and (C) one of the following: (x) a party which in the
ordinary course of its business or activities agrees to pay for healthcare
services or goods received by individuals, including, without limitation,
commercial insurance companies and non-profit insurance companies (such as Blue
Cross and Blue Shield entities) issuing health, personal injury, worker's
compensation or other types of insurance, employers or unions which self- insure
for employee or member health insurance, prepaid healthcare organizations,
preferred provider organizations, health maintenance organizations, group
purchasing organizations, management/administrative service organizations,
health care providers or any other similar persons, or (y) a Payor of the type
described in the definition of Governmental Receivables;
(12) The insurance policy, contract or other instrument
obligating a Payor to make payment with respect to each such Receivable (A)
except with respect to a Governmental Receivable, does not contain any provision
prohibiting the transfer of such payment obligation from the patient to
Borrower, (B) has been duly authorized and, together with such Receivable,
constitutes the legal, valid and binding obligation of the Payor in accordance
with its terms, (C) together with the applicable Receivable, does not contravene
in any material respect any requirement of law applicable thereto, and (D) was
in full force and effect at the time the services or goods rendered to the
patient constituting the basis for such Receivable were performed;
(13) Fees for services or goods which are subject to limitations
imposed by contracts for reimbursement from the related Payor, or applicable
law, do not exceed the limitations imposed thereunder, and each Receivable for
which the fees are so restricted has been clearly identified to FINOVA as being
subject to such restriction;
21
<PAGE>
(14) Except as limited in the case of Governmental Receivables:
(A) Borrower has the right to pledge, collaterally assign and grant a security
interest in each such Receivable to FINOVA pursuant to this Agreement; (B) no
consent from the related Payor or any other person is required to create or
perfect the first priority security interest granted in favor of FINOVA in any
Receivable pursuant to this Agreement; and (C) such grant of a security interest
to FINOVA in each such Receivable has been made in good faith by Borrower and
without intent to hinder, delay or defraud present or future creditors of
Borrower, and will constitute a valid and binding first priority security
interest in such Receivable enforceable against Borrower any Loan Party and all
creditors of and purchasers from Borrower senior and prior to all other
assignments, liens or pledges thereof. With respect to Governmental Receivables,
Borrower shall retain all rights of collection with respect thereto, subject to
the provisions of the Depository Agreement;
(15) There are no proceedings or investigations in which Borrower
is named as party or any other proceedings or investigations pending or
threatened before any Governmental Authority or any arbitration or similar
proceedings under any contract (A) asserting the invalidity of such Receivable
or any contract related thereto, (B) seeking the payment of such Receivable or
any contract related thereto, or (C) seeking any determination or ruling that
might materially and adversely affect the validity or enforceability of such
Receivable or any contract related thereto;
(16) No Receivable or contract related thereto contravenes in any
material respect any federal, state or local law, rule or regulation applicable
thereto (including, without limitation, the Social Security Act and the rules
and regulations of HCFA under the Social Security Act, other federal and state
laws and regulations pertaining to Medicare, Medicaid and other health care
financing programs laws, rules and regulations relating to usury, consumer
protection, truth in lending, fair credit billing, fair credit reporting, equal
credit opportunity, fair debt collection practices and privacy), and no party to
such related contract to the best of Borrower's knowledge is in violation of any
such law, rule or regulation in any material respect;
(17) All descriptions of such Receivable provided to FINOVA on
behalf of Borrower remain true and correct and do not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the descriptions of or statements made therein not misleading; and
If a breach of any of the representations or warranties contained herein
relating to a Receivable may, in the Permitted Discretion of FINOVA, have a
material adverse effect upon the validity, legality or collectibility of such
Receivable then, such Receivable shall no longer be deemed, an "Eligible
Receivable", as defined in Section 1.1 hereof.
B. Borrower has obtained all Medicare and Medicaid certifications
necessary and accreditations to operate its business as now conducted, and
currently is and has been at all times in the last five (5) years in compliance
with all Medicare and Medicaid statutory and regulatory requirements, including,
but not limited to:
(1) the Medicare Program Integrity Requirements of 42 C.F.R. 420
et. seq.;
(2) the requirements under the Conditions for Medicare Payment as
described in 42 C.F.R. 424 et. seq., as applicable;
(3) the requirements under the Medicare Conditions for
Participation of Home Health Agencies, as described in 42 U.S.C. 484 et. seq.;
(4) the requirements for Medicare Provider Agreements and
Supplier Approval, as described in 42 C.F.R. 489 et. seq.;
(5) the Medicaid Program Integrity requirements of 42 C.F.R. 455
et. seq. as implemented by the state Medicaid agency in each State in which
Borrower conduct(s) business;
(6) the requirements for Medicaid provider agreements required by
42 C.F.R. 431.107 as implemented by the State Medicaid agency in each State in
which Borrower conducts business; and
(7) the requirements under the Medicare provisions governing
hospice care, as described in 42 U.S.C. 418 et. seq.
22
<PAGE>
C. Borrower has all Medicare and Medicaid provider number(s), supplier
billing number(s) and Medicare and/or Medicaid provider and/or participation
agreements necessary to submit reimbursement claims to Medicare and/or Medicaid
for any health care activity in which it is currently engaged; all of which are
described fully and accurately on Exhibit A to the Schedule; and Borrower has
not allowed or permitted or authorized any Person other than Borrower to use any
such number or agreement.
D. Borrower is not currently subject to, and has never been subject to,
suspension, revocation or denial of its Medicare and Medicaid certification,
provider number, supplier billing number or termination of its Medicare and
Medicaid provider and/or participation agreement(s).
E. Borrower is not currently nor has in the past been subject to:
(1) any state or local governmental investigation, inspection or
inquiry related to any license or licensure standards applicable to Borrower;
(2) any federal, state, local governmental or private Payor civil
or criminal investigations, inquiries or audits involving and/or related to any
federal, state or private Payor health care fraud and abuse provisions or
contractual prohibition of health care fraud and abuse; or
(3) any federal, state or private Payor inquiry, investigation,
inspection or audit regarding Borrower or its activities, including without
limitation, any federal, state or private Payor inquiry or investigation of any
Person having "ownership, financial or control interest" in Borrower (as that
term is defined in 42 C.F.R. 420.201 et. seq.) involving and/or related to
health care fraud and abuse, false claims under 31 U.S.C. 3729-3731 or any
similar contractual prohibition, or any qui tam action brought pursuant to 31
U.S.C. 3729 et. seq.
(4) No owner, officer, manager, employee or Person with a "direct
or indirect ownership interest" in Borrower as those terms are defined in 42
C.F.R. 420.201):
(5) ad a civil monetary penalty assessed against him or her
pursuant to 42 U.S.C. 1320a- 7a;
(6) has been excluded from participation in a Federal Health Care
Program (as that term is defined in 42 U.S.C. 1320a-7b);
(7) has been convicted (as that term is defined in 42 C.F.R.
1001.2) of any of those offenses described in 42 U.S.C. 1320a-7b or 18 U.S.C.
669, 1035, 1347, 1518, including without limitation any of the following
categories of offenses:
(i) criminal offenses relating to the delivery of an item or
service under any Federal Health Care Program (as that term is defined in 42
U.S.C. 1320a-7b) or health care benefit program (as that term is defined in 18
U.S.C. 24(b);
(ii) criminal offenses under federal or state law relating
to patient neglect or abuse in connection with the delivery of a health care
item or service;
(iii) criminal offenses under federal or state law relating
to fraud and abuse, theft, embezzlement, false statements to third parties,
money laundering, kickbacks, breach of fiduciary responsibility or other
financial misconduct in connection with the delivery of a health care item or
service or with respect to any act or omission in a program operated by or
financed in whole or in part by any federal, state or local governmental agency;
(iv) federal or state laws relating to the interference with
or obstruction of any investigations into any criminal offenses described in (i)
through (iv) above; or
(v) criminal offenses under federal or state law relating to
the unlawful manufacturing, distribution, prescription or dispensing of a
controlled substance; or
(8) has been involved or named in a U.S. Attorney complaint made
or any other action taken pursuant to the False Claims Act under 31 U.S.C. 3729-
3731 or qui tam action brought pursuant to 31 U.S.C. 3729 et. seq.
F. Borrower is and shall continue to be in compliance with all
applicable laws relating to its relationships with physicians.
G. Borrower is and shall continue to be in compliance with all laws,
rules, regulations, orders, decrees and directions of any Governmental Authority
(including, without limitation, the Social Security Act, as amended, the rules
and regulations promulgated by HCFA), and any state laws applicable to the
Receivables, any contracts relating thereto or any other Collateral, or
otherwise applicable to its business and properties, a violation of which could
materially adversely affect its ability to collect it's Receivables or repay the
Obligations.
23
<PAGE>
H. Borrower (1) has all material permits, licenses, accreditations,
registrations, certifications, authorizations, approvals, consents and
agreements of all Payors, accreditation agencies, provider and any other Person,
necessary or required for Borrower to own the assets that it now owns, to carry
on its business as now conducted, to execute, deliver and perform its
Obligations under the Loan Documents, and to receive payments on Receivables
from the applicable Payors; and (2) has not been notified by any such Payor,
accreditation agency, provider or any other Person, during the 24 month period
immediately preceding the date of this Agreement, that such Person has
suspended, revoked or denied renewal, or intends to do so, with respect to any
such permit, license, accreditation, certification, authorization, approval,
consent or provider agreement or other contract granted by it to Borrower or to
which it and Borrower are parties.
I. Borrower has all necessary federal, state and local licenses,
permits, registrations, certifications and other approvals required to conduct
the health care activity in which it is currently engaged; and any Person that
provides any health care services for or on behalf of Borrower (either as an
employee or independent contractor) holds the required federal, state and local
licenses that are necessary to legally perform such services and are not
suspended or limited in any way; and Borrower is in good standing with the
respective governmental, quasi-governmental and other third party Payors and
regulatory agencies that now or hereafter are expected to be involved in such
health care activities.
J. All persons providing care for or on behalf of Borrower (either as an
employee or independent contractor) are licensed.
K. None of Borrower's state and local licenses, permits, registrations,
certifications and other approvals relating to providing health care services
and other services provided by Borrower have been suspended, revoked, limited or
denied renewal.
5.20 Reaffirmations. Each request for a Loan made by Borrower pursuant
to this Agreement shall constitute (i) an automatic representation and warranty
by Borrower to FINOVA that there does not then exist any Event of Default and
(ii) a reaffirmation as of the date of said request and each Loan advance of all
of the representations and warranties of Borrower contained in this Agreement
and the other Loan Documents.
6. COVENANTS.
6.1 Affirmative Covenants. Borrower covenants that, so long as any
Obligation remains outstanding and this Agreement is in effect, it shall:
A. Taxes. File all tax returns and pay or make adequate provision for
the payment of all taxes, assessments and other charges on or prior to the date
when due;
B. Notice of Litigation. Promptly notify FINOVA in writing of any
litigation, suit or administrative proceeding which may materially and adversely
affect the Collateral or Borrower's business, assets, operations, prospects or
condition, financial or otherwise, whether or not the claim is covered by
insurance;
C. ERISA. Notify FINOVA in writing (i) promptly upon the occurrence of
any event described in Paragraph 4043 of ERISA, other than a termination,
partial termination or merger of a Plan or a transfer of a Plan's assets and
(ii) prior to any termination, partial termination or merger of a Plan or a
transfer of a Plan's assets;
D. Change in Location. Notify FINOVA in writing forty-five (45) days
prior to any change in the location of Borrower's chief executive office or the
location of any Collateral, or Borrower's opening or closing of any other place
of business;
E. Entity Existence. Maintain its corporate, limited liability company
or partnership entity existence and its qualification to do business and good
standing in all states necessary for the conduct of its business and the
ownership of its property and maintain adequate assets, licenses, patents,
copyrights, trademarks and trade names for the conduct of its business;
F. Labor Disputes. Promptly notify FINOVA in writing of any labor
dispute to which Borrower is or may become subject and the expiration of any
labor contract to which Borrower is a party or bound;
G. Violations of Law. Promptly notify FINOVA in writing of any violation
of any law, statute, regulation or ordinance of any governmental entity, or of
any agency thereof, applicable to Borrower which may materially and adversely
affect the Collateral or Borrower's business, assets, prospects, operations or
condition, financial or otherwise;
H. Defaults. Notify FINOVA in writing within five (5) Business Days of
Borrower's default under any note, indenture, loan agreement, mortgage, lease or
other agreement to which Borrower is a party or by which Borrower is bound
(including, without limitation, the Subordinated Debt), or of any other default
under any Indebtedness of Borrower;
24
<PAGE>
I. Capital Expenditures. Promptly notify FINOVA in writing of the making
of any Capital Expenditure materially affecting Borrower's business, assets,
prospects, operations or condition, financial or otherwise, except to the extent
permitted in the Schedule;
J. Books and Records. Keep adequate records and books of account with
respect to its business activities in which proper entries are made in
accordance with GAAP, reflecting all of its financial transactions;
K. Leases; Warehouse Agreements. Provide FINOVA with (i) copies of all
agreements between Borrower and any landlord or warehouseman or bailee which
owns any premises at which any Collateral may, from time to time, be located
(whether for processing, storage or otherwise), and (ii) without limiting the
landlord, bailee and/or mortgagee waivers to be provided pursuant to Section
4.1(k) hereof, additional landlord, bailee and/or mortgagee waivers, in form
acceptable to FINOVA with respect to all locations where any Collateral is
hereafter located;
L. Additional Documents. At FINOVA's request, promptly execute or cause
to be executed and delivered to FINOVA any and all documents, instruments or
agreements deemed necessary by FINOVA to facilitate the collection of the
Obligations or the Collateral or otherwise to give effect to or carry out the
terms or intent of this Agreement or any of the other Loan Documents. Without
limiting the generality of the foregoing, if any of the Receivables (other than
Medicare or Medicaid Receivables) with a face value in excess of $5,000 arises
out of a contract with the United States of America or any department, agency,
subdivision or instrumentality thereof, Borrower shall promptly notify FINOVA of
such fact in writing and shall execute any instruments and take any other action
required or requested by FINOVA to comply with the provisions of the Federal
Assignment of Claims Act;
M. Financial Covenants. Comply with the financial covenants set forth on
the Schedule.
N. Millennium Compliance. Borrower shall take all action necessary to
assure that there will be no material adverse change to Borrower's business by
reason of the advent of the year 2000, including without limitation that all
computer-based systems, embedded microchips and other processing capabilities
effectively recognize and process dates after April 1, 1999, except for personal
office computers and network stations which will be compliant by October 1,
1999. At FINOVA's request, Borrower shall provide to FINOVA assurance reasonably
acceptable to FINOVA that Borrower's computer-based systems, embedded microchips
and other processing capabilities are year 2000 compatible.
O. Healthcare Covenants.
(1) Furnish to FINOVA within five (5) days of receipt a copy of
any healthcare related licensure and annual or biannual certification survey
report and any statement of deficiencies and any survey (other than the annual
or biannual survey) indicating a violation or deficiency, and within the time
period required by the particular agency for submission, a copy of the plan of
correction with respect thereto if such plan of correction is required by such
agency issuing the statement of deficiency or notice of violation, and correct
or cause to be corrected any deficiency or violation within the time period
required for cure by such agency, subject to such agency's normal appeal
process, if such deficiency or violation could adversely affect either the right
to continue participation in Medicare, Medicaid or their reimbursement programs
for existing patients or the right to admit new Medicare patients, Medicaid
patients or other reimbursement program patients or result in the loss or
suspension of Borrower's licenses and permits to operate Borrower's business;
(2) Furnish to FINOVA within five (5) days of the receipt by the
Borrower, any and all notices disclosing and adverse finding from any licensing,
certifying and/or reimbursement agencies that Borrower's license, Medicare or
Medicaid certification or provider status or entitlement to payments pursuant to
any reimbursement contract or program of Borrower is being downgraded to a
substandard category, revoked, or suspended, or that action is pending or being
considered to downgrade to a substandard category, revoke, or suspend any rights
pursuant to the Borrower's license, certification or reimbursement contract or
program;
(3) Furnish to FINOVA within five (5) days of the date of the
required filing of cost reports of Borrower with Medicaid, Medicare or other
applicable Governmental Authority or its intermediary or pursuant to any
reimbursement contract or program, or the date of actual filing of such cost
report of Borrower, whichever is earlier, a complete and accurate copy of the
annual Medicaid, Medicare and other cost reports for Borrower, which will be
prepared by an independent certified public accountant or by an experienced cost
report preparer acceptable to FINOVA, and promptly furnish to FINOVA any
amendments filed with respect to such reports and all responses, audit reports
or inquiries with respect to such reports;
25
<PAGE>
(4) Maintain a corporate health care regulatory compliance
program ("CCP") which includes the following components and allows FINOVA and/or
any outside consultants from time to time to review Borrower's CCP:
(5) standards of conduct and procedures that describe Borrower's
compliance policies regarding federal, state and local laws with an emphasis on
prevention of fraud and abuse;
(6) specific officer within high-level personnel of Borrower's
organization identified as having overall responsibility for compliance of
Borrower with such standards and procedures;
(7) training and education programs which effectively communicate
the compliance standards and procedures to employees and agents, including,
without limitation, fraud and abuse laws and illegal billing practices;
(8) auditing and monitoring systems and reasonable steps for
achieving compliance of Borrower with such standards and procedures, including,
without limitation, publicizing a report system to allow employees and other
agents to anonymously report criminal or suspect conduct and potential
compliance problems;
(9) disciplinary guidelines and consistent enforcement of
compliance policies including, without limitation, discipline of individuals
responsible for the failure to detect violations of Borrower's CCP;
(10) mechanisms to immediately respond to detected violations of
Borrower's CCP.
P. Promptly notify FINOVA in the event of any action, suit, proceeding,
dispute, offset, deduction, settlement, defense or counterclaim that is or may
be asserted by a Payor with respect to any material Receivable (except for
denials of Governmental Receivables which shall be disclosed on a monthly basis
by Borrower to FINOVA). This Section does not require Borrower to provide a
notice of denial to FINOVA in those cases where Borrower reasonably believes
that a Payor's notice of denial will be reversed upon the submission of
supplemental information to the Payor;
Q. Make all payments to the applicable Payor necessary to prevent such
Payor from offsetting any earlier overpayment to Borrower against any amount the
Payor may owe on any Receivables;
R. Continue to (i) maintain all state and local licenses, permits,
registrations and certifications required to conduct any health care activity in
which Borrower is engaged, (ii) maintain Medicare and Medicaid provider status;
and
S. Cause the operation of Borrower to be conducted at all times in a
prudent manner in compliance with applicable laws and regulations relating
thereto and cause all licenses, permits, certificates of need, reimbursement
contracts and programs, and any other agreements as may be necessary for
participation in Medicaid, Medicare, and other applicable reimbursement programs
to remain in effect.
6.2 Negative Covenants. Without FINOVA's prior written consent, which
consent FINOVA may withhold in its sole discretion, so long as any Obligation
remains outstanding and this Agreement is in effect, Borrower shall not:
A. Mergers. Merge or consolidate with or acquire any other Person, or
make any other material change in its capital structure or in its business or
operations which might adversely affect the repayment of the Obligations;
B. Loans. Make advances, loans or extensions of credit to, or invest in,
any Person;
C. Dividends. Declare or pay cash dividends upon any of its stock or
ownership interests or distribute any of its property or redeem, retire,
purchase or acquire directly or indirectly any of its stock or ownership
interests;
D. Adverse Transactions. Enter into any transaction which materially and
adversely affects the Collateral or its ability to repay the Obligations in full
as and when due;
E. Guarantee or become directly or contingently liable for the
Indebtedness of any Person, except by endorsement of instruments for deposit and
except for the existing guarantees made by Borrower prior to the date hereof, if
any, which are set forth in the Schedule;
26
<PAGE>
F. Repurchase. Make a sale to any customer on a bill-and-hold,
guaranteed sale, sale and return, sale on approval, consignment, or any other
repurchase or return basis;
G. Name. Use any corporate or fictitious name other than its corporate
name as set forth in its Articles or Certificate of Incorporation on the date
hereof or as set forth on the Schedule;
H. Prepayment. Prepay any Indebtedness other than trade payables and
other than the Obligations;
I. Capital Expenditure. Make or incur any Capital Expenditure if, after
giving effect thereto, the aggregate amount of all Capital Expenditures by
Borrower in any fiscal year would exceed the amount set forth on the Schedule;
J. Pay total compensation, including salaries, withdrawals, fees,
bonuses, commissions, drawing accounts and other payments, whether directly or
indirectly, in money or otherwise, during any fiscal year to all of Borrower's
executives, officers and directors (or any relative thereof) in an amount in
excess of the amount set forth in the Schedule;
K. Indebtedness. Create, incur, assume or permit to exist any
Indebtedness (including Indebtedness in connection with Capital Leases) in
excess of the amount set forth on the Schedule, other than (i) the Obligations,
(ii) trade payables and other contractual obligations to suppliers and customers
incurred in the ordinary course of business, and (iii) other Indebtedness
existing on the date of this Agreement and reflected in the Prepared Financials
(except Indebtedness paid on the date of this Agreement from proceeds of the
initial advances hereunder), and (iv) Subordinated Debt;
L. Affiliate Transactions. Except as set forth below, sell, transfer,
distribute or pay any money or property to any Affiliate, or invest in (by
capital contribution or otherwise) or purchase or repurchase any stock or
Indebtedness, or any property, of any Affiliate, or become liable on any
guaranty of the indebtedness, dividends or other obligations of any Affiliate.
Notwithstanding the foregoing, Borrower may pay compensation permitted by
Section 6.2.10 to employees who are Affiliates and, if no Event of Default has
occurred, Borrower may (i) engage in transactions with Affiliates in the normal
course of business, in amounts and upon terms which are fully disclosed to
FINOVA and which are no less favorable to Borrower than would be obtainable in a
comparable arm's length transaction with a Person who is not an Affiliate, and
(ii) make payments to a Subordinating Creditor that is an Affiliate, subject to
and only to the extent expressly permitted in the Subordination Agreement
between such Subordinating Creditor and FINOVA;
M. Nature of Business. Enter into any new business or make any material
change in any of Borrower's business objectives, purposes or operations;
N. Use the name of FINOVA in connection with any of Borrower's business
or activities, except in connection with internal business matters or as
required in dealings with governmental agencies and financial institutions or
with trade creditors of Borrower, solely for credit reference purposes;
O. Margin Security. Borrower will not (and has not in the past) engaged
principally, or as one of its important activities, in the business of extending
credit for the purpose of purchasing or carrying margin stock (within the
meaning of Regulation G or Regulation U issued by the Board of Governors of the
Federal Reserve System), and no proceeds of any Loan or other advance will be
used to purchase or carry any margin stock or to extend credit to others for the
purpose of purchasing or carrying any margin stock, or in any manner which might
cause such Loan or other advance or the application of such proceeds to violate
(or require any regulatory filing under) Regulation G, Regulation T, Regulation
U, Regulation X or any other regulation of the Board of Governors of the Federal
Reserve System, in each case as in effect on the date or dates of such Loan or
other advance and such use of proceeds. Further, no proceeds of any Loan or
other advance will be used to acquire any security of a class which is
registered pursuant to Section 12 of the Securities Exchange Act of 1934.
P. Purchase or acquire any real property without FINOVA's prior written
consent, a condition of which consent shall include delivery of appropriate
environmental reports and analysis, in form and substance satisfactory to FINOVA
and its counsel.
27
<PAGE>
7. DEFAULT AND REMEDIES.
7.1 Events of Default. Any one or more of the following events shall
constitute an Event of Default under this Agreement:
A. Borrower fails to pay when due and payable any portion of the
Obligations at stated maturity, upon acceleration or otherwise;
B. Borrower or any other Loan Party fails or neglects to perform, keep,
or observe any Obligation including, but not limited to, any term, provision,
condition, covenant or agreement contained in any Loan Document to which
Borrower or such other Loan Party is a party;
C. Any material adverse change occurs in Borrower's business, assets,
operations, prospects or condition, financial or otherwise;
D. The prospect of repayment of any portion of the Obligations or the
value or priority of FINOVA's security interest in the Collateral is materially
impaired;
E. Any material portion of Borrower's assets is seized, attached,
subjected to a writ or distress warrant, is levied upon or comes into the
possession of any judicial officer;
F. Borrower shall generally not pay its debts as they become due or
shall enter into any agreement (whether written or oral), or offer to enter into
any agreement, with all or a significant number of its creditors regarding any
moratorium or other indulgence with respect to its debts or the participation of
such creditors or their representatives in the supervision, management or
control of the business of Borrower;
G. Any bankruptcy or other insolvency proceeding is commenced by
Borrower or Guarantor, or any such proceeding is commenced against Borrower or
Guarantor and remains undischarged or unstayed for thirty (30) days;
H. Any notice of lien, levy or assessment is filed of record with
respect to any of Borrower's assets;
I. Any judgments are entered against Borrower in an aggregate amount
exceeding that are not covered by insurance and all such judgments shall not
have been satisfied, stayed or bonded pending appeal within thirty (30) days
from the entry thereof, provided that all rights of execution on any attachment
or judgment lien or other action by such judgment creditor against Borrower and
the Collateral have been discharged or stayed;
J. Any default shall occur under (i) any material agreement between
Borrower and any third party including, without limitation, any default which
would result in a right by such third party to accelerate the maturity of any
Indebtedness of Borrower to such third party or (ii) the Subordinated Debt;
K. Any representation or warranty made or deemed to be made by Borrower,
any Affiliate or any other Loan Party in any Loan Document or any other
statement, document or report made or delivered to FINOVA in connection
therewith shall prove to have been misleading in any material respect;
L. Any Guarantor dies, breaches, violates, defaults, terminates or
attempts to terminate its Guaranty or any security therefor or becomes subject
to any bankruptcy or other insolvency proceeding; or the Guaranty is terminated
by the Guarantor for any reason, or is terminated as set forth in the Guaranty;
or any Loan Party breaches or violates, terminates or attempts to terminate any
Validity and Support Agreement delivered in connection herewith;
M. Any Prohibited Transaction or Reportable Event shall occur with
respect to a Plan which could have a material adverse effect on the financial
condition of Borrower; any lien upon the assets of Borrower in connection with
any Plan shall arise; Borrower or any of its ERISA Affiliates shall fail to make
full payment when due of all amounts which Borrower or any of its ERISA
Affiliates may be required to pay to any Plan or any Multiemployer Plan as one
or more contributions thereto; Borrower or any of its ERISA Affiliates creates
or permits the creation of any accumulated funding deficiency, whether or not
waived;
N. Any suit is filed against Borrower which, if adversely determined,
could substantially impair the ability of Borrower to perform each and every one
of its obligations under the Loan Documents and Borrower fails to answer such
suit and diligently prosecute the defense of such suit;
O. Any transfer of the issued and outstanding shares of common stock or
other evidence of Ownership of Borrower or election of the Board of Directors
which would constitute a Change in Control of the Borrower;
28
<PAGE>
P. Borrower ceases to do business or terminates its business;
Q. termination of the contract with any Payor which represents a
material portion of Borrower's Receivables;
R. Borrower has issued a Revocation Order to Borrower's Bank under the
Depository Account Agreement or has failed to remit any misdirected payments or
other monies paid by any Payor with respect to any of the Receivables to FINOVA
inconsistent with the rights of FINOVA hereunder;
S. A final revocation of the Certificate of Need or the Medicare or
Medicaid (or any successor programs) Provider Agreements held by Borrower;
NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, FINOVA RESERVES
THE RIGHT TO CEASE MAKING ANY LOANS IF AN EVENT OF DEFAULT HAS OCCURRED.
T. Borrower fails to obtain surety bonds in the minimum required amount
in order to comply with (i) Medicare program requirements or (ii) submit such
sure bonds to HCFA and/or the state Medicaid agency on or before the applicable
deadline date, and thereafter on an annual basis or as otherwise required by
HCFA and/or the proper state Medicare agency, in order the proper state Medicaid
agency, in order to avoid termination of Borrowers provider agreements;
7.2 Remedies. Upon the occurrence of an Event of Default, FINOVA may, at
its option and in its sole discretion and in addition to all of its other rights
under the Loan Documents, cease making Loans,, terminate this Agreement and
declare all of the Obligations to be immediately payable in full. Borrower
agrees that FINOVA shall also have all of its rights and remedies under
applicable law, including, without limitation, the default rights and remedies
of a secured party under the Code, and upon the occurrence of an Event of
Default Borrower hereby consents to the appointment of a receiver by FINOVA in
any action initiated by FINOVA pursuant to this Agreement and to the
jurisdiction and venue set forth in Section 9.26 hereof, and Borrower waives
notice and posting of a bond in connection therewith. Further, FINOVA may, at
any time, take possession of the Collateral and keep it on Borrower's premises,
at no cost to FINOVA, or remove any part of it to such other place(s) as FINOVA
may desire, or Borrower shall, upon FINOVA's demand, at Borrower's sole cost,
assemble the Collateral and make it available to FINOVA at a place reasonably
convenient to FINOVA. FINOVA may sell and deliver any Collateral at public or
private sales, for cash, upon credit or otherwise, at such prices and upon such
terms as FINOVA deems advisable, at FINOVA's discretion, and may, if FINOVA
deems it reasonable, postpone or adjourn any sale of the Collateral by an
announcement at the time and place of sale or of such postponed or adjourned
sale without giving a new notice of sale. Borrower agrees that FINOVA has no
obligation to preserve rights to the Collateral or marshall any Collateral for
the benefit of any Person. FINOVA is hereby granted a license or other right to
use, without charge, Borrower's labels, patents, copyrights, name, trade
secrets, trade names, trademarks and advertising matter, or any similar
property, in completing production, advertising or selling any Collateral and
Borrower's rights under all licenses and all franchise agreements shall inure to
FINOVA's benefit. Any requirement of reasonable notice shall be met if such
notice is mailed postage prepaid to Borrower at its address set forth in the
heading to this Agreement at least five (5) days before sale or other
disposition. The proceeds of sale shall be applied, first, to all attorneys'
fees and other expenses of sale, and second, to the Obligations in such order as
FINOVA shall elect, in its sole discretion. FINOVA shall return any excess to
Borrower and Borrower shall remain liable for any deficiency to the fullest
extent permitted by law.
7.3 Standards for Determining Commercial Reasonableness. Borrower and
FINOVA agree that the following conduct by FINOVA with respect to any
disposition of Collateral shall conclusively be deemed commercially reasonable
(but other conduct by FINOVA, including, but not limited to, FINOVA's use in its
sole discretion of other or different times, places and manners of noticing and
conducting any disposition of Collateral shall not be deemed unreasonable): Any
public or private disposition: (i) as to which on no later than the fifth
calendar day prior thereto written notice thereof is mailed or personally
delivered to Borrower and, with respect to any public disposition, on no later
than the fifth calendar day prior thereto notice thereof describing in general
non-specific terms, the Collateral to be disposed of is published once in a
newspaper of general circulation in the county where the sale is to be conducted
(provided that no notice of any public or private disposition need be given to
the Borrower or published if the Collateral is perishable or threatens to
decline speedily in value or is of a type customarily sold on a recognized
market); (ii) which is conducted at any place designated by FINOVA, with or
without the Collateral being present; and (iii) which commences at any time
between 8:00 a.m. and 5:00 p.m. Without limiting the generality of the
foregoing, Borrower expressly agrees that, with respect to any disposition of
accounts, instruments and general intangibles, it shall be commercially
reasonable for FINOVA to direct any prospective purchaser thereof to ascertain
directly from Borrower any and all information concerning the same, including,
but not limited to, the terms of payment, aging and delinquency, if any, the
financial condition of any obligor or account debtor thereon or guarantor
thereof, and any collateral therefor.
29
<PAGE>
8. EXPENSES AND INDEMNITIES
8.1 Expenses. Borrower covenants that, so long as any Obligation remains
outstanding and this Agreement remains in effect, it shall promptly reimburse
FINOVA for all costs, fees and expenses incurred by FINOVA in connection with
the negotiation, preparation, execution, delivery, administration and
enforcement of each of the Loan Documents, including, but not limited to, the
attorneys' and paralegals' fees of in-house and outside counsel, expert witness
fees, lien, title search and insurance fees, appraisal fees, all charges and
expenses incurred in connection with any and all environmental reports and
environmental remediation activities, and all other costs, expenses, taxes and
filing or recording fees payable in connection with the transactions
contemplated by this Agreement, including without limitation all such costs,
fees and expenses as FINOVA shall incur or for which FINOVA shall become
obligated in connection with (i) any inspection or verification of the
Collateral, (ii) any proceeding relating to the Loan Documents or the
Collateral, (iii) actions taken with respect to the Collateral and FINOVA's
security interest therein, including, without limitation, the defense or
prosecution of any action involving FINOVA and Borrower or any third party, (iv)
enforcement of any of FINOVA's rights and remedies with respect to the
Obligations or Collateral and (v) consultation with FINOVA's attorneys and
participation in any workout, bankruptcy or other insolvency or other proceeding
involving any Loan Party or any Affiliate, whether or not suit is filed or the
issues are peculiar to federal bankruptcy or state insolvency laws. Borrower
shall also pay all FINOVA charges in connection with bank wire transfers,
forwarding of loan proceeds, deposits of checks and other items of payment,
returned checks, establishment and maintenance of lockboxes and other Blocked
Accounts, and all other bank and administrative matters, in accordance with
FINOVA's schedule of bank and administrative fees and charges in effect from
time to time;
8.2 Environmental Matters. The Environmental Certificate dated on or
about the date of this Agreement is incorporated herein for all purposes as if
fully stated in this Agreement.
9. MISCELLANEOUS.
9.1 Examination of Records; Financial Reporting.
A. Examinations. FINOVA shall at all reasonable times have full access
to and the right to examine, audit, make abstracts and copies from and inspect
Borrower's records, computer data, files, books of account and all other
documents, instruments and agreements relating to the Collateral and the right
to check, test and appraise the Collateral (consistent with the State and
Federal laws regarding patient confidentiality) and the rules of JCAHO. Borrower
shall deliver to FINOVA any instrument necessary for FINOVA to obtain records
from any service bureau maintaining records for Borrower. All instruments and
certificates prepared by Borrower showing the value of any of the Collateral
shall be accompanied, upon FINOVA's request, by copies of related purchase
orders and invoices and records relating to the applications of collections of
receivables (including misdirected payments). FINOVA may, at any time after the
occurrence of an Event of Default, remove from Borrower's premises Borrower's
books and records (or copies thereof) or require Borrower to deliver such books
and records or copies to FINOVA. FINOVA may, without expense to FINOVA, use such
of Borrower's personnel, supplies and premises as may be reasonably necessary
for maintaining or enforcing FINOVA's security interest.
B. Reporting Requirements. Borrower shall furnish FINOVA, upon request,
such information and statements as FINOVA shall request from time to time
regarding Borrower's business affairs, financial condition and the results of
its operations. Without limiting the generality of the foregoing, Borrower shall
provide FINOVA with:
(i) on a weekly basis, FINOVA's standard form collateral and loan
report, together with accounts receivable certifications and notice of
assignment documents on a daily basis or as described in the Schedule, together
with cash receipt and revenue reports;
(ii) upon FINOVA's request, copies of sales journals, cash receipt
journals, deposit slips, copies of service invoices, customer statements and
credit memoranda issued, remittance advices and reports, evidence of billing and
copies of shipping and delivery documents;
(iii) within five (5) days of the date due (or earlier if available) all
cost reports (interim and annual) from all Governmental Authorities or other
Persons, as applicable;
(iv) within ten (10) days after the end of each month, (1) monthly
agings (aged from service date) and reconciliations of Receivables (with
listings of concentrated accounts and reconciliations to collateral reports),
and (2) monthly agings (aged from invoice date) of accounts payable, with
outstanding and held check registers;
(v) within thirty (30) days after the end of each month, unaudited
financial statements with respect to the prior month prepared on a basis
consistent with such statements prepared in prior months and otherwise in
accordance with GAAP;
30
<PAGE>
(vi) within thirty (30) days after the end of each quarter, unaudited
financial statements with respect to the prior quarter prepared on a basis
consistent with such statements prepared in prior quarters and otherwise in
accordance with GAAP;
(vii) audited annual consolidated and consolidating financial
statements, prepared in accordance with GAAP applied on a basis consistent with
the most recent Prepared Financials provided to FINOVA by Borrower, including
balance sheets, income and cash flow statements, accompanied by the unqualified
report thereon of independent certified public accountants acceptable to FINOVA,
together with the Management letter, in the form provided to the auditors and
shareholders of Borrower, as soon as available, and in any event, within ninety
(90) days after the end of each of Borrower's fiscal years;
(viii) at least ninety (90) days prior to the end of each fiscal year of
Borrower, annual operating budgets (including income statements, balance sheets
and cashflow statements, by month) for the upcoming fiscal year of Borrower; and
(ix) such certificates relating to the foregoing as FINOVA may request,
including, without limitation, a quarterly certificate from the president or the
chief financial officer of Borrower ("Compliance Certificate") showing
Borrower's compliance with each of the financial covenants set forth in this
Agreement, and stating whether any Event of Default has occurred or event which,
with giving of notice or the passage of time, or both, would constitute an Event
of Default, and if so, the steps being taken to prevent or cure such Event of
Default, and such other certificates relating to the reporting requirements set
forth in this Section 9.1 as FINOVA shall request. All reports or financial
statements submitted by Borrower shall be in reasonable detail and shall be
certified by the principal financial officer of Borrower as being complete and
correct.
C. Guarantor's Financial Statements and Tax Returns. Borrower shall
cause each of the Guarantors to deliver to FINOVA such Guarantor's annual
financial statement (in form acceptable to FINOVA) and a copy of such
Guarantor's federal income tax return with respect to the corresponding year, in
each case on the date when such tax return is due or, if earlier, on the date
when available.
9.2 Term; Termination.
A. Term. The initial term of this Agreement shall be as set forth on the
Schedule (the "Initial Term") and shall be automatically renewed for successive
periods of one (1) year (each, a "Renewal Term"), unless earlier terminated as
provided herein.
B. Prior Notice. Each party shall have the right to terminate this
Agreement effective at the end of the Initial Term or at the end of any Renewal
Term by giving the other party written notice not less than sixty (60) days
prior to the effective date of such termination, by registered or certified
mail.
C. Payment in Full. Upon the effective date of termination, the
Obligations shall become immediately due and payable in full in cash.
D. Early Termination; Termination Fee. In addition to the procedure set
forth in Section 9.2(b), Borrower may terminate this Agreement at any time but
only upon sixty (60) days' prior written notice and prepayment of the
Obligations. Upon any such early termination by Borrower or any termination of
this Agreement by FINOVA upon the occurrence of an Event of Default, then, and
in any such event, Borrower shall pay to FINOVA upon the effective date of such
termination a fee (the "Termination Fee") in an amount equal to the amount shown
on the Schedule.
9.3 Recourse to Security; Certain Waivers. All Obligations shall be
payable by Borrower as provided for herein and, in full, at the termination of
this Agreement; recourse to security shall not be required at any time. Borrower
waives presentment and protest of any instrument and notice thereof, notice of
default and, to the extent permitted by applicable law, all other notices to
which Borrower might otherwise be entitled.
9.4 No Waiver by FINOVA. Neither FINOVA's failure to exercise any right,
remedy or option under this Agreement, any supplement, the Loan Documents or
other agreement between FINOVA and Borrower nor any delay by FINOVA in
exercising the same shall operate as a waiver. No waiver by FINOVA shall be
effective unless in writing and then only to the extent stated. No waiver by
FINOVA shall affect its right to require strict performance of this Agreement.
FINOVA's rights and remedies shall be cumulative and not exclusive.
9.5 Binding on Successor and Assigns. All terms, conditions, promises,
covenants, provisions and warranties shall inure to the benefit of and bind
FINOVA's and Borrower's respective representatives, successors and assigns.
9.6 Severability. If any provision of this Agreement shall be prohibited
or invalid under applicable law, it shall be ineffective only to such extent,
without invalidating the remainder of this Agreement.
31
<PAGE>
9.7 Amendments; Assignments. This Agreement may not be modified, altered
or amended, except by an agreement in writing signed by Borrower and FINOVA.
Borrower may not sell, assign or transfer any interest in this Agreement or any
other Loan Document, or any portion thereof, including, without limitation, any
of Borrower's rights, title, interests, remedies, powers and duties hereunder or
thereunder. Borrower hereby consents to FINOVA's participation, sale,
assignment, transfer or other disposition, at any time or times hereafter, of
this Agreement and any of the other Loan Documents, or of any portion hereof or
thereof, including, without limitation, FINOVA's rights, title, interests,
remedies, powers and duties hereunder or thereunder. In connection therewith,
FINOVA may disclose all documents and information which FINOVA now or hereafter
may have relating to Borrower or Borrower's business. To the extent that FINOVA
assigns its rights and obligations hereunder to a third party, FINOVA shall
thereafter be released from such assigned obligations to Borrower and such
assignment shall effect a novation between Borrower and such third party.
9.8 Integration. This Agreement, together with the Schedule (which is a
part hereof) and the other Loan Documents, reflect the entire understanding of
the parties with respect to the transactions contemplated hereby.
9.9 Survival. All of the representations and warranties of Borrower
contained in this Agreement shall survive the execution, delivery and acceptance
of this Agreement by the parties. No termination of this Agreement or of any
guaranty of the Obligations shall affect or impair the powers, obligations,
duties, rights, representations, warranties or liabilities of the parties hereto
and all shall survive such termination.
9.10 Evidence of Obligations. Each Obligation may, in FINOVA's
discretion, be evidenced by notes or other instruments issued or made by
Borrower to FINOVA. If not so evidenced, such Obligation shall be evidenced
solely by entries upon FINOVA's books and records.
9.11 Loan Requests. Each request for a loan shall be in writing and
shall be made by any Person who purports to be any employee, officer or
authorized agent of Borrower shall be made to FINOVA on or prior to 10:00 a.m.,
Chicago time, on the Business Day on which the proceeds thereof are requested to
be paid to Borrower and shall be conclusively presumed to be made by a Person
authorized by Borrower to do so and the crediting of a loan to Borrower's
operating account shall conclusively establish Borrower's obligation to repay
such loan. Unless and until Borrower otherwise directs FINOVA in writing, all
loans shall be wired to Borrower's operating account set forth on the Schedule.
9.12 Notices. Any notice required hereunder shall be in writing and
addressed to the Borrower and FINOVA at their addresses set forth at the
beginning of this Agreement. Notices hereunder shall be deemed received on the
earlier of receipt, whether by mail, personal delivery, facsimile, or otherwise,
or upon deposit in the United States mail, postage prepaid.
9.13 Brokerage Fees. Borrower represents and warrants to FINOVA that,
with respect to the financing transaction herein contemplated, no Person is
entitled to any brokerage fee or other commission and Borrower agrees to
indemnify and hold FINOVA harmless against any and all such claims.
9.14 Disclosure. No representation or warranty made by Borrower in this
Agreement, or in any financial statement, report, certificate or any other
document furnished in connection herewith contains any untrue statement of a
material fact or omits to state any material fact necessary to make the
statements herein or therein not misleading. There is no fact known to Borrower
or which reasonably should be known to Borrower which Borrower has not disclosed
to FINOVA in writing with respect to the transactions contemplated by this
Agreement which materially and adversely affects the business, assets,
operations, prospects or condition (financial or otherwise), of Borrower.
9.15 Publicity. FINOVA is hereby authorized to issue appropriate press
releases and to cause a tombstone to be published announcing the consummation of
this transaction and the aggregate amount thereof.
9.16 Captions. The Section titles contained in this Agreement are
without substantive meaning and are not part of this Agreement.
9.17 Injunctive Relief. Borrower recognizes that, in the event Borrower
fails to perform, observe or discharge any of its Obligations under this
Agreement, any remedy at law may prove to be inadequate relief to FINOVA.
Therefore, FINOVA, if it so requests, shall be entitled to temporary and
permanent injunctive relief in any such case without the necessity of proving
actual damages.
9.18 Counterparts; Facsimile Execution. This Agreement may be executed
in one or more counterparts, each of which taken together shall constitute one
and the same instrument, admissible into evidence. Delivery of an executed
counterpart of this Agreement by telefacsimile shall be equally as effective as
delivery of a manually executed counterpart of this Agreement. Any party
delivering an executed counterpart of this Agreement by facsimile shall also
deliver a manually executed counterpart of this Agreement, but the failure to
deliver a manually executed counterpart shall not affect the validity,
enforceability, and binding effect of this Agreement.
32
<PAGE>
9.19 Construction. The parties acknowledge that each party and its
counsel have reviewed this Agreement, have participated jointly in the
negotiations and drafting of this Agreement and hereby agree that the normal
rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of this
Agreement or any amendments or exhibits hereto.
9.20 Time of Essence. Time is of the essence for the performance by
Borrower of the Obligations set forth in this Agreement.
9.21 Limitation of Actions. Borrower agrees that any claim or cause of
action by Borrower against FINOVA, or any of FINOVA's directors, officers,
employees, agents, accountants or attorneys, based upon, arising from, or
relating to this Agreement, or any other present or future agreement, or any
other transaction contemplated hereby or thereby or relating hereto or thereto,
or any other matter, cause or thing whatsoever, whether or not relating hereto
or thereto, occurred, done, omitted or suffered to be done by FINOVA, or by
FINOVA's directors, officers, employees, agents, accountants or attorneys,
whether sounding in contract or in tort or otherwise, shall be barred unless
asserted by Borrower by the commencement of an action or proceeding in a court
of competent jurisdiction by the filing of a complaint within one year after the
first act, occurrence or omission upon which such claim or cause of action, or
any part thereof, is based and service of a summons and complaint on an officer
of FINOVA or any other Person authorized to accept service of process on behalf
of FINOVA, within thirty (30) days thereafter. Borrower agrees that such
one-year period of time is a reasonable and sufficient time for Borrower to
investigate and act upon any such claim or cause of action. The one-year period
provided herein shall not be waived, tolled, or extended except by a specific
written agreement of FINOVA. This provision shall survive any termination of
this Loan Agreement or any other agreement.
9.22 Liability. Neither FINOVA nor any FINOVA Affiliate shall be liable
for any indirect, special, incidental or consequential damages in connection
with any breach of contract, tort or other wrong relating to this Agreement or
the Obligations or the establishment, administration or collection thereof
(including without limitation damages for loss of profits, business
interruption, or the like), whether such damages are foreseeable or
unforeseeable, even if FINOVA has been advised of the possibility of such
damages. Neither FINOVA, nor any FINOVA Affiliate shall be liable for any
claims, demands, losses or damages, of any kind whatsoever, made, claimed,
incurred or suffered by the Borrower through the ordinary negligence of FINOVA,
or any FINOVA Affiliate. "FINOVA Affiliate" shall mean FINOVA's directors,
officers, employees, agents, attorneys or any other Person or entity affiliated
with or representing FINOVA.
9.23 Notice of Breach by FINOVA. Borrower agrees to give FINOVA written
notice of (i) any action or inaction by FINOVA or any attorney of FINOVA in
connection with any Loan Documents that may be actionable against FINOVA or any
attorney of FINOVA or (ii) any defense to the payment of the Obligations for any
reason, including, but not limited to, commission of a tort or violation of any
contractual duty or duty implied by law. Borrower agrees that unless such notice
is fully given as promptly as possible (and in any event within thirty (30)
days) after Borrower has knowledge, or with the exercise of reasonable diligence
should have had knowledge, of any such action, inaction or defense, Borrower
shall not assert, and Borrower shall be deemed to have waived, any claim or
defense arising therefrom.
9.24 Application of Insurance Proceeds. The net proceeds of any casualty
insurance insuring the Collateral, after deducting all costs and expenses
(including attorneys' fees) of collection, shall be applied, at FINOVA's option,
either toward replacing or restoring the Collateral, in a manner and on terms
satisfactory to FINOVA, or toward payment of the Obligations. Any proceeds
applied to the payment of Obligations shall be applied in such manner as FINOVA
may elect. In no event shall such application relieve Borrower from payment in
full of all installments of principal and interest which thereafter become due
in the order of maturity thereof.
9.25 Power of Attorney. Borrower appoints FINOVA and its designees as
Borrower's attorney, with the power to endorse Borrower's name on any checks,
notes, acceptances, money orders or other forms of payment or security that come
into FINOVA's possession; to sign Borrower's name on any invoice or other
document relating to any Receivable, on drafts against Payors, on assignments of
Receivables, on notices of assignment, financing statements and other public
records, on verifications of accounts and on notices to Payors or account
debtors; to send requests for verification of Receivables to Payors or account
debtors; after the occurrence of any Event of Default, to notify the post office
authorities to change the address for delivery of Borrower's mail to an address
designated by FINOVA and to open and dispose of all mail addressed to Borrower;
and to do all other things FINOVA deems necessary or desirable to carry out the
terms of this Agreement. Borrower hereby ratifies and approves all acts of such
attorney. Neither FINOVA nor any of its designees shall be liable for any acts
or omissions nor for any error of judgment or mistake of fact or law while
acting as Borrower's attorney. This power, being coupled with an interest, is
irrevocable until the Obligations have been fully satisfied and FINOVA's
obligation to provide loans hereunder shall have terminated.
33
<PAGE>
9.26 Governing Law; Waivers. THIS AGREEMENT, INCLUDING WITHOUT
LIMITATION ENFORCEMENT OF THE OBLIGATIONS, SHALL BE INTERPRETED IN ACCORDANCE
WITH THE INTERNAL LAWS (AND NOT THE CONFLICT OF LAWS RULES) OF THE STATE OF
ARIZONA GOVERNING CONTRACTS TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. BORROWER
HEREBY CONSENTS TO THE EXCLUSIVE JURISDICTION OF ANY STATE OR FEDERAL COURT
LOCATED WITHIN THE COUNTY OF MARICOPA IN THE STATE OF ARIZONA OR, AT THE SOLE
OPTION OF FINOVA, IN ANY OTHER COURT IN WHICH FINOVA SHALL INITIATE LEGAL OR
EQUITABLE PROCEEDINGS AND WHICH HAS SUBJECT MATTER JURISDICTION OVER THE MATTER
IN CONTROVERSY. BORROWER WAIVES ANY OBJECTION OF FORUM NON CONVENIENS AND VENUE.
BORROWER FURTHER WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT, AND
CONSENTS THAT ALL SUCH SERVICE OF PROCESS BE MADE IN THE MANNER SET FORTH IN
SECTION 9.12 HEREOF FOR THE GIVING OF NOTICE. BORROWER FURTHER WAIVES ANY RIGHT
IT MAY OTHERWISE HAVE TO COLLATERALLY ATTACK ANY JUDGMENT ENTERED AGAINST IT.
9.27 MUTUAL WAIVER OF RIGHT TO JURY TRIAL. FINOVA AND BORROWER EACH
HEREBY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON,
ARISING OUT OF, OR IN ANY WAY RELATING TO: (i) THIS AGREEMENT; (ii) ANY OTHER
PRESENT OR FUTURE INSTRUMENT OR AGREEMENT BETWEEN FINOVA AND BORROWER; OR (iii)
ANY CONDUCT, ACTS OR OMISSIONS OF FINOVA OR BORROWER OR ANY OF THEIR DIRECTORS,
OFFICERS, EMPLOYEES, AGENTS, ATTORNEYS OR ANY OTHER PERSONS AFFILIATED WITH
FINOVA OR BORROWER; IN EACH OF THE FOREGOING CASES, WHETHER SOUNDING IN CONTRACT
OR TORT OR OTHERWISE.
9.28 Lien Termination. In recognition of FINOVA's right to have all of
its attorneys' fees and other expenses incurred in connection with this
Agreement secured by the Collateral, notwithstanding the payment in full of the
Obligations, FINOVA shall not be required to record any terminations or
satisfactions of any of its liens on the Collateral unless and until Borrower
and any other Loan Party (to the extent required by FINOVA) have executed and
delivered to FINOVA general releases of all claims, in form and substance
satisfactory to FINOVA
9.29 Intentionally Omitted.
9.30 Releases; Indemnities.
A. To the fullest extent permitted by applicable law, in consideration
of FINOVA's entering into this Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which Borrower hereby
acknowledges, Borrower, on its own behalf and on behalf of its successors
(including, without limitation, any receiver or trustee acting on behalf of
Borrower and any debtor-in-possession with respect to Borrower), assigns,
subsidiaries and Affiliates (collectively, the "Releasors"), hereby forever
release, discharge and acquit FINOVA and its parents, subsidiaries,
shareholders, Affiliates, partners, trustees, officers, employees, directors,
agents and attorneys and their respective successors, heirs and assigns
(collectively, the "Releasees") from any and all claims, demands, liabilities,
responsibilities, disputes, causes, damages, actions and causes of actions
(whether at law or in equity) indebtedness and obligations (collectively,
"Claims") of every type, kind, nature, description or character, including,
without limitation, any so-called "lender liability" claims or defenses, and
irrespective of how, why or by reason of what facts, whether such Claims have
heretofore arisen, are now existing or hereafter arise, or which could, might or
be claimed to exist, of whatever kind or nature, whether known or unknown,
suspected or unsuspected, liquidated or unliquidated, matured or unmatured,
fixed or contingent, each as though fully set forth herein at length, which may
in any way arise out of, are connected with or in any way relate to actions or
omissions which occurred on or prior to the date hereof with respect to
Borrower, this Agreement, the Obligations, any Collateral, the Prior Agreements,
any other Loan Document and any third parties liable in whole or in part for the
Obligations. This provision shall survive and continue in full force and effect
whether or not Borrower shall satisfy all other provisions of this Agreement or
the Loan Documents including payment in full of the Obligations.
B. Each of the Releasors further agrees to indemnify the Releasees and
hold the Releasees harmless from and against any and all such Claims (as such
term is defined in the immediately preceding paragraph) which may be brought
against any of the Releasees on behalf of any entity or Person, including,
without limitation, officers, directors, agents, trustees, creditors, partners
or shareholders of any of the Releasors, whether threatened or initiated,
asserting any claim for legal or equitable remedy under any statutes, regulation
or common law principle arising from or in connection with the negotiation,
preparation, execution, delivery, performance, administration and enforcement of
this Agreement or any other Loan Document, the Obligations, any Collateral or
the Prior Agreements. The foregoing indemnity shall survive the payment in full
of the Obligations and the termination of this Agreement and the other Loan
Documents.]
34
<PAGE>
Signature Page to
Loan and Security Agreement
FINOVA CAPITAL CORPORATION BORROWERS:
By: __________________________ Community Medical Transport, Inc.
Vice President
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Community Ambulette Service, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
First Help Ambulance and
Ambulette, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Empire Ambulance and Ambulette,
Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Century Ambulance and Ambulette,
Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Richards/Decker Operating
Company, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Elite Ambulance and Medical
Coach, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
(Signatures continued on following page)
35
<PAGE>
(Signatures continued from previous page)
Hudson Valley Meddtex, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Clove Professional Services, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Consolidated Collections, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
Richards/Decker Payroll Company, Inc.
By: ____________________________
Dean L. Sloane
Chief Executive Officer
36
<PAGE>
SCHEDULE OF SUBSIDIARIES
Exhibit 21
Schedule of Subsidiaries
- --------------------------------------------------------------------------------
State
Name Incorporation % of Ownership
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
Community Ambulette Service, Inc. Delaware 100%
- --------------------------------------------------------------------------------
First Help Ambulance and Ambulette, Inc. New York 100%
- --------------------------------------------------------------------------------
Empire Ambulance and Ambulette, Inc. New York 100%
- --------------------------------------------------------------------------------
Century Ambulance and Ambulette, Inc. New York 100%
- --------------------------------------------------------------------------------
Richards/Decker Operating Company, Inc. New York 100%
- --------------------------------------------------------------------------------
Elite Ambulance and Medical Coach, Inc. New Jersey 100%
- --------------------------------------------------------------------------------
Hudson Valley Meddtex, Inc. New York 100%
- --------------------------------------------------------------------------------
Clove Professional Services, Inc. New York 100%
- --------------------------------------------------------------------------------
Consolidated Collections, Inc. New York 100%
- --------------------------------------------------------------------------------
Richards/Decker Payroll Company, Inc. New York 100%
- --------------------------------------------------------------------------------
<PAGE>
Exhibit 23.01
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the post-effective
amendment of the Registration Statement on Form S-3 to Form SB-2 (33-80338), and
the Registration Statements on Form S-3 (333-11069), Form S-3 (333-26213), Form
S-3 (333-30301), Form S-3 (333-38401), Form S-8 (333-20639) and Form S-8
(333-23793) of our report dated March 25, 1999 on the consolidated financial
statements of Community Medical Transport, Inc. and subsidiaries included in the
1998 Annual Report on Form 10-KSB. We also consent to the reference to our Firm
under the caption "Experts" in the prospectuses.
/s/ Edward Isaacs & Company, LLP
- --------------------------------
New York, New York
April 14, 1999
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> DEC-31-1999
<CASH> (81,000)
<SECURITIES> 0
<RECEIVABLES> 4,561,000
<ALLOWANCES> 1,495,000
<INVENTORY> 0
<CURRENT-ASSETS> 4,661,000
<PP&E> 7,388,000
<DEPRECIATION> 4,731,000
<TOTAL-ASSETS> 12,083,000
<CURRENT-LIABILITIES> 8,226,000
<BONDS> 0
0
0
<COMMON> 1,000
<OTHER-SE> 3,856,000
<TOTAL-LIABILITY-AND-EQUITY> 12,083,000
<SALES> 0
<TOTAL-REVENUES> 15,808,000
<CGS> 0
<TOTAL-COSTS> 17,408,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 674,000
<INCOME-PRETAX> (2,274,000)
<INCOME-TAX> (432,000)
<INCOME-CONTINUING> (1,842,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,842,000)
<EPS-BASIC> (1.81)
<EPS-DILUTED> (1.81)
</TABLE>
